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Executive Summary  
Introduction 
Young people comprise 1.8 billion people, globally. As adolescents (ages 10-19) and youth (ages 15-
24), this population will undergo puberty and may also become sexually active, married, and/or bear 
children, thus requiring access to sexual and reproductive health (SRH) services, including 
contraception. Policy, financial, cultural, social, or privacy barriers often prevent young people from 
using available SRH services in many settings. As a result, young people face special health 
vulnerabilities: in many regions of the world, young women wanting to avoid pregnancy can be up to 
twice as likely as adult women to have an unmet need for modern contraception.  
To eliminate this unmet need, there has been strong emphasis in developing SRH services for youth 
that are both available as well as ‘adolescent/youth-friendly’, as defined by their acceptability, 
accessibility, appropriateness, effectiveness, and efficiency. Public health facilities have traditionally 
been the focus of efforts to implement youth-friendly services; however, for contraceptive services, 
private pharmacies may also be worth exploring.  
By virtue of being outside of the public health system, pharmacies have traditionally been 
overlooked in youth-targeted programming. That said, international guidelines on contraception 
provision indicate that certain contraceptive services (including condoms, daily and emergency 
hormonal contraceptive pills, and injectable contraception) can be provided by trained pharmacy 
personnel. Additionally, in sub-Saharan Africa and Kenya, where this study took place, evidence 
suggests that pharmacies are already a popular contraceptive outlet. Pharmacies would therefore 
appear to be a promising strategy for a new generation of interventions promoting contraception 
access for young people. However, there is a lack of documentation describing young people’s 
experiences obtaining contraception from pharmacies. Additionally, Kenya like many countries 
struggles with pharmacy service quality and illegal activity.  
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Therefore, this dissertation sought to develop an understanding of how pharmacies were currently 
serving as sources of contraception for young people. This would provide a foundation from which 
programmers and health policymakers could effectively strengthen or even expand the role of 
pharmacy outlets in contraceptive service provision. The dissertation had three specific objectives: 
• Objective 1: Develop a comprehensive understanding of the experiences of young people 
worldwide who access contraception through pharmacies 
• Objective 2: Understand the characteristics of young people (age 18-24) in a peri-urban area 
of a Kenyan coastal county who access contraception from pharmacies, and identify 
specifically what qualities make these establishments appealing or unappealing for young 
users 
• Objective 3: Assess the contraception-dispensing practices of pharmacies for young clients 
(age 18-24) in a peri-urban area of a Kenyan coastal county.  
Methods 
This research consists of a systematic literature review (to address Objective 1), which informed a 
mixed methods study (addressing Objectives 2 and 3). The systematic literature review described the 
experiences of young people (aged 25 and below) accessing contraception and other sexual and 
reproductive health commodities (including abortifacients and STI tests) in pharmacies. The 
subsequent mixed methods study took place in Kwale County, Kenya between November 2017 and 
March 2018. Young people aged 18-24 years, pharmacy personnel, and broader pharmacy practice 
stakeholders were included as participants.  
Youth perspectives were captured through six focus group discussions with young community 
members, 18 in-depth interviews with young people who recently purchased contraception from a 
pharmacy, and a cross-sectional survey of 740 randomly-selected young people from the study area. 
Nineteen key informant interviews with pharmacy personnel and six interviews with local, county 
and national level pharmacy stakeholders captured the perspectives of dispensing pharmacy 
personnel and provided broader context on pharmacy practice in Kenya. Finally, four mystery 
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shoppers each visited 50 pharmacies and attempted to purchase a specific contraception (male 
condom, emergency contraception, or injectable contraception). Details of these interactions were 
recorded. 
Qualitative analysis used the Framework Method. Quantitative analysis of survey data consisted of 
descriptive statistics, followed by bivariate log binomial regressions, and a multivariable Poisson 
regression model, with source of contraception (pharmacy or elsewhere) as the dependent variable. 
Results and Discussion 
Objective 1: Experience of young people accessing contraception through pharmacies, worldwide 
Much of the available literature came from high-income settings and focused on the provision of 
emergency contraception (ECP). The review found that pharmacies’ contraception services were 
appreciated by young people for their longer operating hours, accessibility, and speed. Making ECP 
available through pharmacies without prescription did not result in poor health-related behavioural 
outcomes. Additionally, young people were found to be able to appropriately self-screen and use 
contraceptive products. The systematic review also found that young people and pharmacy 
personnel had some reservations about increased access to contraception leading to adverse health 
and behavioural outcomes. These reservations led pharmacy personnel to deny access to young 
people in some cases. 
Objective 2: In Kwale County, who uses pharmacies and why? 
Nearly 60% (154 out of 263) of young people who reported using modern contraception at last sex 
had obtained it from a pharmacy. Male condoms accounted for 72% of contraception used, ECP was 
another 12%. Use of either condoms or ECP at last sex was the strongest predictor of having gone to 
a pharmacy versus any other source, along with living alone. Young people in Kwale County 
appreciated pharmacies for their: convenience, privacy, non-judgmental personnel, speed, and low 
cost. 
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Objective 3: In Kwale County, how are the contraceptive-dispensing practices in pharmacies? 
In pharmacies, contraception (ECP and condoms, especially) was widely and easily available to young 
people without gatekeeping. However, contraception was rarely dispensed with screening or 
counselling from pharmacy personnel. Injectable contraception could be purchased by young people 
as well and even injected on site in some pharmacies. Though initially reticent or embarrassed to 
approach pharmacies, young people appreciated the non-intrusive nature of interactions. That said, 
they were aware of and concerned by reports of illegal activity and inconsistent quality of pharmacy 
services.  
Looking across the findings, this study found that a young person would choose a pharmacy over 
another source when they had a clear idea of a short-acting contraceptive method they wished to 
obtain. Young pharmacy clients might also have a time-sensitive desire for contraception - recent sex 
(for ECP shoppers) or the potential for sex in the near future (condom shoppers). Pharmacy 
purchasers did not desire counselling.  
Pharmacies were an important option for young people for whom sexual activity was not socially 
acceptable. However, the ability to reliably obtain their desired method via a quick, non-judgmental, 
affordable, and private interaction at a location close by made pharmacies appealing for young 
users, generally. Contraception services in pharmacies, therefore, were perceived to be highly 
acceptable and accessible. These service characteristics carried disproportionate appeal for 
individuals choosing their outlet, outweighing variability in other quality measures (appropriateness, 
effectiveness, and equity). 
Conclusions 
This study was initiated to contribute to a limited evidence base surrounding the use of, appeal of, 
and quality of pharmacies as contraceptive outlets to young people in an East-African setting. 
Contraception services have seen important shifts towards bringing services closer to users, through 
task sharing to pharmacy personnel and other providers, promotion of self-care, and international 
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commitments to ensure universal access to SRH services, including family planning.  This study 
provides several short- and long-term recommendations, should Kenya wish to improve on private 
pharmacies as contraception outlets. All of these must be implemented alongside broader, multi-
sectoral efforts to normalize, destigmatize, and empower contraception use among young people. 
Recommendations include: 
• In-service training for registered pharmacy personnel (through short-courses and Continuing 
Professional Development requirements) can dispel concerns around the safety and 
appropriateness of contraception for young people. 
• Enforcement of existing guidelines around pharmacy premises, including requirements to 
display registration certificates, can provide young people with the clean and professional 
environment desired and as well as a way to identify registered providers.  
• Low-cost, contraception-related health education campaigns in pharmacies can provide key 
information to young people and pharmacy personnel alike, while leaflets in a bag and 
digital health campaigns can discreetly offer specific instructions and referrals to young 
purchasers. 
• Sharing responsibility for regulating certain aspects of pharmacy practice to professional 
associations (self-regulation) can improve monitoring and provide needed support to under-
resourced government regulators.  
• Developing a social franchise or accreditation system can provide an opportunity for 
professional associations, government, and even the private sector to play to their 
strengths, and introduce additional self-regulation into an underregulated sector. 
•  Incorporating data from private pharmacies into Kenya’s health management information 
system can provide needed insight into what contraception products and services are used. 
.  
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1 Introduction  
1.1 Adolescent/Youth Sexual and Reproductive Health 
There are more than 1.8 billion young people around the world between the ages of 10 and 24 
(UNFPA, 2014). The United Nations categorizes young people between the ages of 10-19 as 
‘adolescents’, while those 15-24 are ‘youth’ (UNFPA, 2012). Adolescence captures a period of 
significant physical, emotional, and mental evolution, the biological transition of a person from a 
child to an adult (World Health Organization, 2014). ‘Youth’, on the other hand, encapsulates the 
period societal transition of a person from the roles and responsibilities of a child to those of an 
adult. In this period, young people may transition from being dependents in a household to leading a 
household themselves, leaving school, beginning work, and/or starting a family. The period of the 
life course covered by the term ‘youth’ is largely culturally-determined; as such, many countries 
have their own interpretations of ‘youth’, continuing into the mid-30s in some cases (World Health 
Organization, 2014). 
These periods also have important, lifelong implications for health. In addition to the physical and 
mental changes an adolescent undergoes during and after puberty, adolescents can experiment with 
risky health-related behaviours, or develop lifelong positive health habits (World Health 
Organization, 2014). Many people also first explore sex and sexuality as adolescents/youth 
(Bearinger et al., 2007). These are central parts of being human which can be an enhancing part of 
life, and as with all health-related behaviours, initial sexual experiences can shape sexual health and 
wellbeing in the future (International Planned Parenthood Federation, 2011). Being sexually healthy 
requires a positive and respectful approach to sexuality and sexual relationships and includes the 
ability to have pleasurable and safe sexual experiences (World Health Organization, 2006a). Access 
to comprehensive information about sex and sexuality, access to relevant health services, and living 
in an environment that affirms and promotes sexual health for young people are all key factors to 
being sexually healthy (World Health Organization, 2019b).  
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Unfortunately, millions of young people around the world are not provided with the information, 
services, enabling environment, and agency, to be sexually healthy. Globally, deaths related to 
maternal causes (abortion, maternal haemorrhage, maternal sepsis) is the number two killer of 
young women aged 15-19 and number one killer of young women aged 20-24, while HIV/AIDS is a 
top five killer of young men and women aged 20-24 (Patton et al., 2009). An estimated 8.7 million 
young women aged 15 to 24 undergo unsafe abortions each year (Shah and Åhman, 2012). SRH 
challenges impact morbidity as well: unsafe sex and lack of contraception were the top two 
contributors to DALYs for young women aged 15-24 (Gore et al., 2011). 
Ensuring that adolescents/youth have access to key sexual and reproductive health interventions, 
including contraception services, will help to improve these health statistics and provide young 
people with autonomy over their sexual health and wellbeing. Unfortunately, in many settings, it is a 
challenge for them to obtain and use contraception. Data from 61 LMICs have estimated that 33 
million women aged 15-24 have an unmet need for contraception (MacQuarrie, 2014). An additional 
analysis of Demographic and Health Survey (DHS) data from 52 low- and middle-income countries 
(LMICs), found that married and sexually active young women aged 15-24 have a higher unmet need 
for family planning (31%) as compared to women aged 25-49 (23%) (Sedgh et al., 2016). 
For young women aged 15-24 who do use contraception, an analysis of national survey data from 
123 LMICs found that their ‘method mix’ (the distribution of contraceptive users by method 
(MEASURE Evaluation)) is less diverse than that of older women (Ross et al., 2015).  Use of 
‘traditional methods’ of contraception (rhythm and withdrawal) remains more or less constant 
among women of a reproductive age (aged 15-49). However use of modern contraception among 
women aged 15-24 is dominated by short-acting forms of contraception (injectables, pills – daily oral 
contraceptive pills, and emergency contraceptive pills – and condoms) (Ross et al., 2015). Highly 
effective, long-acting reversible contraception (LARCs), which include implants and intrauterine 
devices (IUDs), as well as permanent forms of contraception (male or female sterilization) become 
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more common among women age 25+. Permanent contraception is usually not an appropriate 
option for young women. However, LARC  – which is an appropriate option and is less subject to 
contraceptive failure than other short-acting contraceptive methods – are often not presented as 
options for adolescent/youth users (High-Impact Practices in Family Planning (HIPs), 2015). 
1.2 Youth challenges to obtaining contraception  
For the young people who don’t use contraception, what stops them? Not being married and 
infrequent sex (particularly among sexually active unmarried women) are cited as common reasons 
for non-use among young women (Sedgh et al., 2016). User concerns about side effects or long-term 
health implications also dissuade young users. So, too, might cultural norms stigmatizing premarital 
sex and sexual activity in general or societal or family pressure to produce a child quickly after 
marriage (Reproductive Health Supplies Coalition, 2017, UNFPA, 2014).  
Additional barriers emerge if a young person decides to try to obtain contraception from a health 
care facility. Unaccompanied, underage, married or unmarried young people can be denied service 
based on actual or perceived laws and policies around who can access services without parental or 
spousal consent (High-Impact Practices in Family Planning (HIPs), 2015). Societal or cultural taboos 
often make it untenable for a young person to be observed in a health facility requesting 
contraception, even when laws and policies support their right to services (World Health 
Organization, 2012b, Mazur et al., 2018). Finally, if a young person makes it into a facility, they may 
encounter mistreatment, bias or be denied services altogether by healthcare providers inside 
(Chandra-Mouli et al., 2014). Any combination of these factors dissuade young people from 
accessing needed contraception services from facilities.  
In recognition that health facilities are not meeting the needs of young people, there has been 
strong emphasis in developing SRH services for youth that are not only available, but also 
‘adolescent/youth-friendly’, as defined by their acceptability, accessibility, appropriateness, 
effectiveness, and equity  (World Health Organization, 2012a). Generic characteristics for each of 
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these elements were proposed by WHO (World Health Organization, 2012a) and are reproduced in 
the table below.  
Table 1.1 Generic characteristics of adolescent-friendly health services within WHO-defined 
dimensions of quality 
Reproduced from WHO’s Making health services adolescent friendly: developing national quality 
standards for adolescent friendly health services(World Health Organization, 2012a) 
EQUITABLE: All adolescents, not just some groups of adolescents, are able to obtain the health 
services that are available 
Characteristics 
Policies and procedures are in place that do not restrict the provision of health services.  
Health care providers treat all adolescent clients with equal care and respect, regardless of 
status.  
Support staff treat all adolescent clients with equal care and respect, regardless of status. 
ACCESSIBLE: Adolescents are able to obtain the health services that are available 
Characteristics 
Policies and procedures are in place that ensure that health services are either free or 
affordable to adolescents. 
Point of service delivery has convenient working hours. 
Adolescents are well-informed about the range of reproductive health service available and 
how to obtain them. 
Community members understand the benefits that adolescents will gain by obtaining the health 
services they need, and support their provision. 
Some health services and health-related commodities are provided to adolescents in the 
community by selected community members, outreach workers, and adolescents themselves 
ACCEPTABLE: Adolescents are willing to obtain the health services that are available  
Characteristics 
Policies and procedures are in place that guarantee client confidentiality. 
Point of service delivery ensures privacy. 
Health care providers are non-judgmental, considerate, and easy to relate to. 
Point of service delivery ensures consultations occur in a short waiting time, with or without an 
appointment, and (where necessary) swift referral. 
Point of service delivery has an appealing and clean environment. 
Point of service delivery provides information and education through a variety of channels. 
Adolescents are actively involved in designing, assessing, and providing health services. 
APPROPRIATE: The right health services (i.e. the ones they need) are provided to them 
Characteristics 
The required package of health care is provided to fulfil the needs of all adolescents either at 
the point of service or through referral linkages 
EFFECTIVE: The right health services are provided in the right way, and make a positive 
contribution to their health 
Characteristics 
Health care providers have the right competencies to work with adolescents and to provide 
them with the required health services. 
Health care providers use evidence-based protocols and guidelines to provide health services. 
Health care providers are able to dedicate sufficient time to effectively deal with their 
adolescent clients. 
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The point of health service delivery has the required equipment, supplies, and basic services 
necessary to deliver the required health services. 
There have been many efforts to identify effective strategies for implementing and scaling up youth-
friendly services, as well as efforts to reflect on what hasn’t worked and why (Denno et al., 2015, 
Chandra-Mouli et al., 2015). Stand-alone ‘youth centres’ provide one example of the latter. Youth 
centres vary substantially in their scope of activities; however, many offer some combination of 
recreational, and vocational or developmental services, as well as health services (Zuurmond et al., 
2012). Evaluations of these centres found that they struggled to reach their intended audience. 
Relatively few young people in the centre’s catchment area used them, and those that did were 
often older male youth (or young adults) who used the centres for their recreational purposes rather 
than their health services (Zuurmond et al., 2012). Despite their persistent popularity among 
programmers, from the perspective of encouraging use of SRH services among their target 
population, they were neither effective nor cost effective (Zuurmond et al., 2012, Denno et al., 
2015). 
Additionally, efforts have been made to establish or incorporate ‘youth-friendly’ services into health 
facilities (hospital centres or community-based facilities, including those run by non-governmental 
organizations and private providers) (Tylee et al., 2007). Approaches have varied widely, for example 
creating adolescent-friendly areas (with games and recreational spaces), or training peer counsellors 
(Dick et al., 2006). Others have focused on making the services themselves and those who 
administer them friendlier to young clients: for example, provider trainings, reworking facilities to 
offer more private spaces, and reducing service cost (Dick et al., 2006). 
Multi-component interventions which train providers, make the facilities more youth-friendly, and 
have community-outreach efforts to generate demand have shown promise (Chandra-Mouli et al., 
2015). Generally, however, evaluations of ‘adolescent/youth-friendly’ interventions have found 
mixed results (Denno et al., 2015). One explanation for this (besides a need for additional, rigorous 
evaluations) may be that adolescent/youth-friendly services can continue to suffer from supply-side 
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constraints, for example variable service quality and availability, distance and opening hours, or poor 
provider performance (Hainsworth et al., 2014, UNFPA, 2016a, Pandey et al., 2019). The five youth-
friendly characteristics were developed from WHO’s broader quality of care standards (World Health 
Organization, 2006b), which is to say that services which are ‘youth-friendly’ are providing a 
standard of care which should be available to all clients (Baraitser et al., 2002). It also means that the 
same constraints which make establishing and maintaining quality general health services a 
challenge also apply to youth-friendly services. 
However, as indicated by evaluations of youth-friendly services in Zambia, Nepal and Egypt, 
challenges to youth-friendly service uptake come from outside the health system too. Social and 
community taboos around premarital sex or reproductive health services for unmarried individuals 
continue to influence health-seeking behaviour (or lack thereof) (UNFPA, 2015, Pandey et al., 2019, 
UNFPA, 2016a, Mmari and Magnani, 2003). A young person choosing to go to youth-friendly facility 
still potentially risks being observed by peers and family members, explaining why young people 
consistently identify ‘confidentiality’ and ‘privacy’ as important traits of health services (Baraitser et 
al., 2002, World Health Organization, 2012a, Barden-O’Fallon et al., 2020). It also provides a 
compelling reason why many young people may not be willing to approach a health facility for 
services, even if it is deemed ‘youth-friendly’.  
1.3 Pharmacies as contraception service providers 
In contexts where multilevel barriers (inside and outside facilities) make young people unwilling or 
unable to visit health facilities for contraception services, pharmacies become an appealing alternate 
option. 
The role of the pharmacist within the broader health system is rapidly evolving as pharmacies 
provide needed access to medicine and care in low- and middle-income countries (LMICs) (Wafula et 
al., 2012). As early as 2000, the World Health Organization (WHO) and the International 
Pharmaceutical Federation (FIP) adopted the concept of a ‘seven-star’ pharmacist, whose 
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multifaceted roles within the health system and community included: caregiver, decision-maker, 
communicator, manager, life-long learner, teacher, and leader (Wiedenmayer K et al., 2006). Later, 
the concept of ‘medication therapy management’ integrated trained pharmacy personnel into direct 
health service provision, including them in medication therapy review; developing and reviewing a 
personal medication record and medication-related action plan; and providing consultative, referral, 
and follow-up services (Burns, 2008, National Association of Chain Drug Stores Foundation and 
American Pharmacists Association, 2008). 
A Cochrane review in 2013 described the health impacts of pharmacist-provided services, finding 
that they could positively-impact certain clinical outcomes related to management of non-
communicable diseases and reduce visits to healthcare providers (Pande et al., 2013). However, 
enthusiasm for using pharmacies to expand the reach of health services is tempered with concerns 
about the quality of services provided: two other systematic reviews of the service quality in LMIC 
pharmacies noted concerns around counselling and questioning of clients, inaccurate diagnoses, 
poor referrals, inappropriate medicine sales, and a lack of adherence to prescribing and advising 
protocols (Smith, 2009b, Miller and Goodman, 2016). In many countries, quality across private 
pharmacies is variable, with compliant and qualified pharmacies often indistinguishable from other 
noncompliant establishments offering substandard services. A global study of pharmacy workforce 
capacity, for example, found more pharmacies than pharmacists reported on average in the African 
region as a whole, calling into question whether there is adequate and appropriate supervision of 
these outlets (Bates et al., 2016). 
The expanded scope of pharmacist-provided services extends also to contraception provision. 
Pharmacies have been identified as a frequent first stop for people requiring contraception 
information or services (World Health Organization, 2017a). An analysis of Demographic and Health 
Survey (DHS) data from 57 low- and middle-income countries found that, depending on the region, 
37-41% of modern contraception users obtain their contraception from a private sector provider. In 
22 
 
sub-Saharan Africa, this was 38% - of this more than 45% reported having gone to a private 
specialized drug seller (a category inclusive of pharmacies) (Campbell et al., 2015a). For short-acting 
reversible methods (male and female condoms, diaphragm, foam/jelly, oral contraceptive pills, 
emergency contraception), in all countries private specialized drug sellers were the single most 
popular source, across all categories of public and private service outlets (Campbell et al., 2015a). A 
survey of public and private family planning service outlets in Nigeria, Ethiopia, and the Democratic 
Republic of Congo, found that pharmacies in all three countries had higher availability of oral 
contraception, condoms, and especially emergency contraception than public facilities (Riley et al., 
2018). Injectable contraception was also found to be available in over 60% of pharmacies in both 
Nigeria and Ethiopia.  
WHO has developed recommendations on task sharing to improve access to contraception, which 
specifically include both cadres of pharmacy-personnel: pharmacists (capturing national cadres 
including pharmacists, chemists, clinical pharmacists, community pharmacists) and pharmacy 
workers (capturing the lower national cadres which usually report to pharmacists, including 
pharmacy assistants, pharmacy technician dispensers, pharmacist aides) (World Health Organization, 
2017c). In these recommendations, pharmacists and pharmacy workers were deemed eligible to 
offer a variety of modern contraception services including: contraception counselling, oral 
contraceptive pills (both combined oral contraceptives as well as progesterone-only oral 
contraceptives), emergency contraceptive pills, as well as condoms, barrier methods and 
spermicides. Additionally, pharmacists (and pharmacy workers in specific circumstances) were also 
deemed eligible to deliver injectable contraceptives, provided they received additional training 
(World Health Organization, 2017c). 
The training requirements and competencies of pharmacists and pharmacy workers is country-
specific. Pharmacists are generally university-educated and the International Pharmaceutical 
Federation’s (FIP) definition indicates that pharmacists are “scientifically trained graduate health 
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care professional who is an expert in all aspects of the supply and use of medicines” (WHO Regional 
Office for Europe, 2019). There is more diversity between countries in the cadres which fall under 
the category of ‘pharmacy workers’. A survey of FIP member organizations in 2015-2016 found that, 
generally, pharmacy workers required either a certificate or diploma level training, consisting of 
three or fewer years, and not constituting an academic degree (which pharmacists must have) 
(Koehler and Brown, 2017). In countries which had some form of pharmacy worker cadre, 
responsibilities fell into one of three categories: 1) pharmacy workers were supervised by 
pharmacists; 2) pharmacy workers perform certain activities unsupervised (but in an environment 
regulated by pharmacists); 3) pharmacy workers work independently from and are not supervised by 
pharmacists (Koehler and Brown, 2017). The last scenario was reportedly seen more in LMICs, where 
pharmacy workers providing services could partially offset the inadequate numbers of trained 
pharmacists and health workforce in general.  
1.4 Pharmacies to improve youth access to contraception – a special appeal? 
For the many youth unwilling or unable to access SRH information and contraception from a health 
facility, pharmacy provision - that is, making commodities available either over-the-counter (openly 
accessible at a pharmacy), or behind-the-counter (dispensing contingent on evaluation from a 
pharmacist) - is one strategy that can help to overcome barriers to access. Removing prescription-
only access and allowing contraception dispensing in pharmacies creates more direct access to SRH 
commodities and a new resource for youth.  
National surveys in high-income countries suggest that the results of this expanded access are 
promising: studies from France, Australia, Canada, and the United Kingdom provide clear evidence 
that improving this access results in high utilization among youth (Hobbs et al., 2011a, Marston et 
al., 2005, Moreau et al., 2006a, Moreau et al., 2006b, Soon et al., 2005, Hobbs et al., 2011b). In 
France, for example, increase in ECP use following deregulation was highest for women under 25, 
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though this increase did not come at the expense of the diffusion of other forms of modern 
contraception (Moreau et al., 2006a).   
1.5 Kenya  
 Youth SRH in Kenya 
In Kenya, young people between the ages of 15 and 24 constituted one-fifth of the total population, 
according to the 2009 national census (Kenya National Bureau of Statistics, 2010). The most recent 
Kenya Demographic and Health Survey (KDHS) found that only 37% of 15-19 year old women and 
49% of 20-24 year-old young women who are currently married, and 49% of 15-19 year old women 
and 64% of 20-24 year old young women who are sexually active but not married, are currently 
using any form of modern contraception (Kenya National Bureau of Statistics et al., 2015). Short-
acting modern contraceptive methods – condoms, pills and injectables, especially – are popular 
among both married and unmarried sexually active young women in this age group (Kenya National 
Bureau of Statistics et al., 2015). However, the KDHS notes that, among currently married young 
women, 23.0% of 15-19 year olds and 18.9% of 20-24 year olds still have an unmet need for family 
planning  – both of which are higher than the national estimate of unmet need among all women of 
a reproductive age (15-49), 17.5% (Kenya National Bureau of Statistics et al., 2015).  
In the last twenty years, the Government of Kenya has increasingly emphasized programming among 
young women, starting with the Kenya Adolescent Reproductive Health Policy (2003). This policy 
aimed to double the use of modern contraceptives among four youth aged 15-24 by 2015 (Kenya 
Ministry of Planning and National Development and Kenya Ministry of Health, 2003). Kenya’s 2009 
national guidelines for family planning (FP) also expressly supported provision of FP services for 
adolescents and youth, and recognized pharmacies as a source of counselling and point of sale for 
certain modern methods of contraception (oral contraception, emergency contraception, condoms) 
(Kenya Ministry of Health, 2010). In 2018, while this study was under way, these guidelines were 
updated (Kenya Ministry of Health, 2018). The update included a specific section on the provision of 
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adolescent/youth-friendly contraceptive services. Also in the update, pharmacists and 
pharmaceutical technologists’ roles were expanded in line with recent WHO recommendations and 
included provision of injectable contraception, with a stipulation that they needed to be specifically 
trained to do so (Kenya Ministry of Health, 2018). 
Given the popularity of short-acting modern contraceptive methods with young women and the 
higher unmet need (as compared with other women of a reproductive age) among this age group, 
pharmacy access is an especially interesting strategy for Kenya. There is sporadic evidence indicating 
pharmacies are already popular with young people in Kenya (Oindo, 2002) and used by certain 
groups of young people in particular (an analysis of Kenya’s most recent DHS found that 21.8% of 
sexually active, unmarried adolescents age 15-19 had obtained their modern contraception from a 
pharmacy(World Health Organization, 2016a)).  
 Pharmacies in Kenya 
Pharmacies are the only legally-recognized retail drug outlet in Kenya (unlike other countries which 
may also recognize lower-level ‘drug shops’) (Riley et al., 2017). Under Kenyan regulations, public 
and private pharmacies are legislated under the Pharmacies and Poisons Act, originally published in 
1957 (with subsequent amendments, most recently in 2012) (National Council for Law Reporting, 
1957 (revised 2012), Kenya Ministry of Medical Services and Kenya Ministry of Public Health and 
Sanitation, 2009). The Act covers the development and dispensing of medicines and regulates the 
pharmaceutical practice. It also establishes the Pharmacy and Poisons Board (PPB), the regulatory 
agency for pharmaceutical practice(Kenya Ministry of Health, 2017, National Council for Law 
Reporting, 1957 (revised 2012), United Nations Industrial Development Organization, 2010). 
Accompanying national policies which ‘operationalize’ pharmaceutical practice include Kenya’s 1994 
National Drug Policy (KNDP), succeeded by the National Pharmaceutical Policy of 2008 and most 
recently, a 2012 Sessional Paper No4 on National Pharmaceutical Policy (KNPP) (Kenya Ministry of 
Medical Services and Kenya Ministry of Public Health and Sanitation, 2012). This revised KNPP is 
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meant to govern pharmaceutical practice through 2030. It recognizes the expanding role of the 
pharmacist as a health care provider as well as the rapid growth in the private pharmacy sector, 
acknowledging for the latter, the need for policy and legal frameworks to grow in tandem, to keep 
the sector regulated. 
The Pharmacy and Poisons Board, therefore, has a large mandate. In collaboration with its 
supporting technical arms (for example, the National Quality Control Laboratory), the PPB is tasked 
with registering drugs, conducting pharmacovigilance (allowing for the reporting of substandard 
products, and monitoring adverse reactions), and monitoring local pharmaceutical manufacturers as 
well as importers (United Nations Industrial Development Organization, 2010). Additionally, the PPB 
maintains a Pharmaceutical Inspectorate tasked with not only inspecting incoming drugs at key 
‘Points of Entry’ but also inspecting individual public and private pharmacies. These inspections are 
meant to confirm that pharmacies are in compliance with rules governing everything from the size of 
the physical premises to drug storage, to counterfeit control (Riley et al., 2017). 
Pharmacists and pharmaceutical technologists are the cadre of health workers officially associated 
with pharmaceutical practice in Kenya. Pharmacist training consists of a minimum Bachelor of 
Pharmacy (a four-year degree program); pharmaceutical technologists go through a two-year, 
diploma-level training. Both cadres undergo compulsory internship and registration exam 
requirements prior to entering service (Kenya Ministry of Health, 2017). While practicing, both 
groups are required to renew their license annually, which can be done online. Additionally, both 
groups have Continuing Professional Development requirements – in recent years, the professional 
associations for each group (the Pharmaceutical Society of Kenya (PSK) for pharmacists, and the 
Kenya Pharmaceutical Association (KPA) for pharmaceutical technologists) have coordinated CPD 
programs for their professionals (Kenya Ministry of Medical Services and Kenya Ministry of Public 
Health and Sanitation, 2013).  
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In 2013, there were 2532 registered pharmacists and 5236 registered pharmaceutical technologists, 
nationwide(Kenya Ministry of Health, 2014). 2014 numbers estimated that there were .512 
pharmacists per 10,000 persons in Kenya (World Health Organization, 2019a). Pharmacy personnel 
and private pharmacies are predominantly based in urban areas and can be few and far between in 
rural or remote parts of Kenya (International Finance Corporation, 2019, Kenya Ministry of Medical 
Services and Kenya Ministry of Public Health and Sanitation, 2012). Nairobi has the highest ratios of 
any county in the country, with 1.9 non-government sector pharmacists per 10,000 people, and 3.6 
pharmaceutical technologists per 10,000 (Kenya Ministry of Health, 2017). By comparison, 15 
counties have zero pharmacists working outside the government sector.   
Pharmacists and pharmaceutical technologists are the only health workers who can open retail 
pharmacies in Kenya. Additionally, all medicines must be dispensed either by or in the presence of a 
pharmacist or pharmaceutical technologist (other health professionals and non-professionals can 
provide support) (Kenya Ministry of Medical Services and Kenya Ministry of Public Health and 
Sanitation, 2009). That said, in practice, there is a proliferation of unregulated activity in both public 
and private pharmacies. One 2008 study of 110 public, faith-based, and private retail pharmacies 
found that in only 38% of public pharmacies and 31% of faith-based health services was the 
dispensing professional in compliance with regulations (Kenya Ministry of Medical Services and 
Kenya Ministry of Public Health and Sanitation, 2009). This jumped to 81% for private retail 
pharmacies; however, the authors of the report attributed this to the fact that only registered 
private pharmacies were included in the sample (Kenya Ministry of Medical Services and Kenya 
Ministry of Public Health and Sanitation, 2009). 
Private pharmacies are not without their own challenges. Illegal pharmacies (not legally registered, 
or opened with purchased licenses or with physical premises that are not regulation-compliant) are 
widespread (Langat, 2019). Additionally, private pharmacies source their medicines independent of 
the public sector’s centralized supply system and so purchase from a variety of private sector 
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wholesalers and distributors (Riley et al., 2017, Kenya Ministry of Medical Services and Kenya 
Ministry of Public Health and Sanitation, 2012). Private drug importers, wholesalers, and distributors 
also fall under the regulatory purview (and limited capacity) of the Pharmacy and Poisons Board: 
counterfeit and substandard commodities from these sources is a challenge (International Finance 
Corporation, 2019).  
Various forms of contraception (including injectables, oral contraceptives, emergency contraception, 
male and female condoms) are found in private pharmacies (Ostola et al., 2015). While 
contraception can be accessed for free in public facilities (Keesara et al., 2015a), it must be 
purchased in pharmacies, also known as ‘chemists’ locally. 
1.6 Research Gap 
As described above, young people’s ability and willingness to access SRH services can be influenced 
by their community, provider, and peers in addition to the availability of services. Increases in use of 
SRH services can happen when these levels are addressed simultaneously (Napierala Mavedzenge et 
al., 2011), with ‘youth-friendly’ efforts which (Chandra-Mouli et al., 2015): 
1. Train and support providers to be non-judgmental and friendly to young clients 
2. Make health facilities welcoming and appealing 
3. Include communication and outreach activities (alerting young people to available services 
and encouraging to use them)  
4. Ensure the community is supportive and recognizes the importance of young people being 
able to access services.  
Often, unfortunately, ‘youth-friendly’ interventions only address some of these items, setting them 
up for failure (Chandra-Mouli et al., 2015). 
There is ample existing evidence in the literature documenting the reasons young people choose not 
to access SRH services in facilities, even those described as ’youth-friendly’. Despite their promise, 
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however, there is a paucity of documentation, especially from low- and middle-income countries, 
describing young people’s experiences in alternate access points like pharmacies. Uptake figures and 
increased support of task-sharing to pharmacy personnel may make it tempting to view pharmacies 
as a panacea for addressing challenges to accessing SRH care for a young population that – in Kenya 
and around the world –struggles to obtain care in facilities. However, sudden attention to 
strengthening pharmacy services might also inadvertently drain them of their appeal to young 
clients. If, for example, pharmacies are appealing for their speed and anonymity, well-intentioned 
efforts to incorporate compulsory counselling, testing, or referrals might strip pharmacies of the 
qualities that draw in young clients in the first place. 
Increased understanding of what kinds of young people choose to purchase contraception from 
pharmacies and why is needed (Denno et al., 2015). This includes developing a concrete 
understanding of what qualities make these sources appealing, and what (if any) additional support 
young people might desire from them.  
1.7 Doctoral research aim and objectives 
The aim of this doctoral research was to understand what drives young people aged 18-24 in need of 
contraception in Kwale County, Kenya to access it from pharmacies. The evidence would provide a 
baseline around which future programs might develop youth-targeted pharmacy-based 
interventions, which responsibly capitalize on the appeal of these establishments without sacrificing 
the qualities which make them so appealing to young people in the first place. Specifically, the 
objectives were to: 
• Objective 1: Develop a comprehensive understanding of the experiences of young people 
worldwide who access contraception through pharmacies 
• Objective 2: Understand the characteristics of young people in a peri-urban area of a Kenyan 
coastal county who access contraception from pharmacies, and identify specifically what 
qualities make these establishments appealing or unappealing for young users 
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• Objective 3: Assess the contraception-dispensing practices of pharmacies in a peri-urban 
area of a Kenyan coastal county for young clients.  
2 Methods 
This dissertation presents the results of a mixed-methods study, informed by a systematic review of 
the peer-reviewed literature. 
2.1 Study site: Kwale County, Kenya 
The study took place in Kwale County, Kenya. Kwale (location marked in 
map to right (County Government of Kwale, 2013)) is one of six counties 
in Kenya’s former Coast province. The total population of Kwale County 
was projected to be 713,487 persons in 2012, with young people aged 
15-29 comprising 26% of the County’s total population (County 
Government of Kwale, 2013). Per 2012 estimates, about 18% of the 
County’s population lives in an urban area (Kwale County Economic 
Planning Division, 2016). The County is predominantly Muslim (75%) and Christian (24%) (Mkutu et 
al., 2016). In 2015, contraceptive prevalence in the county was estimated to be noticeably lower 
than the rest of the country’s at 38.2% versus the national level 53.2% (Kenya Ministry of Health, 
2015a). Adolescent pregnancy in Kwale County is also higher than the national average, with 24.2% 
of women aged 15-19 having begun childbearing compared to the national level 18% (Kenya 
National Bureau of Statistics et al., 2015).  
Data collection took place in Matuga constituency and Ukunda (the most populated, urban area in 
the county).  Eighty percent of Kwale County’s population belongs to one of the region’s mijikenda 
(‘Nine Tribes’) groups – in our study area, people were predominantly Digo (Mkutu et al., 2016, 
Adhoch, 2010). 
Figure 2.1 Kwale County, Kenya (County 
Government of Kwale, 2013) 
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 ARMADILLO Study  
The study was nested within a broader study led by the World Health Organization’s Department of 
Sexual and Reproductive Health and Research (WHO/SRH) in collaboration with the International 
Centre for Reproductive Health – Kenya (ICRHK), with the author of this thesis as the global 
coordinator. This Adolescent/Youth Mobile Access and Delivery Initiative for Love and Life Outcomes 
(ARMADILLO) Study used a three-arm randomized controlled trial to assess the effect of a digital 
health platform that provided youth with SRH content via text messages in two sites in Kenya and 
Peru (Gonsalves et al., 2018).  
The ARMADILLO RCT (which ran from February 2018-December 2018) focused on using mobile 
phones to improve SRH information for youth aged 18-24. ARMADILLO’s primary outcome was the 
dispelling of myths and misconceptions around contraception among participants exposed to the 
digital health intervention versus control groups. ARMADILLO’s secondary outcomes looked at any 
improvements in other SRH knowledge, attitudes and self-efficacy outcomes among participants 
exposed to the intervention versus control groups. Primary results from the trial are expected to be 
published in late 2020. Source of contraception access (either from a pharmacy or another source) 
was not an outcome of interest for the ARMADILLO study. 
The pharmacy-oriented sub-study, by contrast, exclusively explored young peoples’ source of 
contraception, focusing on use of pharmacies and informal market sources. As described below, the 
components of this sub-study that are nested within the ARMADILLO study took place prior to the 
start of the trial itself. As such, the ARMADILLO intervention did not influence the results of this sub-
study. Rather, the ARMADILLO study provided a trusted research partner (ICRHK), an established 
field site, research infrastructure, and funding – in short, an opportunity for this sub-study to be 
implemented.  
WHO/SRH was supportive of nesting this study within the larger ARMADILLO study already in place, 
as it added significant value to its youth sexual and reproductive health portfolio as well as its self-
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care portfolio without requiring substantial additional resources. WHO/SRH recognized that both 
studies were complementary in that they contributed to building a broader understanding of how to 
better address youth SRH needs outside of a health facility setting.  
2.2 Mixed-Methods Study 
Mixed methods, broadly defined by Tashakkori and Cresswell, consists of “research in which the 
investigator collects and analyses data, integrates the findings, and draws inferences using both 
qualitative and quantitative approaches or methods in a single study or a program of inquiry” 
(Tashakkori and Creswell, 2007). There have been many attempts to describe and categorize the 
various conditions under which a researcher might undertake a mixed methods study. As 
summarized by Schoonenboom and Johnson, the qualitative and quantitative components of mixed 
methods studies can be conducted concurrently (in parallel) or sequentially, with regards to data 
collection (Schoonenboom and Johnson, 2017). With regards to data analysis, mixed methods 
studies can be independent or dependent – the latter implies that data analysis for one method 
needs to be completed and informs the subsequent method (Schoonenboom and Johnson, 2017). 
A mixed methods approach was appropriate for this descriptive study. This dissertation’s Objectives 
2 and 3 cover questions related to who used pharmacies, why they were appealing, and what a 
contraception purchase entailed. Study methods (including the initial systematic literature review 
which informed the study) are summarized in Table 2.1 and demonstrate how each method tied to 
one or more objectives. A mixed methods approach allowed for research objectives to be addressed 
with a complementary combination of quantitative and qualitative data from several sources.  
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 Following the systematic literature review, primary data collection for this study was conducted 
from November 2017-March 2018. Focus group discussions took place in November 2017 and 
preliminary review of these transcripts informed the finalization of the cross-sectional survey and 
qualitative interview guides. The cross-sectional survey, in-depth interviews, and key informant 
interviews took place simultaneously (that is, in parallel) starting from February, while the mystery 
shopper exercise was conducted at the end of March and was informed by preliminary findings from 
the other methods. As such, this study can be imperfectly categorized as ‘concurrent and 
dependent’. Individual methods are described in further detail below and in the relevant sections of 
Chapters 3-6.   
 Study Methods  
Systematic Literature Review 
Table 2.1 Dissertation Methods Summary 
Dissertation 
Methods 
Description Objective Addressed  
Systematic 
Literature 
Review  
Global overview of contraception 
access through pharmacies 
(Objective 1) 
 
 
Mixed 
Methods 
Study 
Participant Description Objective and Topics addressed N 
Focus 
Group 
Discussion* 
-18-24 years (Objective 2 and 3) 
Normative profiles of pharmacy 
users 
6  
(58 ppts) 
Cross-
sectional 
survey* 
-18-24 years 
-mobile phone owners 
(Objective 2) 
Self-report contraception source 
740 
In-depth 
interviews  
-18-24 years 
-Recent purchaser (of 
contraception from pharmacies) 
(Objective 2 and 3) 
Personal purchasing experiences 
18 
Key 
informant 
interviews 
-18+ years 
-pharmacy personnel, OR 
-contraception/pharmacy 
stakeholder 
(Objective 2 and 3) 
Provider perspective on user 
profile, dispensing practices 
19 (pharmacy 
personnel) 
6 
(stakeholders) 
Mystery 
shoppers 
Trained youth data collectors (Objective 3) 
Actual dispensing practices 
187 visits 
(4MSx 48 ph.) 
Specific pharmacy study methods which were nested within ARMADILLO are so denoted with an asterisk (*) 
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The objective of the systematic literature review was to describe the experiences of young people 
(aged 25 and younger) accessing contraception and other sexual and reproductive health 
commodities (including abortifacients and STI tests) in pharmacies. The systematic review of the 
literature was conducted in line with the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines (Moher et al., 2009). PubMed, Embase, Popline, and Scopus 
databases were included in the review. For each database, search strategies were developed by 
mapping keywords related to the two areas of interest - SRH commodities and pharmacies –onto 
database-specific search terms (for example, MeSH for PubMed). The Cochrane database was also 
searched for existing or related systematic reviews. No geographic restrictions were placed, and 
articles in English, French, Spanish, or Portuguese were included. As a desk review of the literature 
revealed a global shift in policies to favour pharmacy access (with a majority of literature published 
earlier assessing youth access only in theory), only articles published after 1 January, 2000 were 
included.  
Focus Group Discussions 
Participants: young people aged 18-24 
Six focus group discussions (three with young men, three with young women) were conducted with 
young people purposively recruited from the community. The purpose of these FGDs were to build 
an understanding around youth norms and expectations with regards to where young people of a 
similar age could access contraception, and what factors might influence the selection of one source 
of contraception over another. FGDs took place in a central location in the presence of three trained 
data collectors. One led the discussion (posing questions and probing). The second helped facilitate 
interactive activities (for example, writing on a flip chart the locations suggested by participants for 
where a young person might access contraception). The third person served as a silent observer and 
notetaker. FGD participants were also asked questions related to the ARMADILLO Study’s objectives 
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(namely, identifying common concerns/myths related to contraception use). The study instrument is 
available in Appendix 1  
Cross-sectional survey 
Participants: young people aged 18-24, have their own mobile phone and report regular use, have a 
mobile phone with them at the time of recruitment, report current use of text messaging 
This cross-sectional data was collected through the ARMADILLO baseline survey (completed prior to 
the start of the intervention period). The pharmacy-study relevant parts of the survey were a series 
of previously-validated questions from the Female Questionnaire of Performance Monitoring and 
Accountability 2020 (PMA2020) (Performance Monitoring and Accountability 2020, 2017), as well as 
the Guttmacher Fog Zone Survey of Young Adults (Guttmacher Institute, 2009). These questions 
asked about contraceptive use at last sex, and (if contraception was used): source of the method; 
whether potential side effects were discussed, other types of contraception was discussed; whether 
the contraceptive method initially desired was the one they left with (and if not, why not); whether 
they would return to that provider. Demographic variables to describe the population (and against 
which to run analyses) included: level of education, sex, relationship status, parity, age of sexual 
debut. A trained data collector administered baseline surveys to participants using a webform on a 
tablet. The questions relevant to this study were completed by participants themselves. Participants 
were randomly selected based on a household enumeration that took place in the study area 
(Gonsalves et al., 2018). 
In-depth interviews  
Participants: young people aged 18-24, recently purchased contraception from a pharmacy 
In these in-depth interviews, participants shared their recent experience purchasing contraception in 
a pharmacy; the reasons for selecting a pharmacy over another source; and both positive and 
negative features of the experience. A trained data collector conducted the interview using an open-
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ended, semi-structured question guide (see Appendix 1). Participants were recruited from a cross-
section of private pharmacies after they made a purchase. 
Key informant interviews  
Participants: aged 18+, employed at one of the following:  
• private pharmacy,  
• a local, regional, national regulatory agency directly engaged with contraception access 
through pharmacies, OR 
• a nongovernmental organization/civil society/professional association/advocacy 
group/academic/research organization involved with contraception commodity availability  
Key informant interviews were conducted with pharmacy personnel in the study area to elicit stories 
from stakeholders and 
providers about previous 
commodity dispensing 
experiences (both 
positive and negative) 
with a young client; 
assess the acceptability 
of dispensing 
contraception to young 
people; as well as 
identify any additional SRH support or training a 
Figure 2.2 Results of pharmacy mapping exercise 
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provider may desire. Trained data collectors used a semi-structured interview guide to conduct 
these interviews.  
Participants were selected from a random selection of pharmacies that were identified during a 
mapping exercise conducted in the study area. 60 pharmacies in total were identified. 
Additional interviews were conducted in the study area, Mombasa, and Nairobi with members of the 
Pharmacy and Poisons Board, broader Ministry of Health, professional associations, and relevant 
non-governmental organizations to capture the broader context of how contraception commodities 
are delivered through private pharmacies (and associated opportunities as well as challenges). The 
dissertation author conducted all interviews with these stakeholders.  
Mystery shopper exercise  
Participants: trained youth data collectors, pharmacies in study area 
Finally, four young data collectors were trained as mystery shoppers and each attempted to 
purchase contraception from 50 of the 60 private pharmacies identified during the mapping. In each 
instance, the mystery shopper requested contraception in a pharmacy, taking careful note of the 
interaction.  
Immediately after the mystery client interaction, they completed a semi-structured check-list on a 
webform. The checklist was developed based on WHO’s quality of care standards (World Health 
Organization, 2006b), national dispensing guidelines, and a previous study (Chin-Quee et al., 2006), 
and assessed interactions between staff at pharmacies and young clients seeking contraception. The 
checklist consisted of a combination of close-ended and open-ended questions including, for 
example: information on with whom the client spoke (gender, approximate age, role); where in the 
shop/pharmacy the interaction took place; whether the location provided privacy; how they were 
treated by the pharmacist; what information the pharmacist asked about them; what counselling (if 
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any) they received; length of interaction; whether they received their commodity of choice. This 
checklist is available in Appendix 1. 
Two mystery shoppers were male: one 
attempted to purchase emergency 
contraception, the other condoms. The 
other two mystery shoppers were 
female: one attempted to purchase 
emergency contraception, the other 
inquired about the availability of 
injectable contraception and whether 
she could be injected on site (she did 
not actually purchase or get 
administered injectable contraception). 
Each mystery shopper had a ‘persona’ 
which was developed in a half-day 
workshop with input from young people 
from the community, the data collectors themselves, and preliminary findings from the FGDs, IDIs 
and KIs. These mystery shopper personas are described in full in Appendix 2. 
 Data management and analysis  
Qualitative data collection and analysis was informed by grounded theory (Charmaz, 2006). The 
decision to use grounded theory meant there was no adoption of a specific framework or hypothesis 
at the outset to guide data collection and analysis. Instead question guides/checklists were iteratively 
adapted based on preliminary findings over the course of data collection. Prior knowledge of 
adolescent sexual and reproductive health (ASRH) and its health service challenges also informed the 
structure of the study guides and questions. 
Figure 2.3 Pharmacies in Ukunda town who consented to be visited by 
mystery shoppers 
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Data were analysed using the Framework Method (Gale et al., 2013). All data collected as part of the 
qualitative component of this study (FGDs, IDIs, KIs) was transcribed in the language in which it was 
conducted and then (if necessary) translated into English verbatim and transferred into an electronic 
file containing one transcript for each data collection event. Following an initial open coding of a cross-
section of transcripts and review of the codes with the research team, axial coding (informed by the 
objectives of this research) was used to analyse all qualitative data. Qualitative analyses were 
conducted using Atlas.ti. 
Mystery shopper data were analysed using descriptive statistics. Cross-sectional survey data were 
analysed using descriptive statistics, followed by bivariate log binomial regressions which assessed the 
association between the outcome (having purchased contraception at a pharmacy versus any other 
source) and each behavioural/sociodemographic variable of interest. Any analysis showing a p<.2 
moved the variable into a multivariable Poisson regression model with robust 95% CIs. All quantitative 
analysis was conducted using Stata Version 14. 
All qualitative data from FGDs, IDIs, and KIs were transcribed and translated (if necessary) verbatim. 
 Ethical considerations 
This study obtained ethics approval from the Ethikkommission Nordwest- und Zentralschweiz (EKNZ) 
(Req-2017-00389) in Basel, Switzerland. The ARMADILLO study (in which this study’s FGDs and cross-
sectional survey were embedded) obtained ethics review and approval from the World Health 
Organization’s Research Ethics Review Committee (A65892b). Finally, both studies in their entirety 
received ethics approval from the University of Nairobi/Kenyatta National Hospital (P274/05/2017).  
All participants provided their written consent prior to participation. Consent to conduct the mystery 
shopper visits was obtained during the geographical mapping exercise. The mystery shopper visits 
did not start until two months following the consent visit, so as not to unduly bias pharmacy 
personnel’s behaviour. Quantitative and qualitative data collection took place in private locations. 
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FGDs, IDIs, and KIs were all audio-recorded, with participants’ permission. Data collection took place 
in English, Swahili, or a mix of the two languages, depending on participants’ comfort.  
2.3 Description of dissertation chapters 
The next five chapters present the results of systematic literature review and mixed-methods study. 
They are ordered to respond to each of the three objectives of my doctoral research (Chapter 1.7) 
and are presented as follows:  
Chapter 3 presents the results of the systematic literature review and provides a comprehensive 
understanding of the experiences of young people, worldwide, who access contraception (and other 
SRH commodities) through pharmacies (Objective 1). Chapter 3 was published as a review article in 
Contraception. 
Chapter 4 uses quantitative and qualitative data from the mixed-methods study to describe who 
(among young people in Kwale County) uses pharmacies to get contraception and what makes 
pharmacies so appealing as contraception outlets. (Objective 2). Chapter 4 was published as a 
research article in BMJ Open. 
Chapter 5 uses qualitative data from the mixed-methods study to describe Kwale County 
pharmacies’ emergency contraception and condom dispensing practices (Objective 3), and questions 
whether these services qualify as ‘youth-friendly enough’ for young clients. Chapter 5 was published 
as a research article in the International Journal of Public Health. It was included as a part of an IJPH 
special issue entitled: Sexual and reproductive health of young people – Focus Africa.  
Chapter 6 uses qualitative data from the mixed-method study to focus on Kwale County pharmacies’ 
dispensing (and administering) of injectable contraception (Objective 3), as well as local perceptions 
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as to the quality of pharmacy services in general. Chapter 6 was published as a research article in 
PLOS ONE. 
Finally, Chapter 7 provides a commentary around overarching concerns related to quality of 
contraception services in pharmacies as well as their equity (pertaining specifically to financing) 
(Objective 3). Chapter 7 was published as an editorial in BMJ Sexual and Reproductive Health. 
Chapter 8 provides a general analysis of the findings from across the above five chapters and 
presents broader implications and policy and research recommendations. 
  
42 
 
3 Pharmacy provision of sexual and reproductive health 
commodities to young people: a systematic literature review and 
synthesis of the evidence 
Lianne Gonsalves1, Michelle Hindin1 
1Department of Reproductive Health and Research including UNDP/UNFPA/UNICEF/WHO/World 
Bank Special Programme of Research, Development and Research Training in Human Reproduction 
(HRP), World Health Organization, Geneva, Switzerland 
 
Corresponding author: 
Lianne Gonsalves 
Department of Reproductive Health and Research including UNDP/UNFPA/UNICEF/WHO/World 
Bank Special Programme of Research, Development and Research Training in Human Reproduction 
(HRP) 
World Health Organization  
Avenue Appia 20  
1201 Geneva, Switzerland 
E-mail: gonsalvesl@who.int 
Tel: +41795006554 
 
Keywords: Adolescent, youth, contraception, pharmacy, systematic review 
 
 
 
 
 
Published in Contraception on 23 December, 2016 
https://www.contraceptionjournal.org/article/S0010-7824(16)30540-6/fulltext  
43 
 
3.1 Abstract 
Background: We conducted a systematic review of peer-reviewed literature on youth access to, use 
of, and quality of care of sexual and reproductive health (SRH) commodities through pharmacies. 
Methods: Following PRISMA protocol, we searched for publications from 2000-2016. To be eligible 
for inclusion, articles had to address the experiences of young people (aged 25 and below) accessing 
SRH commodities (e.g., contraception, abortifacients) via pharmacies. The heterogeneity of the 
studies precluded meta-analysis--instead we conducted thematic analysis.   
Results: 2842 titles were screened and 49 met the inclusion criteria. Most (n= 43) were from high-
income countries and 33 examined emergency hormonal contraception provision. Seventeen 
focused on experiences of pharmacy personnel in provision, while 28 assessed client experiences.  
Pharmacy provision of SRH commodities was appealing to and utilized by youth. Increasing access to 
SRH commodities for youth did not correspond to increased risky sexual behaviour.  
Both pharmacists and youth had reservations about the ease of access and its impact on sexual 
behaviours. In settings where regulations allowing pharmacy access were established, some 
pharmacy personnel created barriers to access or refused access entirely.  
Discussion: With training and support, pharmacy personnel can serve as critical SRH resources to 
young people. Further research is needed to better understand how best to capitalize on the 
potential of pharmacy provision of SRH commodities to young people without sacrificing qualities 
which make pharmacies so appealing to young people in the first place.  
3.2 Introduction 
There are over 1.8 billion young people between the ages of 10-24 in the world today, 90% of whom 
live in developing countries (UNFPA, 2012). Comprising one quarter of the world’s total 
population(UNFPA, 2013), youth are faced with a number of challenges to their sexual and 
reproductive health (SRH) and wellbeing. SRH challenges are not unique to this population and are 
faced by men and women of all ages. However, even when services are available in a given 
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community, added financial, cultural, or social barriers may prevent young users from utilizing them, 
especially if providers and communities are biased against youth access (Chandra-Mouli, 2014). 
As a result, 16 million girls aged 15-19 and 1 million girls under age 15 give birth every year, and 
complications during pregnancy and childbirth are the second-leading cause of death for 15-19 year 
old girls, globally (World Health Organization, 2020). Additionally, an estimated 3 million girls aged 
15 to 19 undergo unsafe abortions each year (World Health Organization, 2020). Millions of women 
worldwide have an unmet need for contraception. However in many regions of the world, 
adolescents wanting to avoid pregnancy can be up to twice as likely as adult women to have an 
unmet need for modern contraception (Guttmacher Institute, 2010). Data from 61 low- and middle-
income countries (LMICs) estimates that 33 million young women aged 15-24 have an unmet need 
for contraception (MacQuarrie, 2014), demonstrating a need to improve access to and uptake of 
SRH commodities.  
Pharmacy access - that is, making commodities available either over-the-counter (openly accessible 
at a pharmacy), or behind-the-counter (dispensing contingent on evaluation from a pharmacist) - is 
one strategy that might help to overcome barriers for young people unwilling or unable to access 
services from another healthcare provider.  Pharmacy provision allows for more direct access to SRH 
commodities. To date, there has been very little documentation, for adults or youth, around 
pharmacy-based distribution of reproductive commodities. Encouragingly, however, the health and 
wellbeing of adolescents and young people is receiving increased attention and emphasis in a 
number of global-level collaborations and strategies developed in recent years, including Family 
Planning 2020 (FP2020) (Family Planning 2020); the UN Secretary-General’s Global Strategy for 
Women’s Children’s and Adolescents’ Health (Every Woman Every Child, 2015); and even some 
targets from the newly-minted Sustainable Development Goals (United Nations Department of 
Economic and Social Affairs, 2016). It seemed particularly timely, therefore, to identify strategies for 
best providing needed SRH commodities to a young population. As such, we conducted a systematic 
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review of the peer-reviewed literature to identify any evidence on young people’s (aged 25 or 
younger) access to, use of, and quality of care of SRH commodities in pharmacies.  
3.3 Methods 
We conducted this systematic review according to the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) (Moher et al., 2009). We searched for studies that addressed 
the following research question:  
What is the experience of young people (25 and younger) who access SRH commodities through 
pharmacies? 
 Search Strategy 
We searched PubMed, Embase, Popline, and Scopus databases for relevant publications without 
language restrictions limitations published between 1 Jan 2000 and 1 May 2016. We searched for 
articles published from the year 2000 onwards in light of a noticeable, turn-of-the-century shift in 
policies worldwide towards increasing SRH commodities availability through pharmacy provision. 
The search strategy for each database was developed by mapping keywords associated with the two 
major components of the research question (‘SRH commodities, and ‘pharmacies’) onto established 
controlled vocabulary for the selected database (for example, MeSH for PubMed or Emtree for 
Embase). The search strategies developed for each database are available as Supplementary 
Material. We also searched the Cochrane database for existing or related systematic reviews. We 
screened the references of all articles identified for data extraction. Excluding duplicates, in total we 
identified 2842 records for potential inclusion. Figure 3.1 contains a flow diagram of the study 
selection process. 
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Figure 3.1 Study selection flow diagram 
 
 Screening 
We first screened articles by title, yielding 350 potential articles. We then dual screened (LG and 
MJH) the abstracts for relevance, also eliminating articles that did not have an abstract in English, 
Spanish, Portuguese or French, non-research articles (e.g. commentaries, editorials), and 
posters/presentations from meetings. Where there was disagreement between the screeners as to 
whether an article should be included or excluded, we included the article. All articles that either 
screener was unsure about were discussed in person until an inclusion/exclusion decision was 
reached. We also screened references from two reviews of the literature (the first on community 
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pharmacy supply of emergency hormonal contraception (Kao, 2000), the second on emergency 
contraception in South Africa (Maharaj and Rogan, 2008)); this provided an additional 4 articles for 
full-text review. We were left with 114 articles which were read in full by LG. 
 Inclusion/Exclusion Criteria 
We included all articles that considered the provision of SRH commodities to young people via 
pharmacies. All studies focused on or contained data on people aged 25 years or younger; this also 
meant including broader population-based studies that disaggregated data by age group.  
SRH commodities included contraceptive methods, abortifacients, and STI self-test kits. We were 
interested in the overall experience of commodity provision to young people in pharmacies, either 
from the young person’s or provider’s perspectives.  We excluded all studies that only reported on 
changes in prevalence of pharmacy provision (i.e. population-based trend data) or any other studies 
that did not provide information on young people’s experiences acquiring the commodities. 
Ultimately, LG abstracted 49 articles (presented in Table 3.1), using data extraction forms modified 
from a previous review (Hindin and Kalamar, 2016). The included studies employed qualitative and 
quantitative, experimental and observational designs, and were equally heterogeneous in the 
outcomes measured. As a result, meta-analysis was not possible -- instead we used thematic analysis 
to synthesize results across the diverse data available. Additionally, given the variety of study 
methods used, there was no one (or even two) scoring system that could be used to evaluate 
quality; instead, Table 3.1 also includes detailed notes on each study’s strengths and weaknesses. 
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Table 3.1 Description of studies, ordered by publication year 
Authors/ 
year/country 
Study design 
and methods 
Study 
population  
Relevant 
outcomes 
Regulations  Results Strengths Limitations 
Barrett et al. 
2000 
United 
Kingdom 
(Barrett and 
Harper, 2000) 
Qualitative (in-
depth 
interviews)  
PROVIDERS: 
n=18 
community 
pharmacists  
 
n=6 
general 
practitioners  
Attitudes 
towards over-
the-counter 
availability of 
ECPs 
Deregulation 
ECPs available 
only through 
physician 
prescription 
Providers expressed 
concerns about repeat use 
in terms of promiscuity 
  
Reflexivity and 
first-hand 
accounts of 
providers’ 
beliefs 
Study takes 
place prior to 
deregulation, 
and centres on 
hypothetical 
deregulation 
Wilson et al. 
2000 
United 
Kingdom 
(Wilson and 
Williams, 2000) 
Observational 
(school- and 
mail-based 
survey) 
  
CLIENTS: 
n=711 
males and 
females 
aged 13-19  
Current 
provision of SRH 
commodities in 
pharmacies 
Hormonal 
contraception 
available only 
with a 
prescription  
29% of males, 13% of 
females got contraception 
from pharmacist at last 
intercourse 
 
Embarrassment (55%), lack 
of information (25%), and 
confidentiality (27%)are 
key barriers to pharmacy 
access 
Inclusion of 
males and 
females  
 
Assessed 
views on 
pharmacy 
access versus 
FP clinics and 
GPs 
Low response 
rate for postal 
survey 
component 
 
  
Seston et al. 
2001 
United 
Kingdom 
(Seston et al., 
2001) 
Qualitative 
(focus group 
discussions)  
PROVIDERS: 
n=14 
pharmacists  
  
Concerns about 
deregulation of 
ECPs; Perceived 
support and 
training needs 
for deregulation 
ECPs available 
in pharmacies 
under 
'patient group 
direction' – a 
pharmacist 
protocol to 
determine 
eligibility for 
ECP use 
Pharmacists’ who never 
dispensed ECPs expected 
ECP users to be 
adolescents or sexually 
irresponsible women who 
use ECPs on a regular basis 
 
Pharmacists who did 
dispense found that most 
clients were women in 
their 20s who had 
Includes 
providers who 
had and had 
not dispensed 
ECPs 
ECP provision to 
youth is never 
explicitly 
explored; 
instead it arises 
from concerns 
about who 
might abuse ECP 
access 
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experienced failure of 
contraceptive method 
Sucato et al. 
2001 
United States 
(Washington) 
(Sucato et al., 
2001) 
Observational 
(self-
administered 
survey)  
CLIENTS: 
n=126 
females ages 
15-21, 
received 
ECPs from a 
pharmacist   
Reasons for 
going to a 
pharmacist; 
satisfaction with 
care provided 
by pharmacist 
 
Reasons included ‘easy to 
get to’ and ‘privacy 
protection’. 
If services didn't exist, 20% 
wouldn't know where else 
to go, 22% would wait and 
see if they became 
pregnant 
 
Clients felt counselling was 
clear (99%)and were 
satisfied with time to ask 
questions (95%) 
Respondents 
were able to 
report on 
actual 
decision and 
experience in 
obtaining 
ECPs from a 
pharmacy  
Low response 
rate (36%)  
 
25% of sample 
never received 
the survey 
 
  
Ratanajamit et 
al. 
2002 
Thailand 
(Ratanajamit et 
al., 2002) 
Randomized 
controlled trial 
 
Intervention: 
course to 
increase ECP 
knowledge and 
improve 
dispensing skills. 
Mystery clients 
assess outcomes   
PROVDIERS: 
n=60 
pharmacy 
and 
drugstore 
personnel   
Knowledge of 
and practice in 
dispensing ECPs  
ECPs available 
over-the-
counter 
Significantly higher 
knowledge of ECPs (score 
of 22.1 vs 18.5), higher 
levels of provision of 
dosing information (45 vs 
12 pharmacists providing), 
but no statistical difference 
in medical history taking 
between intervention and 
control group 
Robust study 
design 
 
Three month 
follow-up 
Youth issues 
never explicitly 
explored, study 
included 
because 
mystery clients 
are <25 
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Raymond et al. 
2003 
United States 
(various 
settings) 
(Raymond et 
al., 2003) 
Longitudinal 
 
Study mimics 
pharmacy 
access. Women 
requesting ECPs 
asked to review 
ECP package 
designed for 
OTC use and 
were sold ECPs 
CLIENTS: 
n=585 
females 
presenting 
for an ECP 
prescription 
at 8 Planned 
Parenthood 
sites and 5 
pharmacies 
in 5 cities 
Use of ECP 
product under 
(simulated) OTC 
conditions 
ECPs available 
only through 
physician 
prescription 
With ECP access, minors 
not significantly more likely 
than older women to use 
products in a 
contraindicated or 
incorrect manner and did 
not have more adverse 
events or subsequent 
pregnancy 
Study 
modelled OTC 
setting closely 
 
Low loss to 
follow-up 
(only 7%)  
Limited 
generalizability 
to women self-
selecting ECPs 
Conard et al. 
2003 
United States 
(Indiana) 
(Conard et al., 
2003) 
Cross-sectional 
(self-
administered, 
mail-in survey) 
  
PROVIDERS: 
n=948 
chief 
pharmacists 
of active 
licensed 
pharmacies 
in Indiana  
Pharmacists' 
attitudes and 
practices 
related to SRH 
services for 
adolescents.  
ECPs and 
other 
contraception 
only available 
through 
physician 
prescription 
Pharmacists <45 were 
more likely to state they 
dispensed ECPs 
 
Male pharmacists more 
likely to think adolescents 
asked questions about 
prescriptions 
 
Few felt trained in 
adolescent issues (13%), 
confidentiality (23%) 
Excellent 
response rate 
(70%) 
 
Use of clear 
case studies 
to provide 
insight into 
prescribing 
practices  
Limited 
generalizability 
to other cadres 
of pharmacy 
workers and 
beyond the 
state of Indiana 
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van Bergen et 
al. 
2004 
Netherlands 
(Van Bergen et 
al., 2004) 
Cohort  
(picked up 
Chlamydia 
trachomatis 
screening kit at 
pharmacy and 
followed up for 
test results, 
questionnaire) 
CLIENTS: 
n=446 
women (<30 
years) 
recruited 
from a 
pharmacy, 
who were 
offered kits 
Response rates, 
Chlamydia test 
results, survey 
results   
Prescription 
refills of oral 
contraceptive
s can be 
ordered 
remotely and 
collected at 
pharmacy, no 
GP contact 
required  
CT-positivity detected 
among ethnic minority 
population where 15% 
were CT positive, as 
compared with 6-10% 
found in other Dutch STI 
clinics 
 
Higher rates of CT 
positivity among youth 
(13% among 15-19 year 
olds, and 14% among 20-
24 year olds) as compared 
to older age group  (5% 
among 25-29 year olds) 
Vulnerable 
population 
focus: 
multicultural, 
low-income 
 
Cross-checked 
urine samples 
with test 
results  
 
Explored 
nonparticipati
on  
Generalizability 
to other 
populations, 
pharmacies 
Killick et al. 
2004 
United 
Kingdom 
(Killick and 
Irving, 2004) 
Cross-sectional 
(questionnaire) 
CLIENTS: 
n=419 
pharmacy 
ECP clients 
(ages 16-39)  
Knowledge of 
ECP use, 
planned future 
contraceptive 
use 
ECPs available 
for purchase 
from a 
pharmacist 
for women 
aged 16+  
Most of the users (72%) 
were <20.   
 
49% of women in their 20s, 
20% of women <20 and 
31% of those 30+ paid. 
Data from 112 
different 
pharmacies 
Systematic bias 
in questionnaire 
distribution and 
response rates  
Raymond et al. 
2004 
United States 
(North 
Carolina) 
(Raymond et 
al., 2004) 
Cross-sectional 
(screening data 
to an ECP 
telephone 
counselling and 
prescription 
service) 
CLIENTS: 
n=7774 
female 
callers, 88% 
aged <29 
years, 37% 
aged <19 
years  
ECP use 
patterns 
Special 
program: any 
woman 
needing ECPs 
could call 
service and 
be screened. 
40 USD fee 
for 
prescriptions 
83% adolescent users 
received 1 prescription 
(compared with 84% of 
users overall) 
 
12% adolescent users 
received 2 prescriptions 
(compared with 11% of 
users overall) 
 
5% adolescent users 
received 3 prescriptions 
Generalizable 
data available 
for various 
ethnicities 
and education 
levels 
 
Extended 
hours of call 
service 
provides data 
on weekend 
use 
Only data was 
that obtained as 
part of 
screening 
process, no 
ability to follow 
up with 
participants. 
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(compared with 5% of 
users overall) 
Raine et al. 
2005 
United States 
(California) 
(Raine et al., 
2005) 
Randomized 
controlled trial 
 
Three arms 
(clinic access, 
pharmacy 
access, and 
advanced 
provision to 
ECPs)   
CLIENTS: 
n=2117 
female 
clients (ages 
15-24) 
enrolled 
from 4 FP 
clinics  
Use patterns, 
risky sexual 
behaviours and 
pregnancy/STIs 
State 
legislation 
allowing 
women to 
obtain ECPs 
from 
pharmacies 
without 
consulting a 
physician 
Women in pharmacy group 
were no more likely to use 
ECP than women in the 
clinic group  
 
Women in the pharmacy 
group (8.5%) not more 
likely than women in the 
clinic group to use ECP 2+ 
times  
 
No significant differences 
in sexually risky behaviour, 
pregnancy, or STIs by study 
group 
Explores 
pharmacy 
provision 
distinct from 
advance 
provision  
 
Follow-up 
rates equal 
across groups, 
no difference 
in 
characteristics 
of women lost 
to follow-up 
High 
contamination 
across study 
arms.  
 
Could not be an 
intent-to-treat 
analysis as some 
participants 
were lost to 
follow-up. 
Blanchard et al. 
2005 
South Africa 
(Blanchard et 
al., 2005) 
Quantitative 
(in-person 
questionnaire 
administered to 
pharmacy 
providers 
PROVIDERS: 
n=34 
pharmacy 
providers 
from 28 
pharmacies  
Providers' 
knowledge and 
attitudes 
towards 
providing ECPs  
ECP available 
for purchase 
in pharmacies 
without 
prescription 
and for free in 
public health 
facilities 
Fewer than half felt <18s 
should get ECP access. One 
third did not offer ECP to 
<18s   
 
Fewer than one-third 
thought <18s should get 
advance ECP provision 
 
Concern that ECP access 
increases risky behaviour 
Careful 
screening of 
pharmacies 
for eligibility 
(pharmacies 
visited an 
average of 
four times 
before 
interview 
conducted) 
Response bias  
 
Recall bias: 
reliance on 
pharmacist self-
report  
Lloyd et al. 
2005 
United 
Kingdom 
Observational 
(Retrospective 
pharmacy record 
review) 
 
CLIENTS: 
n=1412 
Records of 
pharmacy 
clients 
Trends in age of 
ECP users  
All 
pharmacies in 
study area 
could provide 
ECPs on 
At beginning, about 21% of 
the clients were <20. 
Increased to 46% after two 
quarters, and afterwards 
clients <20 accounted for 
Study site in a 
rural area 
 
Data available 
Limited 
generalizability 
to other areas 
of the UK 
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(Lloyd and 
Gale, 2005) 
Pharmacies 
submitted 
monthly returns 
over 24 months 
request (14 
and 15 year 
olds had to 
demonstrate 
competence) 
42-45% of consultations 
 
By end of study, 
community pharmacies 
were the largest provider 
of ECP 
from before 
program start  
Harper et al. 
2005 
United States 
(California) 
(Harper et al., 
2005) 
Randomized 
controlled trial 
 
Three arms 
(clinic access, 
pharmacy 
access, and 
advanced 
provision of 
ECPs)   
CLIENTS: 
n=964 
female FP 
clinic clients, 
aged 15-24, 
recruited 
from four 
clinics in 
study area 
Pharmacy use 
by age, risky 
sex, STIs and 
pregnancy 
State 
legislation 
allowing 
women to 
obtain ECPs 
from 
pharmacies 
without 
consulting a 
physician 
Use among adolescents 
<16 (38%) similar to group 
aged 16-17 (38%), and 
higher than those aged 18-
19 (33%). Adults (aged 20-
24) had lower overall use 
(24%). 
 
Pharmacy access no more 
likely than clinic access 
participants to use ECP, 
engage in risky behaviours, 
get STIs or be pregnant 
Robust study 
design with 
specific youth 
focus (15-24), 
computer-
generated 
randomization
, researchers 
blinded to 
participant 
group 
allocation 
Participants 
enrolled from 
clinics, making 
them not 
representative 
of those who 
seek services 
from non-
facility sources 
Bissell et al. 
2006 
United 
Kingdom 
(Bissell et al., 
2006) 
Qualitative (in-
depth 
interviews) 
PROVIDERS: 
n=45 
pharmacists 
participating 
in program 
to supply 
ECPs 
without 
charge 
Pharmacist 
views on 
provision of ECP 
to young people 
ECPs made 
available for 
purchase 
from a 
pharmacist 
for women 
aged 16+. In 
some areas 
there is an 
option for 
obtaining free 
access to 
ECPs 
Confidentiality noted as 
advantage of pharmacies 
 
Concern that pharmacy 
supply encouraged 
'irresponsible' attitudes to 
contraception. Particular 
concern for younger 
women without a regular 
partner and those who 
chose to have unprotected 
sex 
 
Girls <14 requested ECPs 
A diversity in 
gender, 
ethnicity, age 
of 
pharmacists, 
and socio-
demographics 
of areas 
where 
pharmacies 
were located 
Response bias: 
all pharmacists 
were 
participating in 
a special 
program 
designed to 
make ECPs 
more accessible 
to young people 
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Chin-Quee et 
al. 
2006 
Jamaica 
(Chin-Quee et 
al., 2006) 
Qualitative 
(observation, 
interview) 
BOTH: 
n=78 
pharmacists 
interviewed   
 
n=524 
females (age 
not 
specified) 
who 
purchased 
OC 
interviewed  
 
n=14 
adolescent 
mystery 
client 
observations  
Pharmacist 
willingness to 
sell OC to 
minors (<16 
years) 
 
Access to OCs 
for 16 year olds 
Oral 
contraception 
available for 
purchase in 
pharmacies 
without 
prescription 
Mystery client refused 
access by 9 of 15 
pharmacists and told she 
needed prescription. When 
MC could buy the pill, no 
report of negative reaction 
 
When asked whether they 
would sell to minors (<16), 
46% of pharmacists said 
they would not, 38% said 
they would 
 
Age was the most 
mentioned factor in 
pharmacists' decisions to 
restrict customer access to 
OCs 
Use of 
multiple data 
sources allows 
for 
triangulation 
in collection 
of data on 
contraceptive-
accessing 
experience  
Sampling limits 
generalizability 
 
Limited data 
collected on 
youth self-
reported 
experiences as 
only 3% of 
interviewed pill 
customers were 
<20 
Landau et al. 
2006 
United States 
(nationwide) 
(Landau et al., 
2006) 
Cross-sectional 
(nationally 
representative 
telephone 
survey) 
  
CLIENTS: 
n=811 
females, age 
18-44, at risk 
of 
unintended 
pregnancy 
  
Experiences 
with hormonal 
contraception 
and interest in 
pharmacy 
access to 
reproductive 
health 
commodities 
Certain states 
have 
legislation 
allowing 
pharmacy 
access to 
ECPs.  
Younger women (aged 18-
25) nearly twice as likely 
(1.78 OR) as women 36+ to 
support pharmacy access 
to OC, patch and ring 
 
Uninsured, single, and 
young women more likely 
to have had problems 
obtaining a prescription for 
contraception 
Random-digit 
dialling to 
obtain a 
nationally 
representative 
sample 
Majority of data 
is not age-
disaggregated 
and therefore 
not extractable  
 
Low response 
rate (37%) 
Lara et al. 
2006 
Latin America 
(unspecified) 
Qualitative  
(in-person 
interviews with 
pharmacy 
BOTH: 
n=100  
pharmacies 
visited by 
pharmacy staff 
knowledge and 
provision 
practices of 
Abortion 
legally 
restricted, but 
research 
Half of participants knew 
of drug to 'interrupt a 
pregnancy'. Increased to 
74% during MC encounters  
Pharmacy 
staff survey 
followed by 
MC evaluation 
Youth provision 
not explored: 
MC are aged 18 
-25, but no 
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(Lara et al., 
2006) 
personnel and 
mystery clients 
visits to same 
pharmacies) 
mystery 
clients (aged 
15-24, male 
and female) 
 
n=97  
pharmacies 
where a staff 
member was 
interviewed 
  
misoprostol and 
other medical 
abortifacients 
suggests 
many women 
frequently 
use 
misoprostol 
(often 
obtained 
from 
pharmacies) 
to self-induce 
abortion 
 
60% said misoprostol was 
available in interview; 53% 
said it was available to MCs 
 
6% of those 
recommending 
misoprostol in interviews 
and 17% in MC visit 
offered dosage effective 
for medical abortion 
 
61% of the staff 
interviewed reported at 
least one request for 
abortifacient, more from 
women (71%) than men 
(31%); average age of 
requester: 22 
of the same 
pharmacy 
compares 
staff's 
reported and 
actual 
behaviour  
 
Inclusion of 
male and 
female MC 
allows for 
assessment of 
pharmacy 
staff 
interactions 
with clients of 
different sex 
comment on 
any age bias  
 
Same 
pharmacies 
received MC 
visits and staff 
surveys, but MC 
did not 
necessarily 
interview the 
same staff 
member as was 
surveyed 
Lewington et 
al. 
2006 
United 
Kingdom 
(Lewington and 
Marshall, 2006) 
Observational 
(pharmacy 
record review)  
CLIENTS: 
n=203 
females, 
aged 13-20, 
requesting 
ECPs from 
two family 
planning 
clinics, and 
community 
pharmacies  
Differences in 
access 
experience 
between young 
women 
accessing ECPs 
at family 
planning clinics 
vs community 
pharmacy 
settings 
ECPs in study 
community 
could be 
provided free 
to women 
<20.  Women 
<16 who 
could 
demonstrate 
competence 
also had 
access 
Weak but significant 
inverse correlation 
between age and time to 
access ECPs via pharmacy    
 
Clients <16 significantly 
more likely to not have 
used any form of 
contraception  
 
Clients took significantly 
less time to access ECPs 
from pharmacies (41hrs 
median at clinic compared 
to 16hrs at pharmacy) 
Specific focus 
on women 
age 20 and 
under, data 
age-
disaggregated
, provides 
needed focus 
on younger 
adolescents 
(16 and 
under) 
Small sample of 
youth under age 
16 
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Foster et al. 
2006 
United States 
(California) 
(Foster et al., 
2006) 
Cross-sectional 
(questionnaire) 
  
CLIENTS:  
n=426 
females, 
aged 13-47, 
requesting 
ECPs from 
25 
pharmacies 
participating 
in the direct 
ECP access 
program 
Previous use of 
ECP, 
information on 
unprotected 
intercourse, 
reason for 
requesting ECP 
and barriers to 
obtaining ECP  
Post training, 
pharmacists 
can be 
certified to 
provide ECP 
without a 
prescription. 
No federal 
law in place 
providing 
prescription-
free access. 
Pharmacy faster and more 
convenient than a doctor 
 
Interest in getting more 
SRH services from 
pharmacist 
(contraceptives, STI 
testing) 
 
<16s took 27 hours longer 
to access ECP than women 
aged 30+, clinically and 
statistically significant 
delay 
Questionnaire 
completed on 
site, reducing 
barriers to 
participation  
 
Demographic 
information 
available for 
all women 
accessing 
ECPs 
Operating hours 
of pharmacies 
affected time to 
obtain ECP 
 
Respondent bias 
– participants 
women who 
requested ECP  
Peremans et al. 
2007 
Belgium 
(Peremans et 
al., 2007) 
Qualitative  
(focus group 
discussion) 
  
PROVIDERS:  
n=33 (4 
FGDs) 
general 
practitioners 
 
n=24 (3 
FGDs) 
pharmacists 
 
n=26 (5 
FGDs) 
school 
physicians 
Health 
professionals’ 
experiences 
dealing with ECP 
requests  
ECP are 
accessible in 
pharmacies 
free of charge 
Pharmacists report many 
ECPs sold in weekend and 
evenings, reluctance to 
dispense to men and 
young girls 
 
Concern with privacy in 
pharmacy and community 
for counselling young 
patients 
 
Pharmacists at ease with 
opportunity to help 
adolescents, quality 
counselling by pharmacists 
a concern, often refer to 
GPs  
Asking similar 
questions of 
three cadres 
of health 
workers to 
triangulate 
experiences 
 
Including 
health 
professionals 
from both in-
school and 
out-of-school 
settings 
Assessed only 
self-report of 
behaviour - no 
other way to 
compare 
reported views 
and behaviour 
to actual 
performance 
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Griggs et al. 
2007 
United States 
(Texas) 
(Griggs and 
Brown, 2007) 
Cross-sectional 
(mail-in survey) 
PROVIDERS: 
n=148 
community 
pharmacists 
  
Knowledge and 
perceptions of 
ECP and 
dispensing 
ECPs only 
available by 
prescription 
Respondents (57.7%) 
believed patients receiving 
ECP should be a certain 
age: mean of 17.25 years 
Extensive 
piloting of 
study 
instrument 
prior to its 
implementati
on 
Minimal youth-
related data 
Delotte et al. 
2008 
France 
(Delotte et al., 
2008) 
Qualitative 
(adolescent 
mystery client 
requesting ECPs) 
CLIENTS: 
n=53 
pharmacies 
visited by 
MC 
 
random 
sample of all 
pharmacies 
in the city 
Adolescent 
experience 
obtaining ECPs 
in pharmacies 
ECPs available 
anonymously 
and for free 
through 
pharmacies to 
minors who 
meet 
dispensing 
criteria  
Over 1/3 were refused 
ECPs 
Of those that provided, 1/3 
asked for ID, almost half 
asked to confirm minor 
status 
 
Fewer than half that 
provided gave information 
on use or side effects. 
None provided additional 
SRH counselling 
Adolescent 
MC record 
actual rather 
than reported 
pharmacist 
behaviours 
Low 
generalizability 
Krishnamurti et 
al. 
2008 
United States 
(Pennsylvania) 
(Krishnamurti 
et al., 2008) 
Mixed-Methods 
(interviews and 
surveys) 
 
Structured 
surveys were 
administered 
either on paper 
or electronically 
and consisted of 
a combination of 
closed and 
open-ended 
questions  
CLIENTS:  
 n=30 
interviews 
 
n=125  
survey 
 
females 
aged 12-19, 
from 'at-risk' 
communities 
Peer decision-
making around 
sex and 
contraception, 
knowledge of 
ECPs, awareness 
and use of ECPs; 
prediction of 
effect of 
increased ECP 
availability on 
behaviour 
Federal 
approval of 
over-the-
counter sale 
of ECPs to 
women 18+ 
45.8% teens 16+ and 44% 
teens <16 thought their 
peers would have more 
unprotected sex with 
increased ECP access.  
 
When asked who should 
be able to purchase ECPs 
without a prescription, 
18% chose 'anyone aged 
12+', 43% chose 'anyone 
aged 16+' 23% chose 
‘anyone 18+' and 7% said 
no one.  
 
Focus on high-
risk 
populations 
(racial 
minorities, 
urban area) 
 
Open-ended 
interview 
guide allowed 
natural 
conversation 
among 
participants 
talking about 
Social 
desirability and 
response bias 
based on 
sensitivity of 
topics  
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<16s less likely to know 
about ECP, more likely to 
think that greater 
availability would increase 
unprotected sex  
a taboo 
subject  
Arnet et al. 
2009 
Switzerland 
(Arnet et al., 
2009) 
Pharmacy record 
review 
 
Official 1-page 
ECP written 
assessment form 
is used during 
consultation and 
helps 
pharmacists 
make the 
decision to 
administer ECPs   
CLIENTS: 
n=729 (380 
from 2003, 
349 from 
2006) 
females, 
aged 15-49, 
obtaining 
ECPs 
 
accessing 
ECPs from 
18 
pharmacies 
in three 
cities 
Profile of ECP 
users just after 
deregulation 
and three years 
later 
ECPs 
accessible 
without 
prescription 
in pharmacies 
for women 
16+, 
provided: a 
pharmacist 
dispenses, a 
counselling 
interview 
takes place 
Stratification of the study 
population by age groups 
showed no differences in 
the contraceptive methods 
used between groups  
 
Re-use significantly more 
frequent in Group 2006 
women aged 18–21 than 
Group 2003 (21.3% vs 
33.1%, p<0.001). 
Significant correlation 
observed between span of 
time until re-use and age 
(p< 0.01) 
Opportunity 
to assess 
client use of 
ECPs when 
deregulation 
took place 
and three 
years later 
 
Retrospective 
design 
assured that 
pharmacies 
were not 
biased by the 
study 
Forms based on 
patient recall 
and reporting  
 
No age-
disaggregated 
data provided 
on 
contraception 
use during ECP 
request period 
Brabin et al. 
2009 
United 
Kingdom 
(Brabin et al., 
2009) 
Pharmacy record 
review 
 
Pharmacists 
offered 
screening kit 
with 
questionnaire 
after completing 
the ECP protocol 
CLIENTS: 
n=2904 
females, age 
range 
unspecified, 
requesting 
ECPs 
  
Previous ECP 
use and 
chlamydia 
treatment 
ECPs available 
free, without 
prescription 
in pharmacies 
for women 
<25. 
Pharmacies 
also offered 
mail-in 
Chlamydia 
trachomatis 
screening 
Only one quarter of 
women provided ECPs 
were offered a chlamydia 
screening  
 
Using actual (rather than 
grouped) ages, there was a 
significant increase in the 
number of positive tests 
with age.  
 
Pharmacy 
records during 
study allowed 
for later 
screening of 
proportion of 
kits offered to 
clients, and 
proportion of 
kits accepted 
and returned 
by clients 
Lack of 
understanding 
why clients did 
not return the 
test, uncertainty 
as to whether 
clients felt 
obligated to 
accept test kits 
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24/264 returned samples 
in total were positive 
(9.1%) 
Sampson et al. 
2009 
United States 
(California) 
(Sampson et 
al., 2009) 
Mixed-methods 
(mystery client 
(MC) and 
interview) 
 
MC phone calls 
to pharmacies in 
English and 
Spanish, posing 
as a 15- or 18-
year-old needing 
ECPs  
 
  
BOTH: 
n=115 
pharmacies 
called with 
mystery 
clients 
 
n=22 
pharmacists 
and clinical 
providers 
interviewed 
Comfort 
providing ECP to 
adolescents; 
ability for 
adolescent to 
obtain method 
<18s can 
obtain ECPs 
without a 
prescription 
from 
designated 
pharmacies. 
~1/5 of state 
pharmacies 
enrolled in 
this system  
Rural pharmacies calls less 
successful than urban, 
Spanish speakers less 
successful than English 
speakers  
 
Pharmacist concern with 
effect on young girls, 
whether they were 
appropriate health 
professional to prescribe 
 
Those who did dispense 
cited desire to help young 
women 
Study design 
provides 
opportunity to 
compare 
reported vs 
actual 
behaviour  
 
MC 
represented 
understudied 
adolescent 
populations  
Did not assess 
actual provision 
of ECPs 
 
Cannot 
determine how 
age related to 
accessing ability  
Glasier et al. 
2010 
United 
Kingdom 
(Scotland) 
(Glasier et al., 
2010) 
Qualitative 
(mystery client) 
 
Young MC 
visited 
pharmacies with 
a variety of 
scenarios.  
CLIENTS: 
n=40  
pharmacies 
visited by 
mystery 
clients 
  
ability for youth 
to obtain ECPs, 
information 
provided by 
pharmacist, 
perceived 
attitude, privacy 
of consultation 
space 
ECPs available 
for free, 
without a 
prescription 
from 
pharmacies to 
women aged 
13+ across 
Scotland, 
through 
nationwide 
patient group 
direction 
ECP was dispensed in 26 of 
40 (65%) pharmacies. In 12 
(43%) pharmacies where 
ECP was offered, MC asked 
about future plans for 
contraceptive use. 
 
A consultation occurred in 
35 pharmacies, 83% in a 
private consultation room 
 
31 pharmacists (98%) 
considered to be non-
judgemental; 12 were very 
pleasant (34%), 18 
pleasant (51%) 
Random 
selection of 
pharmacies 
for study 
inclusion 
 
Single MC 
visited 
included 
pharmacies, 
completed 
data 
collection 
form 
immediately 
Youth never 
explicitly 
explored, study 
was included 
because 
mystery clients 
are below 25. 
For all intents 
and purposes, 
this is a study of 
adults 
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following 
visits 
Potter et al. 
2010 
United States-
Mexico border 
(Potter et al., 
2010) 
Cross-sectional 
(in-person, 
structured 
survey) 
CLIENTS: 
n=1046 
females, 18-
44 accessing 
OC from a FP 
clinic in 
Texas 
(n=532) or a 
pharmacy in 
Ciudad 
Juarez 
(n=514) 
Experience 
obtaining pills 
and perceived 
advantages and 
disadvantages 
of using that 
source. 
OC available 
free from FP 
clinics in 
United States. 
Women can 
also buy 
contraception 
in Mexico 
without 
prescription 
Age positively associated 
with crossing the border to 
access oral contraception 
from Mexican pharmacies 
 
More US clinic users 
among 18-24 (34% v 23% 
using Ciudad Juarez 
pharmacy) 
Study 
participants 
contain large 
number of 
traditionally 
understudied 
women: 
Spanish-
speaking, low 
income 
Many factors 
explain 
reluctance to 
cross 
international 
border 
 
Minimal age-
disaggregated 
data 
Thomas et al. 
2010 
United 
Kingdom 
(Thomas et al., 
2010) 
Qualitative 
(interviews) 
PROVIDERS:  
n=26 
pharmacists 
completing 
questionnair
e 
 
n=12 
pharmacists 
interviewed 
 
Recruited 
from 
pharmacies 
participating 
in Chlamydia 
trachomatis 
screening  
Experience 
providing 
screening kits to 
clients, 
including why 
many 
pharmacists did 
NOT offer 
screening to 
eligible clients 
Pharmacies in 
study area 
offer free 
ECPs to 
women under 
25 years of 
age. 
Participating 
pharmacies 
also offered 
postal 
chlamydia 
screening 
Pharmacists’ decision to 
offer screening was 
personal rather than 
financial. None willing to 
approach a client in a long-
term relationship 
 
Pharmacists felt ideally 
placed to talk to clients 
 
Less educated clients 
would not see benefit of 
screening 
 
<20s seen as poorly 
informed and at higher risk 
because of 'promiscuity', 
more likely to take a kit. 
Discrepancies 
in knowledge 
versus 
behaviour 
reported in 
questionnaire 
could be 
probed during 
the in-depth 
interview  
Sample was 
pharmacists 
who opted to 
participate in 
the screening 
program. This 
group displayed 
low adherence 
to protocol, in 
that many did 
NOT offer 
screening to 
eligible clients 
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<16s seen as more 
reluctant and shy 
Dabrera et al. 
2011 
United 
Kingdom 
(Dabrera et al., 
2011) 
Qualitative 
(semi-structured 
interviews) 
PROVIDERS: 
n=10 
pharmacists 
from 
pharmacies 
registered 
with 
Chlamydia 
trachomatis 
screening 
program 
  
Challenges to 
offering 
chlamydia 
screening 
Nationwide 
chlamydia 
screening 
program 
offers 
screening 
opportunistic
ally to young 
people (aged 
15-24) in 
pharmacies 
Concerns about privacy 
available. Concerns also 
expressed about offering 
screening to less-
knowledgeable <16s 
 
Perception that screening 
only appropriate in 
relation to other SRH 
services and that it was 
difficult to bring up 
screening when clients 
attended for non-SRH 
complaints. Suggestion to 
use leaflets or promotions 
to encourage screening 
Pharmacists 
interviewed 
reflected mix 
of multiple-
site and 
single-site 
pharmacies in 
the study area 
  
Very small 
sample size, 
subject to 
volunteer bias - 
only 10 of 17 
pharmacists 
approached 
agreed to 
participate 
  
Mackin et al. 
2011 
United States 
(Iowa) 
(Mackin and 
Clark, 2011) 
Cross-sectional 
(telephone 
survey including 
closed and 
open-ended 
questions) 
PROVIDERS: 
n=713 
pharmacies, 
(surveyed 
405 before 
and 308 
after policy 
change 
allowing 
sales of ECPs 
to women 
18+)  
Availability of 
ECPs and 
reasons for 
continued non-
availability 
During data 
collection, 
ECPs 
approved for 
sale without 
prescription 
in pharmacies 
to women 
18+  
After deregulation, 70% of 
pharmacies had ECP 
available  
 
Percentage of pharmacists 
who agreed that ECP is 
safe for teens actually 
decreased significantly, 
from 43.8% before to 
27.9% after deregulation 
State-wide 
study  
 
Comparison of 
stocking 
practices and 
pharmacist 
beliefs before 
and after 
policy change 
Minimal youth-
related data  
 
21% of 
pharmacies 
declined to 
participate in 
study, response 
bias  
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Ehrle et al. 
2011 
Nicaragua 
(Ehrle and 
Sarker, 2011) 
Cross-sectional 
(researcher-
administered 
semi-structured 
survey) 
PROVIDERS:  
n=93 
pharmacy 
personnel  
 
random 
sample of all 
licensed, 
operating 
pharmacies 
in the city 
Knowledge of 
and attitudes 
towards ECPs 
ECPs not 
available 
through 
public health 
services, but 
are available 
with or 
without 
prescription 
in private 
pharmacies 
Majority of participants 
(85%) believed that 
females <16 could not 
safely take ECPs 
 
Concern selling ECPs 
because adolescents could 
abuse it 
 
13% would sell to a minor 
without parental consent. 
Men more willing than 
women to provide to 
minors 
Selected 
pharmacies 
visited up to 
three times 
during study 
in order to 
obtain face-
to-face 
interviews 
with eligible 
participants 
Results not 
generalizable to 
rest of the 
country  
 
Recall and social 
desirability bias 
based on topic 
sensitivity 
Maharaj et al. 
2011 
South Africa 
(Maharaj and 
Rogan, 2011) 
Qualitative  
(in-depth 
interviews) 
PROVIDERS: 
n=30 
retail 
pharmacists 
(n=20), 
health 
workers 
from NGO-
operated FP 
clinics (n=2), 
nurses from 
public clinics 
(n=6), nurses 
from public 
FP clinics 
(n=2)   
Health workers' 
views and 
experiences 
supplying ECPs 
ECPs available 
without a 
doctor's 
prescription. 
Accessible in 
public health 
facilities at no 
cost and are 
sold in 
commercial 
pharmacies 
Providers in private 
facilities report that 
requests for ECP on the 
rise among young women. 
 
Concern of ECP promoting 
sexual promiscuity among 
young people. Private 
sector (pharmacists) only 
stock dedicated ECPs 
because the product is 
more expensive, so people 
need to 'think twice'   
 
Providers reported 
refusing to supply ECPs 
because unsure about age 
at which a client can 
purchase EC products 
In-depth 
perspectives 
of public 
sector health 
providers, 
commercial 
pharmacists, 
and 
specialized FP 
providers 
 
Study 
provides 
opportunity to 
explore 
lingering 
barriers to 
ECP provision 
Limited youth-
related data  
 
Lack of privacy, 
frequent 
interruptions, 
and suspicion 
towards the 
research 
 
Social 
desirability and 
recall bias  
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without a guardian's 
consent 
Rafie et al. 
2011 
United States 
(California) 
(Rafie and El-
Ibiary, 2011) 
Cross-sectional 
(self-
administered, 
web-based or 
paper survey) 
  
PROVIDERS: 
n=502 
pharmacy 
students 
 
recruited 
from all 
California 
schools of 
pharmacy 
Willingness to 
provide 
contraception 
to minors 
ECPs available 
without 
prescription 
in pharmacies 
to women 
18+. State 
regulation 
allows trained 
pharmacists 
to sell ECPs to 
all women. 
Student pharmacists 
indicated interest (96.2%) 
in providing hormonal 
contraception (pill, patch, 
and ring) under state-wide 
protocol to both minors 
and adults (53.3%), adults 
only (40.6%), or minors 
only (6.2%) 
Opportunity 
to assess 
views of new 
pharmacy 
practitioners 
 
Comprehensiv
e coverage of 
all schools of 
pharmacy in 
state 
Limited youth-
related data, as 
questionnaire 
contained only 
one question 
about 
willingness to 
provide to 
minors 
Rubin et al. 
2011 
United States 
(nationwide) 
(Rubin et al., 
2011) 
Cross-sectional 
(self-
administered, 
web-based 
survey) 
CLIENTS: 
n=531 
females, 
aged 14-19, 
who had 
engaged in 
unprotected 
intercourse 
when they 
were aware 
of ECPs 
Access to ECPs, 
barriers to use, 
satisfaction with 
access 
experience 
ECPs available 
without 
prescription 
in pharmacies 
to women 
18+ (17+ by 
study end).  
9 states allow 
access 
without age 
limits 
Participants obtaining ECPs 
without prescription more 
likely to use within 24 hrs 
of unprotected sex than 
those who obtaining with 
prescription (OR: 2.17, 
p<.05) 
 
Minors who obtained in 
pharmacist access states 
more likely to report 
satisfaction with their 
experience (OR: 3.05 
p<.05) 
Ability to 
compare 
experiences of 
adolescents in 
states with 
and without 
pharmacy 
access 
Not able to 
calculate a 
response rate  
 
Response bias  
 
Social 
desirability bias  
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Apikoglu-Rabus 
et al. 
2012 
Turkey 
[50] 
Cross-sectional 
(self-
administered, 
web-based 
survey) 
PROVIDERS: 
n=667 
pharmacists 
 
recruited 
from a 
professional 
networking 
website/onli
ne forum for 
pharmacists 
Counselling 
practices and 
attitudes 
regarding ECP 
ECPs are 
meant to be 
dispensed 
with a 
physician's 
prescription. 
In practice, 
customers 
can purchase 
products 
directly from 
community 
pharmacies 
Only 52-57% of 
pharmacists had positive 
attitude towards: 
'teenagers and youngsters 
can take responsibility for 
the use of ECPs’; ‘ECPs give 
women increased sexual 
safety’; and ‘ECPs increase 
women's control of 
reproduction' 
 
58% of pharmacists agreed 
ECP should be limited for 
sale to 18+. 52% agreed 
that teenagers can 
responsibly use ECP 
Comparisons 
between 
pharmacist 
practices 
based on sex 
and age of 
pharmacists 
 
Insight into 
practice when 
policy does 
not permit 
dispensing 
without a 
prescription 
Recall/social 
desirability bias 
- self-completed 
survey on 
sensitive topic 
 
Limited focus on 
youth as study 
asked ECP 
dispensing in 
general 
Raine et al. 
2012 
United States 
(various) 
(Raine et al., 
2012) 
Longitudinal 
 
Pharmacy 
availability of 
ECPs simulated, 
eligible 
participants read 
study product 
label and self-
determined 
whether to use 
the product (and 
how) 
CLIENTS: 
n=345 
females, 
aged 11-17, 
requesting 
ECPs  
  
ECP use, 
pregnancy, and 
adverse events 
ECPs 
approved for 
sale without 
prescription 
in pharmacies 
to women 
17+ 
nationwide 
during data 
collection. 
Study 
simulates 
access for 
women 11+ 
96.7% (298) of participants 
who received product used 
it by the 1-week follow-up. 
274 (92.9%) correctly used 
it <72 hrs after 
unprotected sex  
 
Neither age nor previous 
use of emergency 
contraception associated 
with correct use 
 
1 in 5 participants who 
used study product 
reported additional ECP 
use within the follow-up 
period 
Participant 
self-screen on 
ECP offers 
detailed data 
on label 
comprehensio
n and access 
competency 
for young 
adolescents  
 
Special focus 
on including 
young 
adolescents in 
sample 
Response bias - 
recruitment 
from FP clinics, 
means 
recruiting care-
seeking youth 
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Richman et al. 
2012 
United States 
(Florida) 
(Richman et al., 
2012) 
Cross-sectional 
(self-
administered, 
mail-in survey) 
PROVIDERS: 
n=272 
practicing 
pharmacists 
 
random 
sample of 
registered 
pharmacists 
in the state 
of Florida 
Knowledge and 
attitudes 
around ECP 
dispensing as 
well as actual 
dispensing 
experience 
ECPs 
approved for 
sale without 
prescription 
in pharmacies 
to women 
18+ 
nationwide. 
State 
conscience 
clauses allows 
for refusal to 
dispense  
Reported comfort in 
dispensing ECPs varied: 
67% reported comfort 
dispensing to adult 
women; 42% to men, 39% 
to adolescents 
Randomly 
selected 
sample of 
pharmacies 
 
Survey 
instrument 
was pilot 
tested for face 
validity. 
Construct 
validity and 
reliability also 
established 
Selection bias - 
only English-
speaking 
pharmacists  
 
Low 
generalizability  
 
Limited youth-
related data 
Wilkinson et al. 
2012 
United States 
(various) 
(Wilkinson et 
al., 2012) 
Qualitative 
(mystery caller) 
 
Mystery client 
telephone calls 
to pharmacies 
posing as 17-
year-old in need 
of ECP or the 
physician of a 
17-year-old 
patient in need 
of ECP 
CLIENTS: 
n=943 
every 
commercial 
pharmacy in 
five US 
cities, called 
by mystery 
client 
  
Accuracy of 
information 
provided to 
adolescents and 
physicians of 
adolescents 
when 
requesting ECPs 
ECPs 
approved for 
sale without 
prescription 
in pharmacies 
to women 
17+ 
nationwide  
Average estimated time for 
medication to be available 
significantly higher for 
adolescents than 
physicians (45 vs 39 hrs, 
p<.0001) 
 
Adolescent callers placed 
on hold more (54% vs 26%, 
p<.0001) and less likely to 
talk to pharmacist (3% vs 
12%, p<.0001) than 
physicians  
 
19% adolescent callers told 
they could not obtain ECP 
at all (vs. 3% in physician 
calls, p<.0001) 
Comprehensiv
e sampling of 
commercial 
pharmacies  
 
Adolescent vs. 
physician MC 
calls 
separated by 
at least two 
weeks  
Calls made only 
during normal 
business hours. 
Cannot know 
how 
evening/weeken
d calls would 
have been 
answered  
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Samartzis et al. 
2012 
Switzerland 
(Samartzis et 
al., 2012) 
Pharmacy record 
review 
 
Retrospective 
analysis of one-
page patient 
assessment 
forms and 
protocol  
CLIENTS: 
n=1500 (750 
in 2004, 750 
in 2009) 
females, 
aged 15-49, 
requesting 
ECPs  
  
Profiles of ECP 
users following 
deregulation 
ECPs available 
for free 
without 
prescription 
for all women 
15+, following 
a medical 
history and a 
pregnancy 
test 
Most ECP users who had 
never visited a 
gynaecologist were <21  
 
Number of repeat ECP 
users rose between 2004 
and 2009  
 
For <20s, condom rupture 
reported significantly more 
frequently as reason for 
ECP use 
Ability to 
assess profiles 
of ECP users 
over time - 
shortly after 
deregulation 
of ECPs and 
five years 
later 
Generalizability 
- recruitment 
took place in 
only one 
pharmacy 
Parsons et al. 
2013 
United 
Kingdom 
(London) 
(Parsons et al., 
2013) 
Mixed methods 
(pharmacy 
record review, 
structured 
questionnaire, 
mystery client) 
 
MC evaluations 
conducted at 
three 
pharmacies, 
using trained 
adolescent 
women 
CLIENTS:  
n=741 
consultation
s  
 
n=99  
females 
client 
intercept 
questionnair
e 
 
n=19 
pharmacy 
visits by MC 
  
Data on 
consultations, 
client 
satisfaction with 
pharmacy 
experience 
Special 
program in 
select 
pharmacies to 
supply oral 
contraceptive
s without 
prescription 
to eligible 
women 16+, 
following 
pharmacist 
training 
Over 40% of consultations 
were with 20-24 year-olds 
(largest proportion), 22.5% 
were with <19s 
 
A majority of adolescent 
mystery clients rated 
counter staff as helpful, no 
one felt uncomfortable at 
the counter, all were 
happy with the privacy, 
most were happy with the 
wait time 
 
Overall, majority of MCs 
were satisfied by 
experience 
Combination 
of pharmacy 
consultation 
data, client 
intercept 
interviews, 
and mystery 
client visits 
offers ability 
to 
contextualize 
provision data 
with reported 
contraceptive-
accessing 
experiences 
MC data is the 
only extractable 
data - other 
data not 
presented with 
age 
disaggregation 
 
Small sample 
size for mystery 
client exercise  
Both et al 
2014 
Ethiopia 
(Both and 
Samuel, 2014) 
Qualitative 
(observations, 
survey, 
interviews) 
  
BOTH: 
n=36 
(survey) 
females and 
males, aged 
youth 
experiences 
accessing ECPs, 
attitudes and 
beliefs of 
ECPs available 
in private 
sector 
pharmacies 
and drug 
Pharmacists worried about 
side effects (e.g. infertility 
or cancer), concerned that 
young people think only of 
pregnancy and not 
Combination 
of 
observation, 
questionnaire, 
and 
Survey data not 
age 
disaggregated, 
making only 
some of the 
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18-29 
 
n=41 
(interviews) 
males and 
females 
(aged 15-
29), adult 
stakeholders
, healthcare 
providers 
 
Observation
s of ECP 
dispensing  
policymakers 
and providers 
around ECP 
access 
stores 
without 
prescription 
preventing HIV/AIDS  
 
Sundays and Mondays 
were popular for ECP 
selling, along with holidays  
 
Providers intimidated to 
counsel youth who want to 
be in and out quickly  
 
Nearly all young people 
ensured visit was discreet. 
Secrecy and shame 
identified as key to young 
people’s experiences of 
sexuality 
interviews 
offer the 
opportunity to 
contextualize 
observed and 
reported 
behaviour  
 
Detailed 
observations 
and surveys of 
both young 
men and 
women 
accessing 
ECPs in 
pharmacies 
qualitative data 
usable  
 
Limited 
generalizability 
 
Recall bias given 
the sensitivity of 
the topic  
Rafie et al. 
2014 
United States 
(California) 
(Rafie and El-
Ibiary, 2014) 
Cross-sectional 
(self-
administered, 
web-based or 
paper survey) 
  
PROVIDERS:  
n=502 
pharmacy 
students 
 
recruited 
from all 
California 
schools of 
pharmacy 
Confidence 
ordering HC for 
minors 
ECPs for sale 
without 
prescription 
in pharmacies 
to women 
18+. 
Agreement 
allows trained 
pharmacists 
to sell ECPs to 
all women 
68.7% of pharmacy 
students claimed to be 
moderately to extremely 
confident ordering HC for 
minors 
Opportunity 
to assess 
views of new 
pharmacy 
practitioners 
 
Comprehensiv
e coverage of 
all schools of 
pharmacy in 
state 
Limited youth-
related data 
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Wilkinson et al. 
2014  
United States 
(various) 
(Wilkinson et 
al., 2014) 
Qualitative 
(mystery client) 
 
Mystery client 
telephone call, 
posing as 17 
year old needing 
ECP and asking 
about 
availability of 
ECP 
CLIENTS: 
n=943 
every 
commercial 
pharmacy in 
five US 
cities, called 
by mystery 
client  
Experiences of 
adolescents 
attempting to 
obtain ECPs 
from 
pharmacies 
ECPs 
approved for 
sale without 
prescription 
in pharmacies 
to women 
17+ 
nationwide 
80% of pharmacies had 
ECP available on the day 
the call was made, 57% of 
available pharmacies 
provided correct 
information to the caller 
regarding ECP access 
 
Pharmacy staff used 
ethics-laden terminology 
to explain policies on 
dispensing ECP 
 
Pharmacy staff attempting 
to help the caller by 
clarifying regulations often 
created barriers 
Comprehensiv
e sampling of 
commercial 
pharmacies  
 
Investigator, 
expert and 
informant 
triangulation 
were all used 
to ensure 
credibility of 
the data 
analysis 
In-depth 
discussions with 
pharmacy staff 
not possible due 
to study design 
Barlassina et al. 
2015 
Republic of 
Ireland 
(Barlassina, 
2015) 
Cross-sectional 
(self-
administered 
survey with both 
closed and 
open-ended 
questions) 
  
CLIENTS: 
n=488 
females, 
aged 18-50, 
presenting a 
prescription 
for oral 
contraceptio
n for 
personal use 
  
Attitudes and 
views on making 
oral 
contraceptives 
available 
without 
prescription 
Oral 
contraception 
available with 
prescription 
Main reason for having 
missed a pill for youth (18-
25) was for prescription 
running out (50.3%). 32.8% 
reported inability to renew 
a prescription as a reason 
for missing a pill 
 
Youth in favour of making 
hormonal contraception 
available without a 
prescription (85.6%) and 
likely to obtain hormonal 
contraception without a 
prescription (89.7%) 
Pharmacies 
were located 
in both rural 
and urban 
areas 
 
Participants 
were existing 
OC users, and 
could 
therefore 
comment on 
related 
personal 
experiences  
Selection bias –
participants 
were only 
current OC 
users 
 
Target sample 
size was not 
reached 
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Fakih et al. 
2015 
United States 
(Michigan) 
(Fakih et al., 
2015) 
Cross-sectional 
(self-
administered 
survey) 
  
BOTH:  
n=343 
female, aged 
23-24 
 
n=94 
all 
community 
pharmacies 
in the 
selected 
county  
Young women's 
perceptions and 
experiences 
with 
contraception 
supply 
ECPs 
approved for 
sale without 
prescription 
and age limit 
nationwide. 
Hormonal 
contraception 
requires 
prescription 
Young women in this study 
did not feel as comfortable 
talking about 
contraceptives with 
pharmacists as with others 
 
Overall, 51.3% of young 
women had a positive 
attitude toward pharmacy 
purchase of contraception 
Linking client 
survey data 
with 
pharmacy 
survey data 
allowed for an 
examination 
of a woman's 
experience in 
the specific 
pharmacy she 
visited 
Very narrow age 
range (23-24), 
not a random 
sample, fairly 
homogenous 
participants 
demographics 
limiting 
generalizability 
Hussainy et al. 
2015 
Australia 
(Hussainy et 
al., 2015) 
Qualitative 
(mystery client) 
 
Mystery client 
telephone calls 
to pharmacies 
including one 
scenario where a 
woman under 16 
years requested 
ECPs 
CLIENTS: 
n=168 
pharmacies 
contacted by 
mystery 
caller 
  
Pharmacist 
decisions to 
provide ECPs or 
not, 
justifications for 
decisions 
ECPs available 
without 
prescription 
in pharmacies 
without age 
restriction (if 
competence 
can be 
demonstrated
)  
41.8% (69/165) declined 
ECP supply.  
 
Reasons pharmacists were 
unwilling to supply: 
- woman was <16; or 
- woman was under 
another specified age  
Other justifications 
included:  
- uncertainty of the safety 
of the ECP or limited data 
regarding its use in 14-16 
year olds    
Telephone 
scripts narrow 
on specific 
component of 
ECP provision 
by 
pharmacists: 
assessing 
pharmacists' 
persistent 
myths/miscon
ceptions 
around ECP 
provision 
 
Random 
sample of 
pharmacies 
selected 
Hawthorne 
effect from 
participants 
receiving 
mystery client 
calls soon after 
being alerted to 
the study 
 
Calls (during 
normal business 
hours) may have 
affected the 
number of 
referrals 
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Manski et al. 
2015 
United States 
(nationwide) 
(Manski and 
Kottke, 2015) 
Cross-sectional 
(self-
administered, 
web-based 
survey, following 
review of a 
mock-up label 
for over-the-
counter oral 
contraceptives) 
CLIENTS: 
n=348 
female, aged 
14-17 
 
recruited via 
Facebook 
advertiseme
nts 
Teenagers' 
attitudes 
towards over-
the-counter 
access to oral 
contraceptives  
Hormonal 
contraception 
available only 
with 
prescription 
Nearly 80% supported 
pharmacy access to oral 
contraceptives, 73% 
supported OTC access to 
contraceptives (60.9% 
indicating they would likely 
use the service) 
 
Greatest advantages of 
increased access: fewer 
teen pregnancies (44.5%), 
easier for teens to get OC 
(22.4%), and more 
confidential (13.5%) 
 
Greatest disadvantages of 
increased access: 
teenagers might not use 
condoms to protect 
against STDs (21.6%), need 
a doctor to decide if oral 
contraceptives are safe for 
teens (18.7%), teens might 
have sex at a younger age 
(18.%), teens might use 
oral contraceptives 
incorrectly (15.8%) 
Focus on 
younger 
adolescents 
(14-17) 
 
Participants 
asked to 
distinguish 
between OTC 
access and 
behind-the-
counter 
access 
 
Study 
provides data 
both on 
younger 
adolescents’ 
interest and 
ability to 
access OC in a 
pharmacy 
Convenience 
sample impacts 
generalizability  
 
Selection bias - 
having to 
actively select 
(via online 
clicks) to 
participate in 
the survey 
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3.4 Results 
Of the 45 studies identified from the 49 abstracted articles, a majority were from high-income countries, 
most notably the United States (22 articles, including one that spanned the US-Mexico border) and the 
United Kingdom (12 articles). Only six articles were from low- and middle-income countries. Emergency 
contraceptive pills (ECPs) were the subject of 33 of the 49 articles; the remaining 16 included provision 
of misoprostol as an abortifacient (one article); oral contraception (seven articles); STI self-screening kits 
(four articles); and SRH commodities in general (four articles). Most (n=28) described client (real or 
simulated) experiences, 17 described the experiences of the pharmacist or pharmacy personnel, while 
the remaining four provided both pharmacists’ and clients’ perspectives. Ten of the 49 articles included 
only adolescent populations (10-19 years), while an additional six focused specifically on youth (10-25 
years). The remaining studies included a broader age range of clients but contained enough age-
disaggregated data that we could report on some adolescent- or youth-related findings. The use of 
mystery clients to assess client experience in pharmacies was a popular methodology and featured in 
ten articles. Below, we summarize our findings into thematic areas. 
 The appeal of pharmacies for reaching young people 
Young people expressed satisfaction with their experience accessing SRH commodities from pharmacies 
(Sucato et al., 2001, Glasier et al., 2010, Rubin et al., 2011, Parsons et al., 2013). Users cited convenience 
as a major draw of pharmacies, specifically their longer operating hours (including evenings and 
weekends) (Peremans et al., 2007, Both and Samuel, 2014, Wilson and Williams, 2000), accessible 
locations (Sucato et al., 2001), and ease of commodity access (Barlassina, 2015, Manski and Kottke, 
2015). Five articles cited the speed to obtain SRH commodities, such as oral contraception or ECPs, as a 
major draw of pharmacy access (Rubin et al., 2011, Parsons et al., 2013, Barlassina, 2015, Lewington and 
Marshall, 2006, Raine et al., 2012). Young people accessed emergency contraception (ECP) faster, with 
fewer hours elapsing from the time of unprotected sex, when ECPs were available over-the-counter or 
without a prescription as compared to clinic or prescription access (Rubin et al., 2011, Lewington and 
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Marshall, 2006). Corroborating these findings, having to obtain a prescription for a needed SRH 
commodity was cited as an obstacle to access for young women in two studies (Barlassina, 2015, Landau 
et al., 2006). 
With regards to anonymity and privacy, the evidence was mixed. Some clients reported privacy as one of 
the advantages of pharmacy provision (Sucato et al., 2001, Glasier et al., 2010, Parsons et al., 2013, 
Manski and Kottke, 2015); however clients and providers also noted a lack of privacy – particularly when 
running through commodity dispensing protocols, or other screening procedures -- as a key concern 
(Peremans et al., 2007, Delotte et al., 2008, Dabrera et al., 2011). 
 SRH Outcomes and ease of use 
3.4.2.1 Repeated ECP use and risky behaviours 
Over one-quarter of the included articles assessed the relationship between pharmacy availability of 
SRH commodities on a variety of SRH outcomes. While updated evidence-based recommendations 
dismiss the notion that repeat use of ECPs is detrimental to women’s health (World Health Organization, 
2015), concerns about repeat use were common at the time of data collection for a number of studies. 
In two studies, easing access to ECPs did not result in repeat use among young women when compared 
to older women (Raymond et al., 2004), or compared to traditional clinic access (Raine et al., 2005). In 
particular, two articles from a randomized controlled trial of 15-24 year olds as well as a 15-19 year old 
subpopulation, found that young women with access to ECPs through pharmacies were no more likely 
to use them than those who obtained their ECPs through traditional family planning clinics (Raine et al., 
2005, Harper et al., 2005). However, two Swiss studies found an increase in repeat use among young 
women following ECP deregulation (Samartzis et al., 2012, Arnet et al., 2009). 
Evidence from three articles found that increasing access to ECPs through pharmacies did not result in a 
rise in sexually risky behaviours such as age at first sex, number of partners, or frequency and 
consistency of condom use (Raine et al., 2005, Harper et al., 2005, Raymond et al., 2003). Additionally, 
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increased access had no adverse effect on unintended pregnancy and STIs (Harper et al., 2005, Raymond 
et al., 2003). 
3.4.2.2 Appropriate self-screen and product use 
When provided the opportunity, young women proved capable of accessing and correctly using 
emergency contraception without pharmacist assistance (Rubin et al., 2011, Raine et al., 2012, Raymond 
et al., 2003). Using ‘simulated’ over-the-counter conditions, minors (girls under age 18) could self-screen 
and use ECPs (Raine et al., 2012), and were no more likely than older women to use the product 
incorrectly (Raymond et al., 2003). 
Importantly, based on pharmacy-level surveys and questionnaires, those under 25 years of age 
comprised a substantial proportion of total users in settings where pharmacies provided access to SRH 
commodities such as ECPs and oral contraception (Parsons et al., 2013, Killick and Irving, 2004, Lloyd and 
Gale, 2005, Foster et al., 2006). The only example where this was not the case was in a study that took 
place at the United States-Mexico border, which found that older women were more likely than younger 
women to cross the border to access oral contraception over-the-counter at a pharmacy (Potter et al., 
2010). However, these results likely reflect the complex dynamics associated with international border 
crossings for younger women.  
It is worth noting that three studies explored opportunities for expanding youth-targeted SRH services, 
namely through provision of self-test, mail-in STI (chlamydia) screening. One UK study offered chlamydia 
screening to young women requesting ECPs at pharmacies (Thomas et al., 2010, Brabin et al., 2009); a 
second UK study followed a national chlamydia screening program offered opportunistically to young 
people between 15-24 (Dabrera et al., 2011); while a third Dutch study targeted mainly ethnic minority 
young (15-29) women visiting pharmacies to collect contraception (Van Bergen et al., 2004). These 
studies had mixed results and low rates of kit acceptance – often due to reluctance on the part of the 
pharmacist to offer the kit (Thomas et al., 2010, Dabrera et al., 2011) - and kit return (between 17-27% 
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of offered kits were returned, as reported by the Dutch and one UK study) (Van Bergen et al., 2004, 
Brabin et al., 2009).  
 Reservations around increased access to SRH commodities 
As detailed above, lowering barriers to SRH commodity access does not translate to increases in sexually 
risky behaviour. Yet, a persistent reservation expressed by both pharmacy personnel and clients was 
that increased access was unsafe for young people and would result in young people making poor 
decisions (Both and Samuel, 2014, Manski and Kottke, 2015, Barrett and Harper, 2000, Seston et al., 
2001, Blanchard et al., 2005, Bissell et al., 2006, Krishnamurti et al., 2008, Mackin and Clark, 2011, Ehrle 
and Sarker, 2011, Maharaj and Rogan, 2011, Apikoglu-Rabus et al., 2012). In two U.S. studies, for 
example, adolescent girl participants voiced concerns that increased commodity availability might lead 
to teenagers having sex at an earlier age (Manski and Kottke, 2015) and engaging in unprotected sex 
(Manski and Kottke, 2015, Krishnamurti et al., 2008). 
Similarly, reservations by pharmacy personnel and other health care providers (including general 
practitioners and nurses) could be largely categorized in two ways. First, they believed that increasing 
availability of SRH commodities (ECPs, in particular) could result in ‘risky and promiscuous’ behaviour 
among youth (Barrett and Harper, 2000, Seston et al., 2001, Bissell et al., 2006, Maharaj and Rogan, 
2011). This notion that ECP availability condones or even encourages promiscuity among younger 
people persisted for some time after deregulation (Bissell et al., 2006, Maharaj and Rogan, 2011). A 
second key reservation of pharmacists and other health care providers centred around a general 
concern that SRH commodities (ECPs, in particular) were not safe for youth (Both and Samuel, 2014, 
Mackin and Clark, 2011), or that youth would not be able to take them as directed (Ehrle and Sarker, 
2011, Apikoglu-Rabus et al., 2012). 
Compounding these concerns about effects on health and behaviour are additional reservations on the 
appropriateness of pharmacy personnel themselves to provide expanded SRH services (Peremans et al., 
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2007, Manski and Kottke, 2015, Conard et al., 2003, Rafie and El-Ibiary, 2011, Richman et al., 2012, Rafie 
and El-Ibiary, 2014, Fakih et al., 2015). Pharmacists did not always feel that it was their place to 
prescribe medicine due to time constraints (Sampson et al., 2009), limited availability and privacy to 
provide quality counselling (Peremans et al., 2007), and feeling that they had not been well trained in 
adolescent-specific issues (Conard et al., 2003). Meanwhile, some clients were concerned about leaving 
the pharmacy without enough information (Wilson and Williams, 2000). 
Especially variable was the quality of reported interactions with clients around the offering or dispensing 
of SRH services and commodities (Peremans et al., 2007, Both and Samuel, 2014, Ratanajamit et al., 
2002, Dabrera et al., 2011, Thomas et al., 2010, Delotte et al., 2008, Fakih et al., 2015). Studies noted 
pharmacy staff’s discomfort (Dabrera et al., 2011, Thomas et al., 2010), even intimidation (Both and 
Samuel, 2014), in approaching clients as a reason that pharmacy interactions suffered. Several studies 
cited the pharmacy environment as a sub-optimal setting to provide proper counselling on SRH-related 
issues (Peremans et al., 2007, Both and Samuel, 2014, Wilson and Williams, 2000, Conard et al., 2003, 
Dabrera et al., 2011, Fakih et al., 2015). In particular, the lack of space and privacy (Peremans et al., 
2007, Dabrera et al., 2011), especially when a pharmacy was busy (Peremans et al., 2007, Both and 
Samuel, 2014), could be hindrances to meaningful pharmacist-client interactions and counselling.  
 Pharmacy access in theory is not pharmacy access in practice 
Even when made available through pharmacies, SRH commodity access was not uniform across age 
groups, with adolescents’ (ages 19 and under) access and uptake often less than that of older youth 
(Chin-Quee et al., 2006, Lewington and Marshall, 2006, Foster et al., 2006, Griggs and Brown, 2007, 
Apikoglu-Rabus et al., 2012, Hussainy et al., 2015); this was despite implied similar levels of need for the 
two groups, as indicated by ECP use (Harper et al., 2005) in an experimental setting. Two studies found 
that younger youth (especially those 18 and under) were consistently and significantly slower to access 
ECPs than older youth and adult women (Lewington and Marshall, 2006, Foster et al., 2006).  
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Evidence indicated that other sub-populations of youth may face additional challenges to access; two 
studies from the United States underlined added barriers encountered by rural communities and certain 
minority groups (particularly those for whom language is a barrier) from pharmacies which may opt not 
to stock desired commodities or from pharmacists who may not be able to provide proper screening or 
counselling (Mackin and Clark, 2011, Sampson et al., 2009). Additionally, two studies revealed a 
reluctance on the part of pharmacists to provide commodities (ECPs) to men (Wilkinson et al., 2014, 
Peremans et al., 2007), in one case out of concern that they may not be well informed about their 
partner’s health history or may take advantage of ECP access for use after rape (Peremans et al., 2007). 
Finally, in settings where SRH commodities are not subsidized or covered by insurance, commodity cost 
may serve as yet another barrier for youth. One South African study found many pharmacists opted to 
only stock dedicated ECP products because they were significantly more expensive than cut-up 
combined oral contraceptives, and would therefore discourage overuse by young people (Maharaj and 
Rogan, 2011). 
Pharmacists themselves could be an insurmountable obstacle for young people (Blanchard et al., 2005, 
Bissell et al., 2006, Chin-Quee et al., 2006, Delotte et al., 2008, Brabin et al., 2009, Glasier et al., 2010, 
Maharaj and Rogan, 2011, Wilkinson et al., 2012, Wilkinson et al., 2014, Hussainy et al., 2015). Six 
studies using mystery clients found that anywhere between 20% and 65% of the time, youth clients 
could not obtain the selected SRH commodity (ECPs or oral contraception), despite regulations allowing 
access (Chin-Quee et al., 2006, Delotte et al., 2008, Sampson et al., 2009, Glasier et al., 2010, Wilkinson 
et al., 2012, Wilkinson et al., 2014, Hussainy et al., 2015). Some evidence indicated differences in 
dispensing practices by sex; two studies found male pharmacists more willing than female pharmacists 
to provide ECPs to minors (Delotte et al., 2008, Ehrle and Sarker, 2011). Pharmacists reported using 
personal comfort and bias to decide whether or not to dispense commodities (Thomas et al., 2010, 
Dabrera et al., 2011, Ehrle and Sarker, 2011, Both and Samuel, 2014). Pharmacist biases about the 
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appropriate age to dispense commodities were common (Chin-Quee et al., 2006, Griggs and Brown, 
2007, Apikoglu-Rabus et al., 2012, Hussainy et al., 2015). A study from Jamaica, where certain oral 
contraceptives were legally available without prescription in pharmacies, found that an adolescent 
mystery client was refused contraception in 60% of pharmacy visits (Chin-Quee et al., 2006). An 
Australian study using telephone scripts found that, following a revision of the national ECP dispensing 
protocol clarifying that there was no reason for ECPs to be restricted on the basis of age, pharmacists 
still declined dispensing ECPs over 40% of the time when the caller was under the age of 16 (Hussainy et 
al., 2015). 
Confusion or misinformation about various SRH commodities and their dispensing guidelines also 
created unnecessary barriers to quality commodity provision and counselling for young people 
(Ratanajamit et al., 2002, Lara et al., 2006, Ehrle and Sarker, 2011, Maharaj and Rogan, 2011, Wilkinson 
et al., 2012, Both and Samuel, 2014, Wilkinson et al., 2014, Hussainy et al., 2015, Peremans et al., 2007, 
Delotte et al., 2008, Glasier et al., 2010). Studies in the United States and South Africa revealed that 
uncertainty as to when young people were legally entitled to access ECPs resulted in pharmacists 
incorrectly denying access to eligible youth (Maharaj and Rogan, 2011, Wilkinson et al., 2014, Wilkinson 
et al., 2012). Young mystery clients requesting ECPs in France found – in contrast to French regulations - 
no pharmacies gave information on regular methods of contraception, prevention of STIs, follow-up 
medical care, or communicated any other place for full contraception education; additionally, fewer 
than half the pharmacies that dispensed ECPs dispensed it with information on how to use it or side 
effects (Delotte et al., 2008). A study on pharmacy provision of abortifacients in a Latin American city 
found that only 17% of pharmacists who correctly recommended misoprostol as an abortifacient to 
young mystery clients recommended a dosage potentially effective for causing a medical abortion (Lara 
et al., 2006). 
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3.5 Discussion 
The evidence from this review suggests that pharmacies have qualities which make them convenient 
points of SRH commodity access for young clients. Between 2000 and 2016, the period covered by this 
review, there was a clear and steady shift towards legal policies and regulations becoming more 
favourable to over-the-counter or pharmacist access of SRH commodities for youth. Contrary to both 
young client and pharmacist concerns, there has been no corresponding increase in sexually risky 
behaviour or adverse health outcomes. A population-based study in France found that five years after 
the deregulation of ECPs, there had been no decrease in the use of other methods of contraception or 
determinants of ECP use (Moreau et al., 2006b); in fact there was an increase in the use of highly 
effective contraceptive methods, especially among young people.(Moreau et al., 2006a)  There is, 
however, clear evidence that increasing access to SRH commodities through pharmacies can result in 
improved access, with trends of SRH commodity use (ECP use, in particular) being especially high among 
youth (Hobbs et al., 2011a, Marston et al., 2005, Moreau et al., 2006a, Moreau et al., 2006b, Soon et al., 
2005, Hobbs et al., 2011b), a population that faces added barriers to obtaining accurate, high-quality 
SRH information and services.  
Despite the convergence of a number of encouraging factors facilitating access to SRH commodities 
through pharmacies - youth expressed and demonstrated willingness to use pharmacies, increasing 
numbers of policies supporting youth access, and no evidence of adverse effects as a result of pharmacy 
access – there is still much to be improved in the access experience itself. Lingering and persistent 
concerns about commodity provision are often rooted in pharmacy personnel’s personal biases, distrust 
of their young clients’ judgment, or general discomfort with providing SRH commodities and any 
accompanying counselling. As a result, young clients can receive subpar, incorrect, or no information on 
their commodity of choice; can encounter arbitrary and unnecessary barriers to access; or can be denied 
access entirely.   
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As the positive impetus towards increasing access continues, and policymakers and medical 
communities become more comfortable with and confident in the ability of pharmacists to be a valuable 
SRH resource to young people worldwide, we must strengthen the quality and coverage of the 
commodity-accessing experience. Pharmacy personnel have enormous potential to become trusted 
sources of SRH commodities for the young people in their communities, but only if provided with 
adequate training and support.  
Many earlier studies taking place before a given country deregulated ECPs assessed smaller programs 
that often required pharmacy personnel to undergo special training in order to be certified to dispense. 
As SRH commodities become more readily available through pharmacies, pharmacy personnel should 
have access to pre-service and in-service training to ensure they have accurate understandings of 
appropriate use, dosing, and side effects of the SRH products they dispense.  
On the other side of the counter is the young client. More efforts are needed to ensure existing 
programs can achieve full coverage to all populations of young people – including younger adolescents, 
those living in rural areas, and minorities – who face added barriers which might delay or prevent their 
ability to access a commodity, even when legally permitted. Additionally, more research is needed in 
low- and middle-income settings – only six of the 49 studies in this review took place in LMICs. It is also 
telling that 33 of the 49 articles presented focused on the provision of ECPs. This demonstrates a dearth 
of documented exploration of the other SRH commodities that young people access through 
pharmacies, such as other methods of contraception; misoprostol for medical abortions; or related SRH 
services, including STI self-testing kits. 
It is critically important to improve our understanding of how young people engage with existing 
pharmacy-provision services. There is a fine line between capitalizing on the potential of pharmacies and 
losing youth engagement; well-intentioned efforts to incorporate compulsory counselling, testing, or 
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referrals could make pharmacies lose their fast and discreet appeal that draw in young clients in the first 
place. A United Kingdom study from this review provides a positive example of improving the pharmacy 
as an SRH resource, without losing youth engagement; pharmacies offer chlamydia screening kits to 
young women already requesting ECPs, bundling commodities with services needed following a discrete 
SRH event (unintended unprotected sex), but minimizing added time in the pharmacy, as the kits can be 
used at home (Brabin et al., 2009, Thomas et al., 2010). Strategies for discretely making youth aware of 
their pharmacy as an SRH resource are also worth exploring; a few articles mentioned provision of 
leaflets (discretely slipped in a shopping bag) as an option (Both and Samuel, 2014, Glasier et al., 2010, 
Dabrera et al., 2011). The proliferation of mobile phones among this age group is also an opportunity to 
provide young people with needed SRH information or resources when needed, at their convenience, 
and with respect to their privacy. 
This review has a number of limitations. First, as this is one of the first systematic reviews of pharmacy 
provision of SRH commodities, we aimed for broad inclusion criteria to allow for a full description of 
what is known about young people’s experiences in pharmacies and providers’ experiences providing 
commodities to young people. Many of the included studies have weak designs (if RCTs are the “gold 
standard”), and few studies included interventions or statistical analyses. However, our aim was to 
describe these experiences rather than draw on statistical inference and generalizability. The trade-off 
with a broad approach is that we could not use a single methodology to assess quality; most studies 
were descriptive in nature and standard scoring methodology was difficult to apply consistently. Instead, 
key limitations (and strengths) of the studies are described in Table 3.1. Future research should consider 
refining our review and assessing quality.  This limitation notwithstanding, the review does indicate the 
context for pharmacy provision of SRH commodities for young people.  
We also had to exclude a number of studies (or components of studies) that included young people as 
part of a broader age range of participants but did not disaggregate data by age group. Additionally, 
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some included studies are only technically youth relevant (for example studies featuring mystery clients 
25 and under in age), but have no primary or even secondary focus on youth access. A number of 
studies reported on trends in pharmacy use but did not provide information on the direct experiences of 
youth or providers. The breadth of studies uncovered reflects a key strength of this review; our search 
strategy did not include age-related search terms; therefore, we were able to screen a wide range of 
SRH commodity-pharmacy articles which may not have explicitly addressed youth in the title or abstract, 
but which contained relevant data in the text. We also conducted a global search for studies, and 
although many came from high-income settings and focused on ECPs, we were able to identify several 
that included lower-income settings and a range of commodities.   
3.6 Conclusion 
Pharmacies have been demonstrated to be a resource young people are willing to use if permitted; 
however, there is a need for additional study in this field to understand how to most effectively harness 
pharmacies to improve young people’s access to SRH commodities. The pharmacy makes for an 
excellent SRH resource to young clients, but should take care not to exactly replicate the health facility 
experience – to do so would risk pharmacies losing the unique qualities that make them so appealing to 
youth in the first place. Instead, pharmacists and pharmacy personnel should be recognized as 
important complements to the role that physicians and other medical practitioners play in the delivery 
of SRH services. For young people especially, seeking commodities from pharmacies may be their only 
option. It is important that future research consider adolescents and young people specifically, as they 
represent a population most in need of alternate forms of access to SRH information, services, and 
commodities. It is also important that pharmacy personnel are provided with clear information on the 
guidelines for provision and do not serve as an unnecessary barrier to access.  
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3.7 Supplementary Material – Search Strategy 
Our search strategy included papers published in any language and had a lower date limit of 1 January, 
2000 and an upper date limit of 1 May, 2016. 
The following search strategy was used for PubMed: "("Contraception"[Mesh:noexp] OR 
"Contraception, Barrier"[Mesh] OR "Contraception, Postcoital"[Mesh] OR "Natural Family Planning 
Methods"[Mesh] OR "Ovulation Inhibition"[Mesh] OR "Contraceptive Devices"[Mesh] OR "Contraceptive 
Agents"[Mesh] OR "Abortion, Induced"[Mesh:noexp] OR "Abortifacient Agents"[Mesh] OR 
("misoprostol"[MeSH] AND "Abortifacient Agents"[Mesh]) OR ("Mifepristone"[Mesh] AND 
"Abortifacient Agents"[Mesh])) AND ("Community Pharmacy Services"[Mesh] OR "Legislation, 
Pharmacy"[Mesh] OR "Education, Pharmacy"[Mesh] OR "Pharmacies"[Mesh])  
The following search strategy was used for Embase: ('contraception'/exp NOT ('female sterilization'/exp 
OR 'male sterilization'/exp) OR 'family planning'/exp OR 'contraceptive device'/exp OR 'contraceptive 
agent'/exp OR 'abortive agent'/exp OR 'induced abortion'/exp) AND ('pharmacy'/exp OR 
'pharmacist'/exp OR 'pharmacist attitude'/exp OR 'hospital department'/exp) 
The following keyword search strategy was used for Popline: (Fertility Control 
Postconception,Abortion,RU486,Misoprostol,Contraceptive Agents Female,Contraceptive Agents 
Male,Contraceptive Agents Progestin,Contraceptive Agents Postcoital,Contraceptive 
Methods,Emergency Contraception,Female Contraception,Male Contraception) AND Administration and 
Dosage,Pharmacy Distribution,Pharmacies,Pharmacists 
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The following search strategy was used for Scopus: KEY ( "Contraception"  OR  "Contraception, 
Barrier"  OR  "Contraception, Postcoital"  OR  "Natural Family Planning Methods"  OR  "Ovulation 
Inhibition"  OR "Contraceptive Devices"  OR  "Contraceptive Agents"  OR  "Abortion, 
Induced"  OR  "Abortifacient Agents"  OR  "misoprostol"  OR  "mifepristone"  OR  "family 
planning"  OR  "contraceptive agent"  OR  "contraceptive device"  OR  "induced abortion"  OR "abortive 
agent"  OR  "emergency contraception" ) 
AND  KEY( "Pharmacy"  OR  "Pharmacists"  OR  "Pharmacies"  OR  "Chemist"  OR  "Apothecary" )  
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4.1 Abstract 
Objectives 
This study sought to answer two questions: 1) what are the characteristics of young Kenyans aged 18-24 
who use contraception obtained at pharmacies, and 2) why are pharmacies appealing sources of 
contraception? 
Design and Setting 
This was a mixed-methods study in one peri-urban part of Kwale County, Kenya. Methods included:  
cross-sectional survey (N=740); six focus group discussions; 18 in-depth interviews; and 25 key 
informant interviews. Quantitative data analysis identified factors pushing young people to pharmacies 
for modern contraception versus other sources. Qualitative data analysis identified reasons pharmacies 
were perceived to be appealing to young clients. 
Participants 
Participants were: 1) young people aged 18-24 from the study area, including a subset who had recently 
purchased contraception from a pharmacy; or 2) pharmacy personnel and pharmacy stakeholders. 
Results  
Among surveyed participants who had ever had sexual intercourse and had used modern contraception 
at last sexual intercourse, 59% obtained it from a pharmacy. In multivariable analysis, participants who 
used a condom or emergency contraception as well as those living alone were significantly more likely 
to get contraception from pharmacies. Pharmacies were valued for their: convenience; privacy; non-
judgmental and personable staff; service speed; and predictable, affordable prices. 
Conclusions 
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Our findings indicate a high percentage of young people in Coastal Kenya use pharmacies for 
contraception. Our inclusion of emergency contraception users partially explains this. Pharmacies were 
perceived to be everything that health facilities are not: fast, private and non-limiting. Policymakers 
should recognize the role of pharmacies as contraception providers and look for opportunities to link 
pharmacies to the public health system. This would create a network of accessible and appealing 
contraception services for young people. 
 Strengths and limitations of this study 
• Participants were asked to specify where they or their partner had obtained the contraception 
used at last sexual intercourse. This is a standard question for studies looking to establish 
contraception prevalence. However, our not further ascertaining who specifically obtained the 
contraception affected our ability to distinguish differences in preferences of young men versus 
young women.  
• One participant group (young people who had recently purchased contraception from a 
pharmacy) was recruited from five purposively selected pharmacies: this may limit the 
generalisability of the findings. 
• This study is strengthened by its mixed methods design and inclusion of both pharmacy 
personnel and young people to triangulate research findings on a sensitive subject. 
4.2 Introduction 
Young people need access to contraception. However, around the world, and in low- and middle-income 
countries in particular, public sector contraceptive services are not meeting this need. Data from 61 low- 
and middle-income countries estimated that 33 million young women aged 15-24 had an unmet need 
for family planning (MacQuarrie, 2014). Adolescents (ages 10-19 years) and youth (15-24 years) are 
often reluctant to access contraception at public health facilities where they may encounter a lack of 
privacy, biased providers, and limited contraceptive options, in addition to broader financial, legal, 
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social, and cultural barriers (Chandra-Mouli et al., 2014, High-Impact Practices in Family Planning (HIPs), 
2015).  
Other parts of the health system may be able to step in to help fill this gap. In Kenya (where this study 
took place) and in the region, private pharmacies have become a source of modern contraception for 
young people (Dougherty et al., 2016, Corroon et al., 2016, High-Impact Practices in Family Planning 
(HIPs), 2013, Ostola et al., 2015). Additional research has indicated that when contraception is 
introduced in pharmacies, access improves for young people (Radovich et al., 2018, Gonsalves and 
Hindin, 2017). An analysis of 33 sub-Saharan African countries found that commercial drug sellers, 
including pharmacies, were the source of the most recent contraceptive method for nearly one in five 
young people between 15-24 years of age (Radovich et al., 2018). When also factoring in other informal 
and non-medical providers, including shops, these sources together serviced nearly half of women age 
15-19 (Radovich et al., 2018). 
Kenya’s National Family Planning Guidelines allow for the provision of several kinds of modern methods 
(World Health Organization, 2018c) of contraception to be dispensed by pharmacists or pharmaceutical 
technologists (Kenya Ministry of Health, 2018)(colloquially referred to as ‘chemists’). These include 
barrier methods like male and female condoms, as well as short-acting methods including emergency 
contraception (ECP), oral contraceptive pills, and injectable contraception. These permissions mean that 
outside of health facilities, private retail pharmacies have the largest selection of modern methods 
available (shopkeepers can also sell condoms, per the guidelines). Private retail pharmacies must be 
opened by and should always operate under the supervision of either a pharmacist or pharmaceutical 
technologist (National Council for Law Reporting, 1957 (revised 2012)). 
Despite their demonstrable popularity among young people, there are little data on the individual-level 
circumstances or characteristics of young people that would drive them to pharmacies for 
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contraception. Therefore, we conducted a mixed-methods study describing how young people (aged 18-
24) in Kwale County obtain contraception from pharmacies. Kwale County is one of six counties in 
Kenya’s former Coast region. Young people between the ages of 15-24 were projected to make up 19% 
of the county’s population by 2018 (Kwale County Government, 2018). In 2014, contraception 
prevalence in the county was 38%, lower than the national average of 53% (Kenya Ministry of Health, 
2015a).  
In this analysis, we sought to answer two questions: 1) what are the characteristics of young people who 
use contraception obtained at pharmacies, and 2) why are pharmacies appealing sources of 
contraception to young people? 
4.3 Methods 
The study took place in the peri-urban areas of Kwale Town and Ukunda, as well as the stretch of 
highway connecting the two towns. Data collection took place between October 2017 and March 2018. 
We used several methods (captured in Table 4.1) to understand the experiences of pharmacy personnel 
and young people themselves. This study was partly-nested in the ARMADILLO randomized controlled 
trial (RCT) (Gonsalves et al., 2018), which assessed the effect of an unrelated digital health intervention 
on sexual and reproductive health-related outcomes for young people aged 18-24. 
Table 4.1 Study Methods 
Method N Eligibility criteria Relevant topics addressed 
Cross-
sectional 
survey* 
740 • Age 18-24 
• Literate 
• Have their own mobile phone 
(with them at time of recruitment) 
and report regular use 
• Report current use of text 
messaging 
• Contraception used at 
last sexual intercourse 
and source 
• Demographic and 
behavioural 
characteristics  
Focus group 
discussions* 
6  
(58 
participants) 
• Age 18-24 
• Community members  
• Sources of 
contraception for young 
people 
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• Characteristics of young 
people who use each 
source 
In-depth 
interviews 
18 • Age 18-24 
• Recently purchased contraception 
at pharmacy 
• Reasons for having 
purchased 
contraception from 
pharmacy 
• What was valued (and 
not valued) about 
experience  
Key-
informant 
interviews 
19  
(pharmacy 
personnel) 
6 
(stakeholders) 
• Age 18+ 
• Pharmacy personnel (any role) OR 
• Pharmacy-related stakeholder 
(Ministry of Health; regulatory 
agency; professional association; 
non-governmental organization) 
• Characteristics of young 
people who purchase 
contraception 
• What clients appreciate 
about experience 
* Methods which were nested in the broader ARMADILLO Study, a digital health intervention RCT. 
Inclusion/exclusion criteria for these nested methods were determined by ARMADILLO’s objectives.  
To capture the perspectives of young people, a cross-sectional survey of young people age 18-24 
captured demographic information and contraceptive use patterns, including source of last 
contraception (these questions were one section of a broader survey conducted as part of the baseline 
assessment for the ARMADILLO trial).  The sample size was calculated based on the ARMADILLO trial’s 
primary outcome – the full protocol for the trial has been previously published (Gonsalves et al., 2018), 
along with details of participants recruited (Gonsalves et al., 2019a). 
To identify participants, we obtained a map of the study area from the Kenya National Bureau of 
Statistics. The KNBS divides the country into so-called ‘enumeration areas’ (EAs) in preparation for the 
country’s 2019 census. EAs consist of blocks of households. Each EA had approximately 100 households. 
In October 2017, data collectors enumerated all age-eligible young people in every household using a 
random selection of 21 EAs in the study area. From this list of age-eligible youth, a random selection of 
households and random selection of one youth per household was generated. Data collectors visited the 
selected households to recruit participants (who met eligibility criteria captured in Table 4.1) starting in 
February 2018. 
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Additionally, six Focus Group Discussions were conducted with young people age 18-24, purposively 
recruited from the community by data collectors. Finally, we conducted in-depth interviews with 18 
young people aged 18-24 who had recently purchased contraception from pharmacies. We purposively 
recruited these young participants in one of two ways. First, we stationed a young data collector outside 
of well-trafficked pharmacies over three evenings, who recruited young people purchasing 
contraception. Second, several pharmacists in the study area were provided with leaflets with study 
information and requested to provide these to young contraception purchasers at the end of a 
transaction. 
To capture the perspectives of pharmacy personnel, data collectors mapped all private, retail 
pharmacies in the study area using a digital form with an embedded geolocator. A random subset of 
pharmacies was generated using the random number generator in Excel. Pharmacies were well-
distributed across the study area. In each selected pharmacy, data collectors were instructed to 
approach the first person behind the counter, regardless of rank or level of training, explain the study 
and ask if they would be interested in participating. Nineteen interviews in total were conducted. An 
additional six key-informant interviews were conducted with stakeholders from the regulatory 
Pharmacy and Poisons Board, Ministry of Health, professional associations, and non-governmental 
organizations. These were conducted in the individuals’ offices in either Ukunda, Mombasa, or Nairobi. 
Stakeholder participants were contacted first by phone or email, the studied explained, and a 
convenient time for an in-person visit set. 
 Data collection and management 
We obtained informed consent from all participants prior to participation. All data were collected in 
English, Swahili, or a mix of the two, depending on participants’ preference. Quantitative surveys were 
close-ended and administered using webforms on a tablet. Data collectors entered responses save for 
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the questions related to participants’ sexual and contraceptive use history; here, to reduce potential 
discomfort and response bias, participants entered their own responses. Interviews and FGDs used 
semi-structured guides: FGD, in-depth interview, and key-informant interview guides are provided as 
Supplementary Material, as are relevant survey components. Qualitative data collection was informed 
by ground theory (Charmaz, 2006), allowing us to adopt an iterative approach, with question guides 
modified based on emerging themes. Qualitative data collection ceased upon reaching saturation. All 
qualitative methods used audio-recording (with participant permission). All study activities were 
conducted in a private location. Data collectors, speaking both English and Swahili, were recruited from 
the study area and specifically trained for this study. 
This study received ethics approval from the Ethikkommission Nordwest- und Zentralschweiz (EKNZ) 
(Req-2017-00389) in Basel, Switzerland, as well as the University of Nairobi/Kenyatta National Hospital 
in Nairobi, Kenya (P274/05/2017). The ARMADILLO RCT also received ethics approval from the World 
Health Organization (Protocol WHO A65892) and is registered with the ISRCTN Registry 
(ISRCTN85156148). 
 Patient and public involvement 
Our population (young people) were directly involved in parts of the study’s design and implementation. 
Our survey data collection team consisted of young people recruited from the study area (Kwale 
County). Qualitative method data collectors were also young people recruited from both Kwale and 
Mombasa Counties. We relied on their insight and lived experience to determine how young people 
would feel most comfortable being recruited. We jointly designed our recruitment and consenting 
procedures. A dissemination meeting involving local, county, and national stakeholders (including some 
pharmacy stakeholder participants) took place in June, 2019. Several young data collectors were invited 
to attend, and they provided commentary on the findings. 
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 Researcher characteristics and reflexivity 
Data collectors were young people (nearly even numbers of men and women – 24 in total) recruited 
from Kwale and Mombasa counties. Kwale County data collectors were familiar with the study area and 
recognized within their communities, which facilitated enumerating pharmacies, recruiting youth 
participants, and getting consent to interview pharmacy personnel. They were also less educated and 
less experienced than data collectors from Mombasa County. This, at times, resulted in a subordinate 
dynamic with some pharmacy personnel participants who were university-educated. The first author 
conducted all interviews with pharmacy stakeholders. She is from the United States (from a racial 
minority group different from the study population) and presented as an outsider (someone not from 
Kenya) to interviewees. Her position (leading the study and professional affiliations) resulted in 
respondents treating her collegially and being open to participate.  
 Analysis 
Quantitative data were analysed in Stata Version 14. The subject of the analyses (as described in Figure 
4.1) were survey participants who reported using one of four contraception commodities available in 
pharmacies (either male or female condom, ECP, daily contraceptive pills, or injectable contraception) at 
last sexual intercourse and who reported their source. Sexual intercourse was presumed to be 
penetrative vaginal sex. Excluded were those participants who had not used contraception at last sexual 
intercourse, who had not used a contraceptive commodity (withdrawal method, calendar days), who 
could not remember where they had obtained their method and/or who had obtained it from a partner 
or friend. We developed a dichotomous ‘source of family planning’ outcome, distinguishing between 
‘pharmacy’ and ‘any other source’. The latter included any public or private health facility, community-
based distributors, non-governmental organizations, shops, schools, supermarkets. Following 
descriptive statistics, bivariate log binomial regressions assessed the association between the outcome 
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and each behavioural/sociodemographic variable of interest. Any analysis showing a p<.2 moved the 
variable into a multivariable Poisson regression model with robust 95% CIs.  
Figure 4.1 Flow Diagram of Study Participants 
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All qualitative data were analysed using the Framework Method (Gale et al., 2013). Data were first 
transcribed verbatim and then translated (if necessary) into English. For a sub-section of Swahili-
language interviews, English-language transcripts were compared against the original Swahili-language 
interview audio file by another member of the research team to ensure consistency. Qualitative analysis 
for the broader study was guided by the five, WHO-defined dimensions of quality health services to 
adolescents: equity, accessibility, acceptability, appropriateness, and effectiveness (World Health 
Organization, 2012a). All transcripts were read once to improve familiarity with the data. Then, 
qualitative analysis was conducted in Atlas.ti Version 8, with deductive and then inductive coding of a 
subset of transcripts to develop and refine a coding framework. Deductive coding was informed by the 
‘accessibility’ and ‘acceptability’ dimensions and broadly captured any reference to pharmacies being 
‘appealing’. Inductive coding of these data then identified specific reasons for appeal, subsequently 
grouping these into broad categories related to pharmacy outlet, personnel, and service appeal. These 
broad categories and individual reasons structure the presentation of the qualitative results. 
4.4 Results 
 Survey sample characteristics 
A total of 1170 youth were approached for participation, of which 740 (63%) consented to participate 
and completed the survey. Reasons for non-participation are captured in Figure 4.1. As seen in Table 
4.2, of the 740 young people aged 18-24 who participated in the cross-sectional survey, 512 (69%) had 
ever had sexual intercourse. Male condoms were the most popular form of contraception purchased, 
used by 190 of the 274 (69%) participants who used contraception at last sexual intercourse. Of the 
participants indicating that they used a modern contraceptive at last sexual intercourse (N=263), 154 
(59%, data not shown) had obtained it from a private, retail pharmacy (hereafter, ‘pharmacy’).  
Table 4.2 Baseline characteristics 
  All surveyed participants (N=740) 
 Female Male  Total 
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Ever had sexual intercourse 231/347 281/393 512/740 (69%) 
Used any contraception at last sexual 
intercourse 
126/231 (55%) 148/281 (53%) 274/512 (54%) 
Used a modern contraceptive at last sexual 
intercourse 
118/231 (51%) 145/281 (52%) 263/512(51%) 
Used pharmacy-available contraception* 116/231 (50%) 143/281 (51%) 259/512 (51%) 
Where contraception was obtained  
Pharmacy 
Shop 
Public dispensary or health centre 
Hospital 
NGO, private doctor 
Community-based distributor, school, 
supermarket  
Other person** 
Other source (not specified)/Don’t 
know ** 
(N=116) 
63% 
5% 
13% 
11% 
3% 
1% 
 
1% 
3% 
(N=143) 
56% 
17% 
7% 
6% 
4% 
2% 
 
4% 
3% 
(N=259) 
59% 
11% 
10% 
8% 
4% 
2% 
 
3% 
3% 
  Included participants using pharmacy-available 
contraception (N=243) 
 Female (N=111) Male (N=132)  Total (N=243) 
Age 
18-19 
20-24 
 
17% 
83% 
 
18% 
82% 
 
18% 
82% 
Education (highest level attended) 
Primary or below 
Secondary 
Post-secondary 
 
54% 
38% 
8% 
 
27% 
55% 
18% 
 
40% 
47% 
14% 
Relationship status 
Single 
Friends with benefits 
Dating 
Cohabiting 
Engaged 
Married 
 
23% 
3% 
42% 
3% 
9% 
20% 
 
42% 
8% 
42% 
1% 
5% 
3% 
 
33% 
5% 
42% 
2% 
7% 
11% 
Any children 
No 
Yes 
 
74% 
26% 
 
92% 
8% 
 
84% 
16% 
Living situation 
Lives alone 
Lives with family (dependent) 
Lives with child or partner 
 
8% 
66% 
26% 
 
23% 
73% 
4% 
 
16% 
70% 
14% 
Contraception used*** 
Male condom 
Female condom 
ECP 
Daily contraceptive pills 
Injection 
 
56% 
4% 
20% 
5% 
16% 
 
86% 
2% 
6% 
2% 
5% 
 
72% 
2% 
12% 
3% 
10% 
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*these included male or female condom, emergency contraception (ECP), daily contraceptive pills, and injectable 
contraception 
**these were excluded from analysis 
***Participants could enter one contraceptive method 
 
Of the 243 participants who were included in bivariate and multivariable analyses, 54% were male, 61% 
had attended secondary school or higher, and 70% were dependents (living with parents, grandparents, 
or other older family members). A higher proportion of female participants than male participants were 
cohabiting, engaged, or married and had at least one child. Male participants had attended higher levels 
of schooling than female participants. Supplementary Table 4.1 presents selected characteristics of the 
243 participants disaggregated by whether they obtained contraception at a pharmacy, shop, or any 
other source: most shop users were male and purchased condoms. 
 Who accesses contraception from pharmacies? 
Bivariate analyses (Table 4.3) indicated there was no evidence of an association between either age, sex, 
or education and a young person’s contraception being from a pharmacy. There was an association 
between pharmacy-purchased contraception and a participant’s relationship status, and whether they 
had children. The greatest predictors of whether a young person had visited a pharmacy were the type 
of contraception they purchased and with whom they lived. Following multivariable analysis (Table 4.3), 
there remained strong evidence of an association between pharmacy purchase of contraception and a 
young person’s relationship status, living situation, as well as the type of contraception they used. Young 
people living alone were almost twice as likely to have sourced contraception from a pharmacy as those 
living with a child or partner (Adjusted PR 1.96, 95% CI [1.07-3.59]). Use of ECP remained the greatest 
predictor of a pharmacy purchase (Adjusted PR 2.27 as compared with pill/injection use 95% CI [1.21-
4.27]). 
 
Table 4.3 Bivariate and multivariable analysis to identify personal characteristics that may be 
associated with a young person obtaining contraception from a pharmacy (vs any other source) 
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 Purchased 
contraception 
from 
pharmacy 
Unadjusted 
Prevalence 
Ratio (PR) 
[95% CI] 
 p-
value* 
Adjusted 
Prevalence 
Ratio (PR) 
[95% CI] 
p-
value 
All 153/243 (63%)     
Age 
18-19 
20-24 
 
27/43 (63%) 
126/200 (63%) 
 
Ref 
1.00 [0.78-1.29] 
 
 
0.979 
  
Sex 
Male 
Female 
 
80/132 (61%) 
73/111 (66%) 
 
Ref 
1.09 [0.90-1.32] 
 
 
0.405 
  
Education 
Primary or below 
Secondary or above 
 
60/96 (63%) 
93/147 (63%) 
 
Ref 
1.01 [0.83-1.23] 
 
 
0.904 
  
Relationship status 
Single 
 
Dating/’Friends with 
benefits’ 
Married/Engaged/Cohabiting 
 
46/81 (57%) 
 
86/115 (75%) 
 
21/47 (45%) 
 
0.76 [0.61-0.94] 
 
Ref 
 
0.60 [0.43-0.84] 
 
0.0013 
 
0.75 [0.61-
0.93] 
Ref  
 
0.95 [0.67-
1.35] 
 
0.0284 
Children 
No 
 
Yes 
 
139/204 (68%) 
 
14/39 (36%) 
 
1.89 [1.24-2.92] 
 
Ref 
 
0.003 
 
1.25 [0.80-
1.97] 
Ref 
 
0.318 
Living situation 
Lives alone 
 
Lives with family 
(dependent) 
Lives with child or partner 
 
30/39 (77%) 
 
113/170 (66%) 
 
10/34 (29%) 
 
 
2.62 [1.51-4.53] 
 
2.26 [1.33-3.85] 
 
Ref 
 
0.0024 
 
 
 
1.96 [1.07-
3.59] 
1.53 [0.84-
2.82] 
Ref 
 
0.0119 
 
 
Contraception used 
Condom (m/f) 
 
ECP 
 
Pills/Injection 
 
120/181 (66%) 
 
24/30 (80%) 
 
9/32 (28%) 
 
2.36 [1.34-4.14] 
 
2.84 [1.59-5.09] 
 
Ref 
 
0.0014 
 
1.87 [1.02- 
3.43] 
2.27 [1.21-
4.27] 
Ref 
 
 
0.0224 
*any variable with p-values <.2 in bivariate analysis were included in the multivariable analysis 
 Qualitative methods participant characteristics 
Three FGDs were held with young men, and three with young women – each FGD had approximately ten 
participants. Of the 18 in-depth interview participants, ten were young women and eight were young 
men. Female IDI participants had most recently purchased emergency contraception (n=7), injection 
(n=2), and condom (n=1). Male IDI participants had most recently purchased condom (n=6), and 
emergency contraception (n=2).  
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Of the 19 key informant participants, 10 interviewed pharmacy personnel were women, 9 were men. 
Participants were not probed in detail on their formal training (and therefore whether they should be 
operating in their current role). That said, we could ascertain that 13 of the participants had an 
appropriate amount of training for their reported tasks, and four did not (the final two were unclear). 
Self-reported education ranged from having some secondary education to full training as a pharmacist 
or pharmaceutical technologist. One participant was a nurse. Stakeholders demographics are not 
described to ensure they remain unidentifiable.  
 Why are pharmacies appealing? 
Participants indicated that it was a combination of the pharmacy outlet, the pharmacy personnel 
themselves, and the services provided by the pharmacy which together made these establishments the 
preferred source of contraception for many young people (Table 4.4).  
Table 4.4 Reasons why pharmacies are appealing (selected excerpts from qualitative data) 
Outlet appeal The physical pharmacy environment and its operation 
Convenience 
(locations and 
hours) 
“The chemist is near and whenever you want it [family planning] you can access 
it, anytime.” Female pharmacy purchaser: injection 
 
“The good thing with chemist is that they are many of them…when you missed a 
certain contraceptive at a certain chemist you can go to the next chemist 
because they are several of them, not like the hospital” – Female community 
member (FGD) 
 
“Yes, majority of them [young people] don’t live near health centres. Second, 
health centres are usually busy. And it’s not every day they [can be] attended to: 
there are specific days they have clinics… [The client] won’t be able to make it 
there…even if the treatment was free. But there is a chemist - [they] can go for 
similar services.” – Pharmacist  
Anonymity “At the chemist there are not many people. I may go to Diani dispensary [a local 
public health facility], and there is someone who knows me and I go for family 
planning. I saw it would be better to go the chemist because I know that will be 
my secret and the attendant.” Female pharmacy purchaser: emergency 
contraception 
 
“When you go to the facility, when you go to the FP room, everyone knows that 
you’ve gone to get FP. For young people [especially] because no one will want to 
see me - I’m 18, I’m 16 and I’m already using family planning. I’m not supposed 
to be sexually active. The kind of population that is in those FP areas, around 
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those FP areas it’s your mothers who are either breastfeeding, or they’re 
pregnant and have gone for ANC.” – Ministry of Health official, County level 
Personnel appeal The person behind the counter 
Interpersonal 
relationship 
“the chemist is just within the neighbourhood and I know the guy he is my friend 
outside job, so it wasn’t stressful for me in fact it was really fast and easy.” – 
Male pharmacy purchaser: ECP and condoms 
 
“The person in charge is my friend, I can go to him with my problems and he 
would assist me, he is not that far for me to reach him with my phone - he is my 
neighbour I could have a problem even at night and be able to reach out to him.” 
-Male pharmacy purchaser: ECP 
Seen as part of 
the community 
“I chose it because it has been there for many years even before I was born till 
the time I finished school. The attendants are just normal. Many people get help 
from there, so I saw it good to also go there.” – Female pharmacy purchaser: ECP 
and injection 
 
“What I had said about the hospital, when you get there you will find the person 
who served you before is transferred but when you come to the chemist you will 
find the person that served you before.” – Female community member (FGD) 
Non-judgmental “I thought at the chemist they will understand me, and I would talk to them 
[better] than at the hospital where they will say I do not need to use those 
things or even talk to me harshly.” –Male pharmacy purchaser: ECP and 
condoms 
 
“At the chemist, that person wants - since it is a business – [to] just give, as 
compared to the hospital where when you get there you will find nurses who are 
arrogant or other doctors who will insult you.” Male community member (FGD) 
Service appeal The contraception-purchasing transaction  
Speed You know at the dispensary it is a must you meet with the doctor for more 
explanation. And maybe there is a service you need to pay for, the expenses are 
many at the dispensary unlike the chemist where everything is fast, when you 
get there you get what you want and leave. – Youth female, has purchased ECP 
and condoms 
 
“You get in a hospital, there are so many people queueing outside that are 
waiting to see a doctor. Here comes a young lady who is in a hurry. That 
particular person will find it more convenient to go to a chemist shop rather 
than going to a hospital.” – Pharmacist 
Cost It is not easy for the government hospital. It is best, if you have money, you go to 
private hospitals. Now that is why you see if someone does not have money, or 
us the young people, we just go to the chemist because there is no cash to see a 
doctor for Ksh 600. At the chemist you just go direct and you are served. – Male 
pharmacy purchaser: ECP and condoms 
 
Chemists are not expensive like hospitals. In hospital you can be told it is a 
government hospital, but you end up being asked to give out a lot of money. In 
[the] chemist the money you get asked is for [paying for] P2 [an emergency 
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contraceptive], yah but in hospital you will be told to do some test because we 
think it is this and this. – Female pharmacy purchaser: ECP 
 
Free does not always mean free. Sometimes, something will be free, but by the 
time you get it, the process is a lot. Because for us, we don’t just offer family 
planning, we do [mandatory] counselling. The person who is going to a chemist 
is someone who has made up his or her mind. But in the public facilities, you are 
counselled, you are explained to, you are told the different methods, then you 
are given a chance to make an informed choice. So, I think that…is a barrier 
somehow. – Ministry of Health Official, County level 
Pharmacy outlets were appealing because of the convenience and anonymity they offered young clients. 
Pharmacies were located where young people lived, worked, and spent time, making them easy 
contraception access points. If one pharmacy lacked what a young person was looking for, it was a short 
trip to the next one. ‘Convenience’ also extended to the days and hours pharmacies were open. This 
made them especially important on days where health facilities were known to be busy, or evening and 
weekend hours when young people might need contraception. 
Additionally, the relative privacy offered by pharmacies was especially important to young clients. 
Participants perceived pharmacies, with interactions limited to a pharmacy attendant and a client, to be 
far more discreet than similar services offered at public health facilities. Public health facilities had 
public waiting areas where young people may see someone they knew. Additionally, services in the 
health facility might be categorized by service type (for example, contraceptive services separated from 
immunization services, etc). This left young clients feeling particularly exposed should they need to walk 
up to a labelled ‘family planning’ window or step forward if a public announcement about contraceptive 
services was made.  
The individuals behind the counter, and how they interacted with young people, were additional 
reasons young people preferred to obtain contraception from pharmacies. Pharmacy personnel were 
perceived to be established, fellow community members. Young clients appreciated seeing the same 
familiar faces, with less of the personnel turnover associated with public health facilities. When 
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personnel were a similar age to young clients (a very strong preference of all young participants), many 
reported being able to communicate openly with pharmacy personnel and being more comfortable 
interacting with them. 
Pharmacy personnel were perceived to be non-judgmental compared with those working in health 
facilities. There was a perception that a trip to a facility would result in difficult questions, and a possible 
refusal to provide the desired contraceptive. Pharmacy personnel, by contrast, would treat young 
people “well”. That is, they would provide the desired contraceptive without interrogation. Several 
participants speculated that the for-profit aspect of pharmacies could be a reason that they were 
treated better and not refused services.  
Finally, pharmacy contraception services themselves were appreciated for being fast and cheap. 
Participants routinely referenced the queueing for services and long wait times driving young people 
away from health facilities and into pharmacies instead. Services were also perceived to be cheaper than 
both private health facility services as well as public health facility services. Private health facilities were 
considered out of financial reach for most young people – making a pharmacy a more affordable option. 
However, at public health facilities, where contraception-related services are meant to be free, 
participants indicated that this was often not the case in practice. Expenses related to travel, or ‘tests’ 
(for example, a pregnancy test) ordered by health care providers prior to dispensing contraception made 
real costs related to public services difficult to predict. Finally, as one government official acknowledged, 
even when services were free, the time and processes required could deter young people who knew 
what they wanted from going to facilities.  
4.5 Discussion 
This mixed-method study determined pharmacies to be the most popular source of contraception for 
young people in a peri-urban area of Kwale County. In total, 59% of participants (and 63% female 
participants) who had ever had sex and self-reported use of a modern contraceptive at last sexual 
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intercourse had obtained their contraception from a pharmacy. This is higher than previously reported 
for Kenya as a whole (Radovich et al., 2018). Multivariable analyses indicated that young people who 
were living alone relied more heavily on pharmacies for contraception than their peers. That said, the 
strongest predictor of young people’s contraception coming from pharmacies was the type of 
contraception they used, specifically emergency contraception. Qualitative findings demonstrated that 
young people valued pharmacies for their convenience, anonymity, non-judgmental and personable 
staff, service speed, as well as predictable and affordable prices. 
Together, these mixed methods indicate that pharmacies provide a valued source of contraception for 
those young people who may face increased scrutiny or gatekeeping in health facilities. For young 
people using condoms or ECP, the reported convenience and speed of service explains the strong 
preference for pharmacies. Following unprotected sex, a young person needing ECP would 
understandably prefer to pay for it at a nearby pharmacy instead of traveling to a health care facility, 
waiting in line, and negotiating with a possibly reluctant health worker to obtain it for free (assuming 
the public facility stocked ECP (Riley et al., 2018)).  
This study had several limitations. In the survey, participants were asked to specify where they or their 
partner had obtained the contraception used at last sexual intercourse. This question is standard in 
studies looking to establish contraception prevalence. However, our not further ascertaining whether it 
was the respondent or their partner who picked up the contraception affected our ability to distinguish 
differences in preferred sources between young men who obtain contraception versus young women 
who obtain contraception. Second, to recruit young people who had recently purchased contraception 
from pharmacies, we relied on assistance from five pharmacies, purposively selected. It is possible that 
young purchasers patronizing different pharmacies might have had different experiences than those 
captured here. Finally, our youth participants in focus group discussions may have felt uncomfortable 
discussing contraceptive use in a group; we attempted to mediate this by structuring discussion around 
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vignettes of ‘typical’ young people. This study is strengthened by its mixed methods design and its use of 
multiple qualitative methods, and inclusion of both pharmacy personnel and young people to 
triangulate research findings on a sensitive subject. 
Our quantitative findings differ substantially from an analysis of Kenya’s DHS (KDHS) data, which found 
that nationwide, 13% of Kenyan women aged 15-24 currently using contraception reported obtaining it 
at a commercial drug seller (Radovich et al., 2018). There may be several reasons for this, in addition to 
the four years between the KDHS and our own data collection. Our study area was a peri-urban setting 
while the DHS analysis uses nationwide data. Over 70% of Kenya’s population is rural (The World Bank, 
2018). Finally, our study’s inclusion of emergency contraception and measuring contraception use at last 
sexual intercourse (rather than ‘current use’) is also a likely contributor. Twelve percent of participants 
in this study used emergency contraception at last sexual intercourse, and the KDHS did not specifically 
capture emergency contraception use (Kenya National Bureau of Statistics et al., 2015). The DHS’s 
measures of contraception ‘current use’ in general has been previously critiqued for not being able to 
capture contraceptive methods which may be used periodically, including ECP (Marston et al., 2017). 
Our link between ECP purchasers and pharmacies are in line with earlier data from urban Kenya, which 
indicated that upwards of 96% of adult women needing emergency contraception obtained it at a 
pharmacy (International Consortium for Emergency Contraception, 2013a). 
By contrast, our qualitative findings were largely in line with previous research. One systematic review 
featuring studies mostly from high-income countries (HICs) affirms that young people appreciate 
pharmacies for their convenience, speed of service and ease of contraception access (Gonsalves and 
Hindin, 2017). However, this review also reported mixed evidence (all from HICs) as to whether 
pharmacy services were considered ‘private’ (Gonsalves and Hindin, 2017), while our study found an 
almost universal appreciation of pharmacies for their anonymity/privacy. This difference may be a result 
of different dispensing protocols and establishment layouts in pharmacies and public health facilities in 
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HICs vs LMICs. Evidence from other LMICs corroborates our findings that among young people 
(Cartwright et al., 2019), and the general population (Peterson et al., 2019), pharmacies’ contraception 
services are appreciated for the privacy offered.  
While this study focused on pharmacies, its findings also cover perceptions around how contraception 
services are delivered to young people in public health facilities. Pharmacies were naturally contrasted 
with health facilities when participants explained young people’s preferences and were perceived to be 
everything that health facilities were not: fast, private and non-limiting. The extra ‘procedures’ required 
to obtain contraception in health facilities – which in many cases are unnecessary (World Health 
Organization, 2016b) and have been demonstrated in other settings to limit access (Grossman et al., 
2006, Leeman, 2007) -  were especially unwelcome for young people, who were uninterested in 
extended counselling and wary of laboratory tests. As a result, pharmacy services were deemed more 
‘predictable’ than those obtained in health facilities (public or private).  
For Kenya, pharmacies are likely to remain a preferred choice of contraception as long as barrier 
methods and short-acting forms of contraception are popular with young people (Kenya National 
Bureau of Statistics et al., 2015). Policymakers should therefore recognize their role as contraception 
providers, especially for a community’s younger members. Finding ways to link the myriad licensed 
pharmacies to focal points in public health facilities could strengthen a supportive ‘network’ of 
accessible and appealing contraception services available to young people. A similar hub-and-spoke 
approach is used in the implementation of Kenya’s broader Community Health Strategy, where 
community health volunteers are embedded within the community and report back to a facility-based 
community health extension worker (Oliver et al., 2015). Such a system, complemented by improved 
adolescent-friendliness of public health facilities, would also enable easier referral of young people to 
providers who can offer them more effective forms of contraception. However none of this can succeed 
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without taking needed steps to improve pharmacy regulation, personnel training, and the overall quality 
of services (Gonsalves et al., 2019b). 
Our data revealed that shops were the second most popular source of contraception for young men. 
The reliance on shops and lower-level drug dispensaries is seen elsewhere in the region: one survey in 
Nigeria found that among young people age 15 to 24, around half sourced their contraception from 
‘chemists/patent medicine shops’ (a cadre of establishment below pharmacies, which does not exist in 
Kenya) (Oye-Adeniran et al., 2005). Unfortunately, exploring shops in further detail was beyond the 
scope of our data collection. Additional research is needed to understand how to incorporate these 
more informal sources into contraception interventions. That said, integrating them into the broader 
‘network’ of contraception providers for young people will be even more challenging: lower-level drug 
dispensers are only peripherally associated with the health system in many settings, while shops are not 
associated at all. 
Finally, we must acknowledge those still left behind. Of participants who reported ever having sex, 
almost half of them (49%) had not used any modern contraception at last sexual intercourse. Aside from 
those who wished to conceive, these are young people who are not being reached by the current 
network of public and private health facilities, pharmacies, and even neighbourhood shops. They are a 
reminder that improving the quality of services in these outlets is necessary but not sufficient to address 
young people’s contraceptive needs. There is a continued need for multi-sectoral interventions, 
including comprehensive sexuality education, to increase demand for contraception among youth 
(dispelling myths, addressing taboos and stigma, and increasing agency) (World Health Organization, 
2017b), address barriers to accessing it (including community norms around acceptability) (High-Impact 
Practices in Family Planning (HIPs), 2015), and promote uptake of highly effective forms of 
contraception.  
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Young people in Coastal Kenya steadily rely on pharmacies for contraception and often prefer them to 
health facility services. Many of the pharmacy qualities most appreciated by young participants are also 
hallmarks of youth-friendly health services, which should be available in any outlet a young person 
accesses health services (Erulkar et al., 2005, World Health Organization, 2012a). If a young person 
chooses to use modern contraception, their selection of an outlet will be determined by several factors, 
including the type of contraception desired, living situation, and relationship status. Collaboration 
between health facilities and retail pharmacies at local levels can exchange operational strengths 
between these providers. Then, wherever a young person presents for contraceptive services, they 
encounter one part of a supportive network of quality providers. 
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4.6 Supplementary Material 
The BMJ Open publication included several instruments as supplementary material: focus group 
discussion guide, in-depth interview guide for young contraception purchasers, key informant interview 
guide and relevant survey components. These can be found in Appendix 1. 
Supplementary Table 4.1 Selected characteristics of young people purchasing contraception at a 
pharmacy, shop, or any other source 
 Pharmacy (N=153) Shop (N=29) Any other source (N=61) 
Age    
18-19 27 (18%) 6 (21%) 10 (16%) 
20+ 126 (82%) 23 (79%) 51 (84%) 
    
Sex    
Male 80 (52%) 24 (83%) 28 (46%) 
Female 73 (48%) 5 (17%) 33 (54%) 
    
Education    
Primary or below 60 (39%) 7 (24%) 29 (48%) 
Secondary or above 93 (61%) 22 (76%) 32 (52%) 
    
Relationship status    
Single 46 (30%) 10 (34%) 25 (41%) 
Dating 86 (56%) 18 (62%) 11 (18%) 
Cohabiting/Married 21 (14%) 1 (3%) 25 (41%) 
    
Children    
No 139 (91%) 28 (97%) 37 (61%) 
Yes 14 (9%) 1 (3%) 24 (39%) 
    
Living situation    
Lives alone 30 (20%) 3 (10%) 6 (10%) 
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Lives with family 
(dependent) 
113 (74%) 25 (86%) 32 (53%) 
Lives with child or 
partner 
10 (7%) 1 (3%) 23 (38%) 
    
Contraception purchased     
Condom 120 (78%) 28 (97%) 33 (54%) 
ECP 24 (16%) 1 (3%) 5 (8%) 
Pills/Injections 9 (6%) 0 (0%) 23 (38%) 
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5.1 Abstract  
Objectives: This Kenya-based study ascertained whether pharmacies were an untapped source of 
‘youth-friendly’ health services by determining 1) whether young people (aged 18-24) could successfully 
obtain condoms and emergency contraception (ECP); 2) if contraceptives were dispensed according to 
national guidelines; and 3) how young people felt about obtaining ECP and condoms from pharmacy 
personnel. 
Methods: This study used several methods to capture and cross-check purchasing experiences as 
reported by young people with those of dispensing pharmacy personnel. These included: focus group 
discussions; in-depth interviews; key informant interviews; and mystery shoppers. 
Results: When in stock, young people were successfully able to obtain ECP and condoms from 
pharmacies. Counselling was sporadic: when it happened, it was not always accurate. Despite a lack of 
counselling, young people reported being satisfied with the quick, transactional interaction with 
pharmacy personnel.  
Conclusion: The brief, transactional interactions between pharmacy personnel and young clients appear 
to be ‘youth-friendly enough’. While there is room to strengthen the services provided (improving both 
accuracy and scope), this should be done in a manner that does not fundamentally alter the current 
interaction. 
5.2 Introduction  
There are over 1.2 billion young people between the ages of 15-24 in the world today, 86% of whom live 
in low- and middle-income countries (United Nations Secretariat, 2015). Young people face special 
vulnerabilities related to their sexual and reproductive health (SRH) and wellbeing (World Health 
Organization, 2018a, Patton et al., 2009). They also struggle to obtain and use SRH information and 
services and family planning  commodities from health facilities and health care providers (Chandra-
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Mouli et al., 2014). As a result, in many regions, young women wanting to avoid pregnancy can be up to 
twice as likely as adult women to have an unmet need for modern contraception (Guttmacher Institute, 
2010). Data from 61 low- and middle-income countries (LMICs) estimate that 33 million women aged 15-
24 have an unmet need for contraception (MacQuarrie, 2014). 
In response, many countries have introduced ‘youth-friendly health services’ aimed at improving care 
for young clients by ensuring quality services meet established criteria around equitability, accessibility, 
acceptability, appropriateness, and effectiveness (World Health Organization, 2012a). However, 
challenges to effectively designing, implementing or scaling up these services mean that, in practice, 
facility-based youth-friendly health services may be unavailable or underutilized by their target 
population (Chandra-Mouli et al., 2015, High-Impact Practices in Family Planning (HIPs), 2015, Chandra-
Mouli et al., 2014). Additionally, public sector facilities may not always have short-acting forms of 
contraception (particularly emergency contraception) available (Riley et al., 2018).  
For youth unwilling or unable to go to a health facility, pharmacy provision of contraception - that is, 
over-the-counter (openly accessible at a pharmacy), or behind-the-counter (dispensing contingent on 
evaluation from a pharmacist) provision of contraceptives - can help to overcome barriers to access for 
young people (World Health Organization, 2017a, Chandra-Mouli et al., 2014). Studies from France, 
Australia, Canada, and the United Kingdom demonstrate that improved access to emergency 
contraception (ECP) through pharmacies results in high utilization among youth (Hobbs et al., 2011a, 
Marston et al., 2005, Moreau et al., 2006a, Moreau et al., 2006b, Soon et al., 2005, Hobbs et al., 2011b).  
Additional studies have assessed how pharmacy access is operationalized (pharmacist personnel’s 
feelings about dispensing, young people’s actual ability to purchase contraception) (Gonsalves and 
Hindin, 2017). Data from Kenya, Nigeria and Ethiopia also suggest that young people and unmarried 
people access emergency contraception from pharmacies (Corroon et al., 2016, Gold, 2011); however 
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there is a general paucity of documentation from LMICs on what this access looks like in practice 
(Gonsalves and Hindin, 2017).  
In Kenya, young people between the ages of 15 and 24 constitute one-fifth of the total population 
(Kenya National Bureau of Statistics, 2010). The 2014 Kenya Demographic and Health Survey found that 
short-acting modern contraceptive methods – condoms, pills and injectables, particularly – were 
popular among both married and unmarried sexually active young women aged 15-24 (Kenya National 
Bureau of Statistics et al., 2015). However, it also noted that among currently married young women, 
23.0% of 15-19 year-olds and 18.9% of 20-24 year-olds still have an unmet need for family planning. 
Among sexually active unmarried women, 49.9% of 15-19 year-olds and 30.7% of 20-24 year-olds are 
not currently using any contraceptive.  
Over the last twenty years, Kenya’s government has increasingly prioritized SRH programming for this 
age group, with an Adolescent Reproductive Health Policy (2003) which aimed to double the use of 
modern contraceptives among 15-24 year-olds by 2015 (Kenya Ministry of Planning and National 
Development and Kenya Ministry of Health, 2003) and the updated 2015 Adolescent Sexual and 
Reproductive Health Strategy aspiring to have 75% of 15-24 year-olds using a condom at sexual debut by 
2025 (Kenya Ministry of Health, 2015b). Additionally, Kenya’s National Family Planning Guidelines for 
Service Providers expressly supported provision of contraceptive services for adolescents and 
youth(Kenya Ministry of Health, 2018). 
Importantly, these Family Planning Guidelines also authorize pharmacies to dispense various forms of 
contraception, including emergency contraception and male condoms (Kenya Ministry of Health, 2018). 
These can be accessed for free in Kenyan public facilities (Keesara et al., 2015b) and are available for 
purchase from private pharmacies (sometimes locally referred to as “chemists”). Specifically, for 
emergency contraception (ECP), the guidelines authorize two available ECP types for pharmacies (Kenya 
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Ministry of Health, 2018): combined oral contraceptives (the Yuzpe method), and dedicated progestin-
only ECPs. The first dose for all available methods should be taken as soon as possible after unprotected 
sex, up to 120 hours (World Health Organization, 2018b). Anyone dispensing ECP is expected to explain 
how it works and possible side effects, inform users of other available family planning methods, counsel 
on STIs or HIV/AIDS risks and testing, and refer for any needed SRH services. In dispensing condoms, the 
guidelines indicate that clients should be advised on proper use and disposal.  
Against a backdrop of continued unmet need for contraception and supportive national policies for 
pharmacy provision of contraception, this study aimed to determine whether pharmacies in Coastal 
Kenya, might be an untapped potential source of youth-friendly modern contraceptive sources. 
Specifically, we aimed to answer three questions: 1) can youth (aged 18-24) successfully obtain 
emergency contraception and condoms from pharmacies; 2) are these contraceptives dispensed 
according to Kenya’s National Family Planning Guidelines; and 3) how do youth purchasing ECP or 
condoms act and react to the experience?   
5.3 Methods  
This analysis was part of a broader, mixed methods study aiming to understand what drives young 
people in Kwale County in need of any contraception to obtain it from pharmacies. Emergency 
contraception and condoms are the focus of this analysis given their over-the-counter availability 
globally (International Consortium for Emergency Contraception, 2013b), their popularity among young 
people in the study area (data unpublished), their connection to a single sex act, and the fact that they 
are self-administered (rather than requiring intervention from a trained provider).  
Kwale County is one of six counties in Kenya’s former Coast province, and young people aged 15-24 are 
estimated to comprise 19% of the County’s total population (Kwale County Economic Planning Division, 
2017). This study took place in the peri-urban towns of Kwale and Ukunda, as well as the stretch of 
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highway connecting the two. Data was collected between November 2017 and March 2018. Young data 
collectors, speaking both English and Swahili, were recruited from the study area and from nearby 
Mombasa and specifically trained for this study. As captured in Table 5.1, this study used several 
methods to capture and cross-check experiences as reported by young people aged 18-24 who might 
purchase contraception from pharmacies, and pharmacy personnel tasked with dispensing 
contraception. 
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Table 5.1 Description of study methods (Kenya, 2017-2018) 
 Participant inclusion criteria Topics addressed N Youth 
perspective 
Dispenser 
perspective 
Focus Group 
Discussions 
• Age 18-24 • Locations in the community 
where young people obtain 
contraception and why 
• The type of young person who 
would rely on each given 
location 
6 
(58 participants) 
x  
In-depth 
interviews 
• Age 18-24 
• Recently purchased 
contraception from pharmacy 
• Detailing personal experience 
buying contraception from a 
pharmacy 
• Reasons for choosing to buy 
contraception at a pharmacy 
18 x  
Key 
Informant 
Interviews 
• Age 18+ 
• Currently works (in any capacity) 
at pharmacy OR 
• Pharmacy-related stakeholder 
(Ministry of Health; professional 
association; non-governmental 
organization) 
• General personal/pharmacy 
policies for dispensing 
contraception 
• Detailing personal experience 
dispensing contraception to 
young people 
• Feelings about dispensing 
contraception to young people 
19 (pharmacy 
personnel) 
 
6 (stakeholders) 
 x 
Mystery 
shopper 
Trained data collectors (aged 18-24) 
served as mystery clients 
• Documenting purchase-related 
interactions with pharmacy 
personnel 
• Objective assessment of the 
interaction 
142 visits x x 
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Six Focus Group Discussions (FGDs) with young people aged 18-24 (three FGDs with young men, three 
with young women) were conducted with 8-10 participants each. We also conducted 18 in-depth 
interviews with young people who had recently purchased some form of contraception from a 
pharmacy. Recent-purchasers were recruited through local pharmacies: after a young person had 
purchased the contraception, participating pharmacists were instructed to provide a leaflet with 
information about the study to the client. Additionally, one young data collector spent three evenings 
stationed outside of two pharmacies with high client traffic and recruited young people who had just 
purchased contraception.  
Data collectors mapped all the pharmacies in the study area. Pharmacies (whether open or closed at the 
time of the visit) were mapped via digital form with an embedded geolocator. A total of 60 pharmacies 
were enumerated. Data collectors conducted interviews of pharmacy personnel in a random sample of 
the enumerated pharmacies. A total of 19 interviews were conducted, and data collectors interviewed 
whomever they found dispensing medicines behind the counter, regardless of their qualifications or 
formal role. An additional six key-informant interviews were conducted with Kwale County and Federal-
level Ministry of Health stakeholders, as well as representatives from the Pharmaceutical Society of 
Kenya (the professional association for practicing pharmacists) and non-governmental organizations 
working on contraception access.  
During the mapping process, 50 of the 60 pharmacies also consented to be visited by mystery shoppers. 
Two of the 50 participating pharmacies were permanently closed when data collection began, leaving 48 
pharmacies to be visited by each shopper. Three mystery shoppers (two male, one female) visited these 
pharmacies with fictitious personas reflecting common situations in which a young Kenyan would need 
contraception. The personas (further detailed in Table 5.2) were developed jointly with youth from the 
area and informed by preliminary findings from the qualitative data collection described above. Mystery 
shoppers were provided a set amount of money with which to purchase their assigned contraceptive. All 
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mystery shoppers were instructed to answer questions put to them by pharmacy attendants; however, 
their self-initiated interactions were limited to asking for their specific contraception. Each mystery 
shopper piloted their persona in two pharmacies outside of the study area prior to beginning data 
collection. 
Table 5.2 Description of mystery shopper personas (Kenya, 2018) 
Mystery 
Shopper (MS) 
Persona description 
Characters were developed to reflect common scenarios which might send a 
young person to a pharmacy for ECP or condom. Additionally, they reflect typical 
backstories, concerns, and knowledge that young people purchasers might have. 
MS 1 Emergency 
contraception 
(female) 
Student, 22 years old. Had sex with her boyfriend two days ago. They used a 
condom, but it burst. This is her first time using ECP. She does not know her 
boyfriend’s HIV status but is only worried about pregnancy, not HIV/STIs. Has 
100 Kenyan shillings to purchase ECP. 
MS 2 Emergency 
contraception 
(male) 
Student, 21 years old. Has a girlfriend but he doesn’t use a condom during sex 
because ‘he trusts her’ – they use ECP instead. He is purchasing ECP on his 
girlfriend’s behalf and does not know the instructions for use. Has 100 Kenyan 
shillings to purchase ECP. 
MS 3 Condom 
(male) 
Secondary school graduate, 19 years old. Single, known as a ‘hit and run’ 
(someone who has sex with many women but does not date them). He is going 
to a party in the evening, and wants to purchase condoms in advance. Knows 
about HIV/STIs but more worried about pregnancy. Has 50 Kenyan shillings to 
purchase condoms. 
 
 Data Collection 
Semi-structured interview guides were developed and used for focus group discussions, key informant 
interviews, and in-depth interviews. After obtaining informed consent from participants, all FGDs and 
interviews were audio recorded. Qualitative data collection was in Swahili, English, or a mix of the two, 
depending on the participant’s preference. The time and location of interviews were set based on 
participants’ availability and preference: in the case of pharmacy personnel and stakeholders, this was 
often the participant’s place of work. Mystery shoppers were provided with short, semi-structured 
digital forms to complete on mobile phones. The forms were adapted from a previous family planning 
mystery shopper study (Chin-Quee et al., 2006) and included questions about the pharmacy, its staff, 
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and the purchase-related interaction. Mystery shoppers were instructed to complete the form 
immediately after each visit.  
This study received ethics approval from the Ethikkommission Nordwest- und Zentralschweiz (EKNZ) 
(Req-2017-00389) in Basel, Switzerland, as well as the University of Nairobi/Kenyatta National Hospital 
in Nairobi, Kenya. 
 Analysis 
All qualitative data was transcribed and translated (if necessary) into English. Data collection and 
analysis were informed by an iterative approach, allowing for adapting and modifying of question guides 
and checklists as data collection evolved. The qualitative data were analysed through thematic analysis, 
using inductive and deductive coding (the latter of which was informed by a research objective to 
understand dispensing practice) on an initial cross-section of transcripts to develop a coding framework. 
Qualitative analyses were conducted in Atlas.ti Version 8. Mystery shopper data was analysed in Stata 
Version 14, with analysis consisting of descriptive statistics. 
5.4 Results 
 Young people successfully obtain condoms and ECP from pharmacies 
Focus Group Discussion and interviews indicated that young people could readily access both 
emergency contraception and condoms from pharmacies in the study area. The mystery shopper 
exercise confirmed this. As seen in Table 5.3, emergency contraceptive pills and condoms – when in 
stock – were always dispensed to the mystery shoppers. The female ECP shopper successfully purchased 
emergency contraception in every pharmacy she visited. The male ECP shopper was nearly as successful, 
being denied ECP in only one pharmacy due to its being out of stock. The condom shopper was able to 
purchase a pack of three condoms at 33 pharmacies and left empty-handed if condoms were out of 
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stock (in six pharmacies) or if they were too expensive (in five pharmacies). One additional pharmacy did 
not sell condoms, and two more pharmacies were closed when visited.   
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Table 5.3 Number of pharmacies visited, number of successful purchases, and ‘additional interactions’ (above and beyond the purchasing 
itself) between pharmacy personnel and mystery shopper, by mystery shopper (Kenya, 2018) 
  Pharmacies 
visited  
(N=48) 
Successfully 
purchased family 
planning  
Any 
additional 
interaction* 
Additional interaction details 
Mystery Shopper (MS)  n (%) n (%)** (n)*** 
MS 1 Emergency contraception 
(female) 
47 47(100) 8(17.0) • Timing of unprotected sex (1) 
• MS age and student status (1) 
• Brand description/recommendation (6) 
• Instructions on use (4) 
MS 2 Emergency contraception (male)  48 47(98) 4(8.5) • Timing of unprotected sex (1) 
• Whether MS knew how to use ECP (1) 
• Brand description/ recommendation (1) 
• Instructions on use (2) 
MS 3 Condom (male)  47 33(70) 4(12.1) • Brand description/ recommendation (4) 
Total  142 127(89) 16(12.6)  
*additional interactions were described as any interaction beyond the purchase itself, and were broadly grouped into three categories: 1) 
assessment of need/prior use; 2) personal questions; 3) assistance selecting contraception (including instructions on use) 
** percentages are presented as a proportion of any additional interaction in pharmacies where contraception was successfully purchased. 
***number of pharmacies where additional interaction took place – note, multiple interactions may have taken place in the same pharmacy.
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 Condoms and ECP are not consistently dispensed with counselling  
Most interview participants reported that young clients only received counselling if they requested it. 
Otherwise, they were just given the contraception. 
“We don’t bother unless they ask us, ‘Oh, I don’t know how to use this.’ That is when we can 
explain but if they don’t, we just dispense and they are gone.” – Pharmacy attendant (no formal 
training) (Pharmacy A2).  
“When you ask questions, they [pharmacy personnel] explain to you and they advise 
you…unless you do not want advice. But when you ask any question on family planning, they 
answer you.” – Youth interview 10, female, has purchased ECP and condoms. 
Among pharmacy personnel who admitted that they dispensed contraception without counselling, some 
did so under an assumption that a client asking for a specific product already knew how to use it.  
“now they will want for example, the emergency pill…sometimes, there is that kind of 
atmosphere with the person, so you dispense it because they kind of know what they want, they 
have asked their friends.”- Pharmaceutical technologist (Pharmacy F2). 
More often, however, pharmacy personnel indicated that they could see that a young client did not 
want questions, advice, or prying. 
“A girl coming to buy e-pills…just telling them how to use that drug is a challenge, she will pick it 
up and right away put it in her bag and does not want any explanation about it from you.” – 
Pharmacy personnel (training not specified), (Pharmacy B1). 
Several pharmacy personnel insisted that young clients received some counselling when purchasing 
emergency contraception. However, the counselling described consisted of ECP counselling and 
eligibility screening based on inaccurate information. For example, participants thought ECP was usable 
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only up to 72 hours following unprotected sex, rather than 120 hours. This may be a result of 
commercial brands of ECP in Kenya still being labelled for use up to 72 hours, and pharmacy personnel 
reading this labelling.  
[re-enacting a purchase with a fellow pharmacy attendant] “When you have had sex, let not 72 
hours pass… after 72 hours this drug will not be of help but before that it is okay. And it is 
important to know your safe days…so, if you are sure you are unsafe I will sell to you the drug.” 
– Pharmacist (Pharmacy C10).  
Reported counselling also included warnings that ‘overuse’ of ECP could result in health problems 
(another unfounded concern).  
“I tell her that these [emergency] pills are good and bad as well, because if you use them 
consecutively for six months, they might cause a growth in your stomach. Other times, it is said 
they can bring problems when you are trying to have a baby.” – Pharmaceutical technologist 
(Pharmacy C9). 
In practice, the mystery shopper exercise (detailed in Table 5.3) confirmed a lack of engagement 
between pharmacy personnel and young people, including around issues which would ensure quality 
service provision. For example, each ECP shopper was asked about the timing of unprotected sex 
(critical for determining eligibility) in only one pharmacy. ECP shoppers received instructions on how to 
take the pills – also an expected interaction - in four pharmacies for the female ECP shopper, and twice 
for the male ECP shopper.  
The lack of engagement also extended to unnecessary questioning. ECP shoppers were asked very few 
intimate questions regarding age, relationship status, and/or whether they were students (none of 
which are relevant to determining their ability to access ECP). In one pharmacy, for example, the female 
ECP shopper reported receiving a ‘little lecture’ from a ‘shocked’ pharmacy attendant. The male ECP 
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shopper also reported that one pharmacist indicated that he should ‘give money to his girlfriend so she 
could come herself’; however, he was still able to purchase the ECP. Finally, in a handful of interactions, 
pharmacy personnel shared their personal views on ECP brands, including perceived differences in cost, 
effectiveness, and quality, as well as personal favourites.  
Engagement between pharmacy personnel and the condom mystery shopper was even more hands-off: 
the only non-purchase-related interaction for this shopper was pharmacy personnel in four pharmacies 
sharing their personal preference for condom brands. It is worth emphasizing that any interactions 
documented by the three mystery shoppers were the exception rather than the norm: in 111 out of a 
total 127 mystery shopper-pharmacist interactions, shoppers entered, requested their contraceptive, 
received it, paid for it, and left. There was no additional interaction with the person behind the counter. 
 Young people are pleasantly surprised by polite, transactional purchasing experiences 
Both pharmacy personnel and youth participants reported that young purchasers initially approached 
pharmacies with trepidation. Young purchasers worried about the pharmacy attendant being older 
and/or of the opposite sex; what they would be required to disclose about their personal lives; and what 
lecture they might have to endure as a result.  
“I was relieved, because I thought he was going to judge me or lecture me, but it was a relief 
knowing it was easy to purchase. I thought he was going to ask if I had an ID and [say] that I was 
still young and what in the world was I going to do with them because they were meant for 
adults…but he did not.” – Youth interview 16, male, has purchased ECP and condoms. 
As a result, both groups reported that young people sometimes sent friends or partners to purchase on 
their behalf. If they went themselves, participants reported the young person waiting to purchase 
contraceptives until the pharmacy was empty. 
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[Describing a young person purchasing a condom] “It is something that needs a lot of courage in 
a young person…some send others instead. Some wait until no others customer is present at the 
chemist. They check first [and then] they approach. Even if he came first, others get served first 
and then go so that he may get his turn. He’ll say, ‘I’m in no rush, serve them.’” -Trained 
pharmacist or pharmaceutical technologist (not specified), (Pharmacy D5). 
Once in the pharmacy, young people had strategies to keep their contraceptive purchase discreet.  
“Say for example, a young man comes in and he wants ‘Trust’ [a popular condom brand]. He will 
gesture, pointing.  ‘Can I have that?’ He is pointing, so, if you are not keen you might not know 
what the young man wants. Alternatively, they will use coded language, which luckily enough, 
we happen to know.” – Pharmacist (Pharmacy I1). 
Specific codewords identified included ‘lifesavers’ or ‘our tablets’ for emergency contraception and 
‘balloon’ or ‘socks’ for condoms. The use of codes and gestures (pointing, or miming what was needed) 
stemmed from discomfort or embarrassment with requesting these contraceptive methods out loud or 
being overheard by other customers. This same fear contributed to young participants’ appreciation of 
brisk, transactional interactions with pharmacy personnel, devoid of counselling. 
“He did not give me any advice, because when I went there, I did not want any stories. I wanted 
him to give me what I wanted [and] then I leave. I did not want to create a conversation because 
I feared other people could walk in and find me purchasing” – Youth interview 17, male, has 
purchased condoms. 
After the purchase was complete, young purchasers indicated they left in a hurry, with a lingering worry 
that a pharmacy attendant would think poorly of them. However, overall, despite needing to “gather 
courage” to enter the shop, every young purchaser interviewed described polite, transactional 
experiences purchasing condoms and emergency contraception. In fact, more than one third of the 
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young purchasers interviewed reported that they had purchased contraception from pharmacies more 
than once. 
“The interaction is very fast, because you want to buy and leave. He served me well, because he 
took it that I was a young person who just wants to avoid the pregnancy and protect herself.” – 
Youth interview 10, female, has purchased ECP and condoms. 
5.5 Discussion 
Our findings indicated that a young Kenyan, aged 18-24 who wished to purchase either condoms or 
emergency contraception from a pharmacy could expect to successfully do so via a brisk, non-intrusive 
interaction with pharmacy personnel. This meant that young ECP purchasers rarely received eligibility 
screening or instruction on use. However, it also meant that pharmacy personnel rarely subjected young 
purchasers to unnecessary values-based questioning related to marital/relationship status, age, or the 
appropriateness of engaging in sex. With some exceptions, counselling was only provided when the 
client asked for it (in line with previous findings from a mystery shopper exercise in Kenya (Liambila et 
al., 2010)), out of an assumption that the young purchaser prioritized speed and discretion over 
information. When this happened, young clients were satisfied with the information they received and 
way it was conveyed. Interactions with pharmacy personnel that were neutral at worst and warm at 
best left them pleasantly surprised and more comfortable returning to the pharmacy in the future. The 
pharmacy purchase experience in its current form, for these contraception types, is ‘youth-friendly 
enough’. 
Recognition that young people should be able to access quality health services, including SRH services, in 
a ‘youth-friendly’ environment has resulted in a focus on improved public SRH services (Chandra-Mouli 
et al., 2015, UNAIDS Inter-agency Task Team on Young People, 2006). The role of the private sector, 
specifically pharmacies, as an important source of contraception has been less clear. WHO’s 2001 
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consensus statement from a Global Consultation on Adolescent Friendly Health Services acknowledged 
that adolescents used pharmacies and that these anonymous, rapid, and numerous contraception 
sources warranted further study (World Health Organization, 2002). Nearly 15 years later, a systematic 
review found that assessments of most out-of-facility interventions (including pharmacies) as effective 
providers of ASRH services were still lacking (Denno et al., 2015). This study is contributing to the body 
of knowledge by documenting the role of pharmacies as a source of youth-friendly services.  
Clients vote with their feet and in Kenya, as in many countries, the popularity of pharmacies for ECP is 
clear (Benevides et al., 2014, Liambila and Gathitu, 2013, Kenya National Bureau of Statistics et al., 
2015). Progestin-only emergency contraception in particular has been extensively studied and deemed 
safe (World Health Organization, 2018b) and appropriate for over-the-counter sale (International 
Consortium for Emergency Contraception, 2013b), as condoms are. This makes engagement with a 
pharmacist (per global evidence), ideal but not necessary. That said, these current interactions are still a 
missed opportunity to discuss SRH more broadly and bridge interested young people to a more regular 
form of contraception. The challenge, therefore, is to improve pharmacy personnel-youth interactions 
around ECP and condom dispensing without fundamentally modifying an interaction which appears to 
be youth-friendly enough for young people (Liambila and Gathitu, 2013).  
Creative ways to unobtrusively link young customers with additional information or services (Liambila 
and Gathitu, 2013), such as a digital health campaign(L’Engle et al., 2016) or an easy-to-read leaflet in a 
bag (Both and Samuel, 2014), can provide young people with instructions on use and further 
contraception referrals they may be open to, at a moment of their choosing. Youth-targeted information 
and education (IEC) materials displayed in pharmacies (Both and Samuel, 2014) can provide basic 
information, address common concerns, and encourage young people to speak up and discuss their 
purchase with pharmacy personnel. IEC materials also become a resource for pharmacy personnel 
themselves.  
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This study demonstrated that there appear to be lingering and pervasive misconceptions among trained 
and untrained pharmacy personnel about ECP’s effectiveness beyond 72 hours as well as its safety. 
Despite clear consensus about ECP’s safety and window of use (World Health Organization, 2010), the 
misinformation about ECP’s safety is not limited to pharmacists. A previous review demonstrated that a 
variety of providers in various LMIC settings shared concerns about ECP possibly causing congenital 
abnormalities, infertility, even cancer (Dawson et al., 2015). There is also apparent disconnect between 
what national (and international) guidelines say for ECP’s window of use (120 hours) and what 
registered drugs on the market advertise (72 hours). This discrepancy likely contributes to continued 
confusion among pharmacy personnel.  
Collaboration between professional associations, pharmaceutical training institutions, Ministry of 
Health, and even ECP retailers, can provide pharmacy personnel with improved pre-service training as 
well as in-service refreshers (Liambila and Gathitu, 2013, Benevides et al., 2014) and resources which 
dispel myths and reinforce important messages around ECP and contraception more broadly. Any 
initiatives to strengthen pharmacy services will have to consider opportunities and challenges created by 
their dual role as health service provider and for-profit business. For example, at present, pharmacists 
will not likely deny a young person contraception; at the same time, they have no particular incentive to 
provide additional counselling. 
This study and analysis had certain limitations. The goal of the mystery shopper exercise was to observe 
dispensing practices of pharmacy personnel, without any prompting from a client. As such, this exercise 
could not probe pharmacy personnel on their beliefs about emergency contraception or systematically 
test the accuracy of the ECP-related counselling among pharmacy personnel: further research might 
explore these. Additionally, during the early rounds of interviews with pharmacists, we discovered 
barrier methods like condom and the post-facto ECP were not always considered ‘family planning’ by 
this group. This created a challenge during data analysis in determining whether ECP was included when 
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pharmacy personnel shared their thoughts about contraception in general: as a result, we only included 
data that made explicit reference to ECP or condoms. Also, as we visited all pharmacies to obtain 
consent for a mystery shopper visit prior to the exercise, there is a risk of observation bias – that is, 
pharmacies modifying their normal treatment of young people knowing that one customer might be a 
mystery shopper. That said, our mystery shopper exercise only began about two months after the initial 
visit. Finally, social desirability bias likely caused participants to overstate the level of pharmacist-youth 
engagement for the benefit of our data collectors. This would explain the discrepancies between 
qualitative participants reporting more engagement than our mystery shoppers observed in practice, 
and reinforces the benefit and importance of triangulation across different methods, especially in 
research which explores culturally sensitive topics.  
 Conclusion 
As a preferred source of condoms and ECP for young people, this study demonstrated that pharmacies 
in Coastal Kenya currently dispense ECP and condoms in a manner responsive to young customers’ self-
reported needs. In Kenya, pharmacies have an essential role to play in youth SRH service provision, 
which could be capitalized upon under the country’s broader health agenda. In 2017, Kenya’s president 
unveiled his ‘Big Four’ development agenda, which included universal health coverage as one pillar 
(Otinga, 2018). Under this umbrella, there has been interest to link with private sector healthcare 
providers in order to improve the reach of health services beyond what the public sector can offer (The 
Star, 2018).  
If pharmacy-based care were considered under this initiative, it would necessitate close collaboration 
with pharmacy stakeholders, public health service providers, and especially young people to ensure 
quality of care, and continued youth-friendliness. However, for an otherwise healthy young person, a 
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visit with the neighbourhood pharmacist may be their only health system engagement for their SRH:  
exploring improvements and expansions of SRH services in pharmacies is a worthwhile undertaking.  
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6.1 Abstract 
Young people worldwide are often reticent to access family planning services from public health 
facilities: instead, they choose to get contraception from private, retail pharmacies. In Kenya, certain 
contraceptives are available in pharmacies: these include injectables, which can be dispensed but not 
administered, according national guidelines. However, Kenya struggles with enforcement of its 
pharmacy regulations and addressing illegal activity. Therefore, in this qualitative study, we assessed 
private pharmacies as an existing source of injectable contraception for young Kenyans (age 18-24), and 
investigated the perceived quality of service provision. This study used: focus group discussions (6) with 
young community members; in-depth interviews (18) with youth who had purchased contraception 
from pharmacies; key informant interviews with pharmacy personnel and pharmacy stakeholders (25); 
and a mystery shopper (visiting 45 pharmacies).  
The study found that for injectable contraception, private pharmacies had expanded to service 
provision, and pharmacy personnel’s roles had transcended formal or informal training previously 
received – young people could both purchase and be injected in many pharmacies. Pharmacies were 
perceived to lack consistent quality or strong regulation, resulting in young clients, pharmacy personnel, 
and regulators being concerned about illegal activity. Participants’ suggestions to improve pharmacy 
service quality and regulation compliance focused on empowering consumers to demand quality 
service; strengthening regulatory mechanisms; expanding training opportunities to personnel in private 
pharmacies; and establishing a quality-based ‘brand’ for pharmacies. 
Kenya’s recent commitments to universal health coverage and interest in revising pharmacy policy 
provide an opportunity to improve pharmacy quality. Multi-pronged initiatives with both public and 
private partners are needed to improve pharmacy practice, update and enforce regulations, and 
educate the public. Additionally, the advent of self-administrable injectables present a new possible role 
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for pharmacies, and could offer young clients a clean, discreet place to self-inject, with pharmacy 
personnel serving as educators and dispensers. 
6.2 Introduction  
Young people around the world are often reticent to access sexual and reproductive health (SRH) 
services, including family planning services, from public health facilities – well-established obstacles 
include provider bias, a lack of privacy, few contraceptive options, limited financial resources, and legal 
and policy (real or presumed) barriers (High-Impact Practices in Family Planning (HIPs), 2015). Instead, 
they may seek contraception from non-judgmental, confidential, and convenient sources: retail 
pharmacies provide one such option (Gonsalves and Hindin, 2017, High-Impact Practices in Family 
Planning (HIPs), 2013). Pharmacies are sources of contraceptive commodities and services (High-Impact 
Practices in Family Planning (HIPs), 2013), particularly condoms, emergency contraception, and daily oral 
contraceptive pills, all of which can be accessed informally or formally without prescriptions in many 
countries (OCs OTC Working Group, 2018, International Consortium for Emergency Contraception, 
2018). Very effective injectable contraceptives (Curtis et al., 2016), including the popular depot 
medroxyprogesterone acetate (DMPA) are also sold (Riley et al., 2017). 
For both contraceptive and broader health services, the role of pharmacists in low- and middle-income 
countries (LMICs) has rapidly broadened into that of a service provider. A Cochrane review in 2013 
described the health impacts of pharmacist-provided services, finding that they could positively-impact 
certain clinical outcomes related to management of non-communicable diseases (e.g. management of 
glucose levels for diabetic clients, as well as management of hypertension and asthma) and reduce visits 
to healthcare providers (Pande et al., 2013). However, enthusiasm for using pharmacies to expand the 
reach of health services is tempered with apprehension about the quality of services provided: two 
systematic reviews of pharmacy services in LMICs found common problems in counselling and 
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questioning of clients, inaccurate diagnoses, poor referral, inappropriate medicine sales, and a lack of 
adherence to prescribing and advising protocols (Smith, 2009b, Miller and Goodman, 2016). 
 Retail pharmacy policy in Kenya 
In Kenya, private retail pharmacies (locally referred to as chemist shops), are registered, regulated and 
inspected by the Ministry of Health’s specialized agency, the Pharmacy and Poisons Board (PPB) 
(National Council for Law Reporting, 1957 (revised 2012)). The PPB is also tasked with licensing 
pharmacy professionals, and registering and regulating the manufacture and sale of medicines and 
medical devices (National Council for Law Reporting, 1957 (revised 2012)). Pharmacy compliance 
standards are determined by the country’s Pharmacy and Poisons Act (National Council for Law 
Reporting, 1957 (revised 2012)), originally drafted in 1957 when pharmacy activities were traditionally 
limited to drug supply and dispensing. Private pharmacies can only be legally opened by registered 
pharmacists (requiring a five-year bachelor’s degree in pharmacy or higher) or pharmaceutical 
technologists (requiring a two year, post-secondary diploma program) (National Council for Law 
Reporting, 1957 (revised 2012)). Once open, they operate independently as for-profit businesses, fully 
removed from the commodity procurement, reporting, and training infrastructure used in public sector 
pharmacies. Private pharmacy registrations must be renewed annually (National Council for Law 
Reporting, 1957 (revised 2012)). These private pharmacies are the only legally recognized tier of retail 
drug outlet, making Kenya unique in a region where other countries also accredit lower-tier drug shops 
(Riley et al., 2017).  
Pharmacists and pharmaceutical technologists must renew their licenses ever year (Aywak et al., 2017). 
Throughout their practicing career and as a mechanism for maintaining and building knowledge and 
skills, pharmacists and pharmaceutical technologists have to complete a certain number of ‘continuing 
professional development’ (CPD) credits per year. A number of membership-based professional 
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societies, including the Kenya Pharmaceutical Association (for pharmaceutical technologists) and the 
Pharmaceutical Society of Kenya (for pharmacists) have traditionally carried out CPD for their respective 
cadres (Kenya Ministry of Health - Pharmacy and Poisons Board, 2013, Kenya Ministry of Medical 
Services and Kenya Ministry of Public Health and Sanitation, 2013). That said, CPD programs have been 
challenged by a limited capacity to regulate and enforce CPD requirements, poor organization, and 
limited support from pharmacists’ employers (Kenya Ministry of Medical Services and Kenya Ministry of 
Public Health and Sanitation, 2013).  
 Kenyan policies on contraception provision through pharmacies, including to young 
people  
For contraception specifically, Kenya’s 2009 National Family Planning Guidelines, indicate that an array 
of commodities, including condoms, emergency contraception, daily contraceptive pills, and injectables 
can be dispensed in pharmacies (Kenya Ministry of Health, 2010). Both progestin-only injectables (such 
as DMPA) as well as combined injectable contraceptives are available in private pharmacies, with a 
single note adding that the client is to be referred for the injection itself (Kenya Ministry of Health, 
2010).   
Young people’s ability to access contraception was strongly supported by Kenya’s Adolescent 
Reproductive Health Policy in 2003, which aimed to double the use of modern contraceptives among 15-
24 year-old by 2015 (Kenya Ministry of Planning and National Development and Kenya Ministry of 
Health, 2003). The updated 2015 Adolescent Sexual and Reproductive Health Strategy affirmed a 
commitment to promoting young people’s sexual and reproductive health and rights, and acknowledged 
the need for strategic partnerships between the public and private sector to ensure SRH services were 
delivered in a manner responsive to adolescents’ specific needs and vulnerabilities (Kenya Ministry of 
Health, 2015b). That said, there are no specific references to the role that pharmacies play in 
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contraception provision (injectable or otherwise) in these adolescent-specific strategic documents. 
Additionally, pharmacy practice guidance documents also contain no instructions on pharmacy provision 
of any contraception (Riley et al., 2017). 
According to the 2014 Kenya Demographic and Health Survey, the unmet need for family planning 
among young women remains high: 23.0% of currently married 15-19 year-old women and 18.9% of 
currently married 20-24 year-old women. Among sexually active, unmarried young women, 49.9% of 15-
19 year-olds and 30.7% of 20-24 year-olds are not currently using any contraceptive (Kenya National 
Bureau of Statistics et al., 2015). Short-acting modern family methods available through pharmacies 
(including injectable contraception) have proven popular among sexually active young women (Kenya 
National Bureau of Statistics et al., 2015), and private pharmacies in Kenya are a relied-upon source of 
contraception commodities for adults and young people alike (Kenya National Bureau of Statistics et al., 
2015, Ostola et al., 2015, Corroon et al., 2016). 
It is important to support contraception provision through the existing channels preferred by young 
people. However, like many countries, Kenya struggles with enforcement of its existing pharmacy 
regulations and addressing illegal pharmacy activity (Riley et al., 2017, Monja, 2018). Additionally, there 
has been minimal documentation as to the quality of contraception provision services in Kenyan 
pharmacies, and we are not aware of any study exploring the quality of injectable contraception 
provision to young clients in particular. Therefore, in this qualitative study, we investigated private 
pharmacies as an existing source of injectable contraception for young Kenyans, and sought to 
understand the quality of the service provision and perceived influence of the current regulatory 
climate.  
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6.3 Methods 
This study was embedded in a larger mixed methods study which sought to understand how young 
people aged 18-24 in Coastal Kenya use their local pharmacies to access contraception. Data collection 
took place in Kwale County (one of six counties in Kenya’s former Coast Province), specifically the peri-
urban towns and surroundings of Kwale and Ukunda between November 2017 and March 2018. Table 
6.1 describes all the methods used. 
Table 6.1 Description of study methods  
 Participant inclusion criteria Topics addressed N 
Focus Group 
Discussions 
• Age 18-24 
• Community members  
• What happens when young people 
attempt to access contraception in 
pharmacies 
• Feelings about contraception 
service quality at all access points 
• Suggestions to improve the 
regulation and quality of 
pharmacy services 
6 
(58 
participants) 
In-depth 
interviews 
• Age 18-24 
• Recently purchased 
contraception at 
pharmacy 
• Actual experience accessing 
injectable or other contraception 
in private pharmacies 
• Feelings about quality of 
contraceptive service provided 
• Suggestions to improve the 
regulation and quality of 
pharmacy services 
18 
Key 
Informant 
Interviews 
• Age 18+ 
• Pharmacy personnel 
(any role) OR 
• Pharmacy-related 
stakeholder (Ministry of 
Health; regulatory 
agency; professional 
association; non-
governmental 
organization) 
• Current pharmacy policies in 
Kenya, especially as they relate to 
injectable provision for young 
people 
• What happens when young people 
attempt to access contraception in 
pharmacies 
• Suggestions to improve the 
regulation and quality of 
pharmacy services 
19  
(pharmacy 
personnel) 
 
6 
(stakeholders) 
Mystery 
shopper 
Trained youth data collector 
served as mystery client 
• Actual experience accessing 
injectable contraception in private 
pharmacies 
45 visits 
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We used several qualitative methods to describe the experience dispensing and administering injectable 
contraception and other contraceptive methods, both from the perspectives of young people who might 
purchase it, as well as the pharmacy personnel who provide it. Six focus group discussions (FGDs) were 
carried out with people aged 18-24, purposively recruited by data collectors from the study area. Three 
FGDs were conducted with men, and three with women; there were 8-10 participants in each FGD. 
Additionally, 18 in-depth interviews (IDI) were conducted with young people aged 18-24 who had 
recently purchased contraception from a pharmacy. IDI participants were recruited in one of two ways: 
1) selected pharmacists in the study area handed out leaflets with the study information to young 
customers following their purchase of any contraception, and; 2) a young data collector spent three 
evenings stationed outside of two popular pharmacies recruiting young people who had just purchased 
contraception by describing the study and collecting their contact information. 
Data collectors also conducted a full mapping of the pharmacies in the study area, identifying 60 
pharmacies in total. Pharmacies (whether open or closed at the time of the visit) were mapped via 
digital form with an embedded geolocator. From this group, a random sample of pharmacies was 
generated, and data collectors conducted key informant interviews with one person working at the 
pharmacy (their training or formal role was not important), until saturation was reached. A total of 19 
interviews of pharmacy personnel were conducted. Additionally, six interviews were conducted with 
representatives of the Ministry of Health, Pharmacy and Poisons Board (PPB), the Pharmaceutical 
Society of Kenya, and non-governmental organizations working on contraceptive commodity 
development and provision. These stakeholders worked at either County (Kwale-based), Regional 
(Mombasa-based), or National (Nairobi-based) levels.  
Fifty of the 60 enumerated pharmacies also consented to be visited by a mystery shopper, whose 
objective was to observe first-hand whether any family planning injection was available for sale in each 
pharmacy and to inquire whether she could be injected on site. Our mystery shopper was a young data 
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collector who assumed the fictional persona of a typical young Kenyan who would need an injectable 
contraception. Her persona, developed in close collaboration with young people in the community and 
our youth data collectors, was: a newly married 24-year-old with no children, who had received her first 
ever Depo Provera injection from a health clinic three months prior (making her due for another 
injection). Our mystery shopper successfully visited 45 of the 50 pharmacies. 
 Data collection 
All qualitative methods used semi-structured guides. FGD, IDI and key-informant interviews were audio-
recorded with participants’ permission and data was collected in Swahili, English or a mix of the two, 
based on participant preference. The time and location of interviews were set based on participants’ 
availability and preference. The mystery shopper was provided with short, semi-structured digital forms 
to complete on mobile phones. The form was adapted from a previous family planning mystery shopper 
study (Chin-Quee et al., 2006) and included questions about the pharmacy, its staff, and the purchase-
related interaction. The mystery shopper was instructed to complete the form immediately after each 
visit. We were able to determine the registration status of 40 of the 45 pharmacies visited by the 
mystery shopper using an official list of registered pharmacies in Kwale County, obtained from Kenya’s 
Pharmacy and Poisons Board. 
 Analysis  
All qualitative data was transcribed and translated (if necessary) into English. The qualitative data were 
analysed through an iterative approach to thematic analysis, using inductive and deductive (informed by 
a research objective to understand dispensing practice) coding on an initial cross-section of transcripts 
to develop a coding framework. Qualitative analyses were conducted in Atlas.ti Version 8. Quantitative 
data from the mystery shopper exercise was analysed in Stata Version 14, and analyses consisted of 
descriptive statistics and a chi-square test to test any association between a pharmacy being willing to 
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inject our mystery shopper and its registration status. Quantitative and qualitative results were 
triangulated across methods to validate findings. 
 Ethics  
Informed consent was obtained from all participants in writing. This study received ethics approval from 
the Ethikkommission Nordwest- und Zentralschweiz (EKNZ) (Req-2017-00389) in Basel, Switzerland, as 
well as the University of Nairobi/Kenyatta National Hospital in Nairobi, Kenya (P274/05/2017). 
6.4 Results 
 Current private pharmacy practice: Can young people obtain injectable contraception? 
Participants confirmed that injectable contraceptives were routinely sold and administered in 
pharmacies. Youth interview participants who reported recently purchasing an injectable contraceptive 
indicated that they had also been injected at the pharmacy. The mystery shopper’s experience reflected 
the qualitative findings as well. As can be seen in Table 6.2, the mystery shopper was told that she 
would be able to purchase the injection in 29 of the 45 (65%) pharmacy shops she visited; in the 16 
(36%) where she could not purchase the injectable, it was because the injectable was either out of stock 
(15 pharmacies) or was not stocked at all (one pharmacy). In 44% of the visited pharmacies, the mystery 
shopper was told she could both purchase and receive the injection on site. However, in 12 (27%) 
pharmacies, she was told that the contraceptive injection was not available and that the pharmacy did 
not inject. It should be noted of the 21 (47%) pharmacies where the mystery shopper was told that she 
could not be injected on site, she reported that 12 referred her to either an individual or clinic qualified 
to provide the injections. 
Table 6.2 Ability of mystery shopper to both purchase injectable contraception from the pharmacy 
and be injected on site, as reported to her by attending pharmacy personnel 
  Can be injected on site 
Can purchase injectable No (n=21) Yes (n=24) Total (n=45) 
No (n=16) 27% 9% 36% 
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Yes (n=29) 20% 44% 64% 
Total (n=45) 47% 53% 100% 
Finally, of the 40 pharmacies visited by our mystery shopper whose registration status we could verify, 
almost two-thirds (63%) were not appropriately registered. Registration status was not significantly 
associated with being willing to inject (chi2 = .3274, P=.567). 
In alignment with national family planning guidelines, pharmacy stakeholders and personnel all agreed 
that trained pharmacy personnel could dispense injectables. However, when it came to injectable 
administering, opinions and rationale diverged. All told, pharmacy stakeholders and personnel identified 
two ways in which clients purchasing injectable contraception could also be injected at a pharmacy: a 
qualified medical professional administers the injection (regulation-compliant); or a trained or untrained 
pharmacy personnel administers the injection (regulation non-compliant).  
Some pharmacies (especially larger pharmacies) might be staffed by both a pharmacist/pharmaceutical 
technician to dispense medication as well as another medical professional who was also authorized to 
administer injections, such as a clinical officer or a nurse. In these scenarios, pharmacies effectively 
became a private, one-stop-shop for certain health services, including injectable contraception 
provision. 
“The other person who works here is the clinical officer…His roles are like those of giving 
injections. He told me not to give injections to anyone…He does that work…Other problems like 
chest problems, he listens to the heart like asthma or pneumonia, things like that. The rest, I am 
the one who does.” – Pharmaceutical technologist  
Alternatively, interviews with both pharmacy stakeholders and local pharmacy personnel also revealed 
that injections were also administered by pharmacists, pharmaceutical technicians and untrained 
pharmacy workers. Only one untrained pharmacy worker admitted to a data collector that she had been 
instructed to provide injections herself. Of the two additional interviewees who said that they personally 
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administered injections, in one of these cases the respondent – a nurse – also indicated that she also 
owned the pharmacy, which she was not authorized to do. 
One additional, regulation-compliant option was a reciprocal referral system between pharmacies and 
nearby public or private clinics. Many interviewed pharmacy personnel who said that they would not 
inject clients themselves described themselves as having close ties to neighbourhood doctors or clinics 
(usually located very close to the pharmacy). 
“Aah I don’t inject. There is a clinic in front here where they inject, so most times when they 
come, we sell them the injectable and she goes to get injected. The referral is just near here.” – 
Pharmacist  
Some respondents indicated that they would even offer to call a doctor at the clinic, to let them know a 
customer was coming. Many interviewed pharmacy personnel added that this relationship was 
reciprocal, and clinics would send clients to their pharmacy to purchase an injectable contraceptive.  
 Perception of quality of private pharmacy service provision  
Both pharmacy regulators and young client participants agreed that private pharmacies lacked 
consistent quality. Participants were aware of the variation in whether and how injectables (and other 
contraception services) were provided and expressed concern about a lack of regulation among private 
pharmacies in Kenya. Both groups described an illegal part of the pharmacy sector, which included 
persons offering health products of doubtful quality (in the worst case, counterfeit); owning and 
operating a pharmacy without appropriate licensing or training; or dispensing commodities without 
trainings.  
Youth participants indicated that a visit to a new pharmacy in the area risked the purchase of sub-
standard commodities from an untrained worker in an unlicensed establishment.  
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 “Those who sell those drugs [in a pharmacy] most of them are not people who are qualified. 
Most of them are people from school, and being told to go and help there, the person will help. 
When you go there to buy drugs you find that he/she is selling otherwise, and those drugs were 
needed in another dose.” – Youth female community member 
Young community members also expressed concern at the government’s inability to regulate this illegal 
activity. 
“The government should be keen on licensing these people that open up those chemist because 
there are things like medicine, [some] go through the right channel but others go through the 
back [illegal] door.” – Youth male community member  
For their part, regulators recognized that their ability to monitor with current resources was limited, and 
they indicated that they did not feel like they were able to keep pace with illegal pharmacies. One 
inspector described challenges to conducting mandated periodic inspections of the pharmacies in Kwale 
County:  
“You’ll find that these [illegal pharmacies] they’ve just sprung up suddenly. When they find that 
we are heading towards that place, they normally close it. And they have …these social media 
network: the person will just text and say that ‘PPB, their vehicle was seen somewhere in 
Kwale’. We move around and find that the illegal outlets are closed…so we have to wait for the 
next day. We try to [show] that we are going back to Mombasa and then come back maybe in 
the evening and see whether they are open.” – Pharmacy and Poisons Board inspector 
Regulators and other pharmacy stakeholders, therefore, shared young people’s concerns about 
unqualified pharmacy personnel dispensing counterfeit commodities, including contraception 
commodities. 
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“Quacks are people without any level of- any form of pharmaceutical training or any formal 
training. Maybe they were um, employed in a pharmacy …and then they’ve seen ‘oh, this is a 
good business, it’s about just giving drugs when people come!’ and they set up their own 
pharmacy outlets. They may employ [pay] a registered professional who lends them their 
license. But the quack runs the show.” – Pharmaceutical Society of Kenya board member 
“Especially at the Coast, it’s very porous. They [drugs] come from Tanzania through unofficial 
routes – in buses, in suitcases. It’s only the authorized medicines that should be in the market… 
Especially with the family planning commodities – we’ve had problems. Either they are 
counterfeit or falsified products, especially Postinor-2 [an emergency contraceptive pill] - we’ve 
received so many complaints.” – Pharmacy and Poisons Board regulator  
Regulators indicated that there were existing mechanisms for increasing accountability, but that these 
often worked better in theory than practice and did not necessarily deter illegal activity. For example, 
the Pharmacy and Poisons Board had implemented an SMS-based pharmacy registration system with 
the goal of providing community members with a tool to verify the registration status, licensed owner, 
and location of the pharmacy they visited. However, when asked how the system functioned in practice, 
one respondent noted: 
“People are using it but it’s not up to what we were expecting initially, despite the fact that it is 
free of charge…It’s only for the licensed [pharmacies]. Because, for the unlicensed, number one, 
they should not be there (laughs), then secondly, uh, you don’t have much control.” – Pharmacy 
and Poisons Board regulator 
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 Suggestions to improve pharmacy service quality and regulation compliance 
Study participants had suggestions to improve service quality and regulation compliance in private 
pharmacies. One was educating consumers as to what they should look for when seeking quality 
pharmacy services and empower them to demand it. 
“We advise them [customers] to use drugs that are registered because there are some drugs 
that are from black market, so we advise them to [visit] a registered shop, ask for drugs that you 
can confirm if they are original drugs.“ – Trained pharmacist or pharmaceutical technologist (not 
specified) 
“I would like the chemist to keep papers to show that this is a doctor or a chemist attendant. So 
that we can avoid those who act to be doctors and they are not.” – Young female contraception 
purchaser (injection) 
Participants also indicated a desire to see regulatory mechanisms strengthened. In particular, county 
and national-level stakeholders and policies routinely referenced need for an overhaul of the country’s 
Pharmacy and Poisons Act, expressing frustration that Act remained the source legislation for present-
day pharmacy practice in Kenya, despite its not having kept pace with decades worth of changes in 
evidence and pharmacy practice. Respondents also speculated that the Act’s punitive measures on 
unregistered pharmacies would hardly be considered a deterrent in modern-day Kenya.  
Additionally, participants identified a need to improve opportunities for professionals working in retail 
pharmacies to participate in CPD and other training opportunities. They noted that trainings usually only 
actively targeted private pharmacy personnel when driven by a non-governmental organization, 
external donor initiative, or pharmaceutical company.  
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“There is this organization called [international NGO] that has been empowering us, they call us 
to seminars and empower us on that, so then we are able to help the community with that 
information.” –Pharmacist  
Participants encouraged more of these strategic collaborations to reach private sector pharmacy 
personnel, in order to both reinforce existing skills but also expand their scope of authorized activities, 
including contraception provision activities. 
“For example, in the past we were unable to test for malaria in the chemist, but we were taken 
for training and nowadays we test. If donors would come and say we also want pharmacists to 
help [with family planning] injections, they help us. So that if someone comes and wants to be 
injected we can help such a client.” – Trained pharmacist or pharmaceutical technologist (not 
specified) 
Finally, a board member of the Pharmaceutical Society of Kenya suggested ‘branding’ pharmacies, that 
is, developing a visible and recognized mark of quality which pharmacies could join through 
demonstrated adherence to a set of standards. Such an exercise would require collaboration across 
governmental, non-governmental, and possibly private stakeholders. Incentives to join would include 
opportunities for training and the ability to provide an expanded set of services (as suggested above).  
“Let’s say I own a pharmacy, my own personal pharmacy – I would want to train my staff on 
certain things: customer service, even pharmaceutical knowledge just to refresh their 
knowledge. We have partners who are ready to do that, so when we offer those kinds of 
[trainings], we believe a lot of pharmacists will want to join the chaining and branding initiative. 
And then of course because of the standards we’ll have for joining, if you’re a quack you won’t 
join. You’ll have to be a registered and licensed professional to join. And in this proposal, we’re 
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proposing expanded services at the pharmacies. So, we need approval from- we need buy-in 
from the Ministry of Health.” – Pharmaceutical Society of Kenya board member 
6.5 Discussion  
This study described a private retail pharmacy sector dispensing contraception with its own momentum, 
its regulators a few steps behind. Specifically for injectable contraception, in Kwale County under the 
current regulatory policy, some pharmacies had become ‘one-stop-shops’ when it came to injectable 
contraception. Clients wanting a contraceptive injection could often purchase the contraceptive and be 
injected on site, either through strategic collaborations with other health system personnel, or through 
pharmacy staff expanding their scope of services on their own (without authorization). These models 
are common around the world. Pharmacies are an established source for injectable contraception across 
Africa and Asia (High-Impact Practices in Family Planning (HIPs), 2013, Riley et al., 2017) and nurses, 
doctors, and other clinical officers have also been observed working as drug-dispensing (and 
administering) staff elsewhere in the region (Mayora et al., 2018), though there is a lack of evidence 
from LMICs evaluating these multidisciplinary collaborations between pharmacy personnel and other 
medical personnel (Pande et al., 2013). Similar to reports from this study of pharmacy personnel 
injecting clients, pharmacy personnel in Uganda have also reported providing injections themselves, 
without official authorization (Janowitz, 2012). 
Regulators and young community members using pharmacies described the sector as being difficult to 
monitor, support, empower and track. This had a deleterious effect on the profession’s reputation, 
including among the young people who relied on pharmacies as a source for contraception services. Our 
young community participants – even those who regularly purchased contraception from pharmacies - 
were all aware that among the private pharmacies in Kwale County, there were unregistered 
establishments with unqualified personnel dispensing poor-quality commodities. Young people 
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frequently cited uneducated pharmacy personnel as a drawback to accessing care at pharmacies and did 
not feel able to identify unqualified personnel themselves. Their concerns mirror findings elsewhere in 
the literature. One systematic review on the quality of private pharmacy services highlighted similar 
shortcomings across 30 studies in 15 countries relating to dispensing of appropriate medicines in correct 
dosages, a lack of qualified pharmacy personnel doing the dispensing, and varying quality in advice given 
to clients, if it was given at all (Smith, 2009b). Another systematic review looking at practices of 
‘specialized drug shops’ in sub-Saharan Africa found 62 articles describing similar variance in pharmacy 
personnel’s training, their knowledge, and dispensing practices (Wafula et al., 2012).  
Pharmacy services in Kenya have received increasing attention over the last few years. There have been 
recent, controversial efforts to revise the Pharmacy and Poisons Act (CAP 244) (Otieno, 2018), and 
proposals to create a new regulatory agency, the Kenya Food and Drug Authority (Sunday, 2019).  
Additionally, in 2017 Kenya’s president named universal health coverage as one of the country’s four 
key development priorities. In this context, there is renewed interest to link with private sector 
healthcare providers in order to improve the reach of health services beyond what the public sector can 
offer (The Star, 2018). Now is the time to propose measures to improve the quality of pharmacy services 
and personnel. Participants in this study had several ideas in this regard.  
Participants suggested measures to increase clients’ awareness of and demand for regulated, quality 
pharmacy services. There is existing client-side awareness of the need for quality services: the concerns 
expressed by this study’s participants are corroborated by recurring news coverage of illegal 
pharmacies, unqualified pharmacists, and counterfeit medicines (Monja, 2018). The existing SMS based 
system for clients to check the registration and ownership status for their neighbourhood pharmacy can 
help to improve client-side accountability. A similar proposed system to improve the quality, safety, and 
effective use of medicines available in Kenya would also apply unique codes to any imported and locally-
manufactured medicines, so that clients could obtain SMS-based information on whether the drug was 
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real and registered, as well as its side effects (Thiong'o, 2019). However, Kenya’s Pharmacy and Poisons 
Board will need adequate resources to ensure that pharmacy clients around the country are sensitized 
to these services and empowered to use them.  
Participants also emphasized a need for improved government regulations, as well as improved access 
to CPD and other in-service training for retail pharmacy personnel. For contraceptive injections in 
particular, respondents recognized the opportunity to officially expand access of injectable provision by 
training pharmacy personnel to both dispense and inject. While this proposal is out of line with the with 
Kenya’s current family planning guidance, a 2017 family planning task sharing brief from the World 
Health Organization indicated that pharmacists, and even pharmacy workers in certain circumstances, 
could administer injectable contraceptive services, provided they received appropriate training (World 
Health Organization, 2017c). Additionally, the very recent advent of self-administrable injectable 
contraception (DMPA-SC) and growing evidence that self-administration can match or improve rates of 
injection continuation as compared with provider administration (Kennedy et al., 2019), presents 
another possible role for pharmacy personnel: that of counsellor and dispenser, with pharmacies 
offering women a clean, discreet place to self-inject and safely dispose of their injectable. 
Finally, the suggestion of a branding exercise to create a network of ‘quality’ pharmacies, brings 
together all of the above and describes a multi-faceted approach to improving pharmacies as 
contraception providers: client- and provider-focused interventions as well as improved regulatory 
capacity. The need to holistically change pharmacy practice has been recognized elsewhere in the 
literature (Mayora et al., 2018, Hermansyah et al., 2016, Smith, 2009a), notably in neighbouring 
Tanzania. For its lower-tier drug shops, Tanzania’s accredited drug dispensing outlet (ADDO) program 
implemented a series of interventions to improve public-sector regulatory capacity; educate the public 
on pharmacy service quality and treatment compliance; train and supervise staff on dispensing skills; 
train drug shop owners on business skills; and provide business incentives for achieving ADDO 
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accreditation (for example, access to microfinancing, or the ability to sell an expanded set of essential 
medicine) (Rutta et al., 2015). Similar accreditation and social franchising programs have been launched 
in Liberia and Uganda (Rutta et al., 2015, Embrey, 2018), Thailand and Vietnam(Hermansyah et al., 
2016), and are being explored in Bangladesh (Systems for Improved Access to Pharmaceuticals and 
Services (SIAPS) Program, 2015, High-Impact Practices in Family Planning (HIPs), 2013). Accreditation 
programs combine business incentives with public sector standards-setting and may provide a rich 
potential ground for collaboration between Kenyan public sector regulatory agencies; educational 
institutions; professional associations; drug distributors; and individual retail pharmacies.   
This study had some limitations. Our mystery shopper could only inquire as to whether she could 
receive a contraceptive injection on site, so in those cases where she was told on-site injection was 
possible, she could not confirm who would have administered it and had to rely on what she was told by 
the pharmacy personnel. As our mystery shopper was meant to reflect likely actions of a nervous young 
client, she was also not able to ask for the training or position of the person who assisted her. Our youth 
participants in focus group discussions may have felt uncomfortable discussing contraception in a group 
environment; we did our best to mitigate any discomfort by using a series of vignettes for participants to 
react to and having our data collectors keep any discussion from lingering on personal experiences. 
Additionally, during interviews with pharmacy personnel, the participant’s background and training 
often came up in discussion; however, in an oversight, we did not systematically confirm training in all 
interviews, so there were some participants for whom this information was missing. Social desirability 
bias may have also caused certain interviewed pharmacy personnel to not report their dispensing 
practices accurately, especially if they knew they were out of line with regulations. However, a major 
strength of this study was the use of multiple methods and inclusion of both young clients and 
pharmacy personnel to triangulate actual pharmaceutical practices from the various reported practices. 
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6.6 Conclusion 
Pharmacy personnel (trained and untrained) around the world serve as clients’ primary point of contact 
with the health system. As observed in this study focusing on injectable contraception provision to 
young people, retail pharmacies have expanded to contraception service provision, and pharmacy 
personnel’s roles have transcended formal or informal training previously received. However, Kenya like 
many other countries, faces challenges in monitoring the types of services available in pharmacies, the 
quality with which they are provided, and who does the providing. Public health initiatives, including 
those related to contraception, often struggle to engage with private providers who fall out of the public 
healthcare system. That said, investing in multi-pronged initiatives with both public and private partners 
to improve overall pharmacy practice, update and enforce regulations, and educate the public can 
strengthen services at young people’s preferred point of care. 
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7.1 Pharmacies enabling youth ‘self-care’ in sexual and reproductive health 
Youth (older adolescents and young adults between the ages of 15-24) face a variety of barriers when 
trying to access sexual and reproductive health (SRH) services – particularly contraceptive services – 
from health facilities (High-Impact Practices in Family Planning (HIPs), 2015). Policy restrictions and 
community norms which deem youth access ‘inappropriate’ can dissuade young people from going to a 
facility. Those who do go often encounter ‘unfriendly’ staff, and facilities with inconvenient opening 
hours or a lack of confidentiality and privacy (High-Impact Practices in Family Planning (HIPs), 2015). 
In recent years, evidence on the safety and efficacy of contraceptives, coupled with global commitments 
by countries and donors to address health systems barriers and expand access to contraception 
(through Family Planning 2020 (Family Planning 2020, 2020) and other global initiatives), have resulted 
in key services and products being made available outside of health facilities (World Health 
Organization, 2017c). As a result, certain contraceptive services, including emergency contraception and 
daily contraceptive pills, are now available through retail pharmacies and drug shops (lower-tier 
establishments which do not employ a trained pharmacist, and are limited in the drugs they can 
dispense (High-Impact Practices in Family Planning (HIPs), 2013, World Health Organization, 2017a). 
Additionally, the recent advance of self-administered injectable contraception reflects a trend towards 
broader ‘self-care’ (individuals addressing their own health needs, with or without support of a health-
care provider) and user autonomy in accessing and using modern contraception (World Health 
Organization, 2019c, Kennedy et al., 2019). 
Pharmacies and drug shops, therefore, could be considered an important alternate contraception source 
for young people, especially in low- and middle-income countries (LMICs) (High-Impact Practices in 
Family Planning (HIPs), 2013). Yet they are not uniformly lauded as a panacea to meet young people’s 
need for contraception. The breadth of contraception available in many pharmacies remains narrow. 
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Also, many LMICs struggle with illegal pharmacy activity: unregistered premises, untrained personnel, 
and/or substandard commodities makes the quality of services variable. So, to what extent can 
pharmacies and drug shops be a quality catalyst for empowering a young population around their SRH? 
7.2 ‘Youth-friendly enough’ – pharmacies as contraception providers to young people 
Service provision to young people in general can be assessed by five tenets of quality, or 
adolescent/youth-“friendliness”: accessibility, acceptability, appropriateness, effectiveness, equity 
(World Health Organization, 2012a). From a programming perspective, all five qualities must be present 
to ensure quality services are available to all young people who need them. However, studies which 
have explored young people’s access to contraception services through pharmacies indicate that these 
standards may not be equally valued by young users (Gonsalves and Hindin, 2017). 
Appropriateness (ensuring the right health services are provided) and effectiveness (ensuring the right 
services are delivered in the correct manner) are essential for health programmers and governments. 
However, young people encountering individual, family, and/or community resistance related to sexual 
activity value confidentiality and respectful treatment (both elements of acceptability) (World Health 
Organization, 2012a). Similarly, young people appreciate pharmacy services for their acceptability and 
accessibility: non-judgmental personnel (in certain settings), privacy (in certain settings), convenient 
locations and proximity, opening hours, speed of service, and ease of access (Gonsalves and Hindin, 
2017). As a result, young people seek support from pharmacies and drug shops, even where there are 
concerns about service appropriateness, effectiveness, or cost. Put simply, young pharmacy customers 
prioritize a narrower set of ‘quality’ standards than health programmers or policy makers. 
7.3 Attention to equity – financing contraception services in pharmacies 
Pharmacy personnel providing contraception services and broader support for ‘self-care’ brings 
contraception closer to users of all ages. Additionally, ‘self-care’ has generated enthusiasm for its 
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potential to improve the cost-effectiveness of delivering SRH interventions. For pharmacy interventions, 
however, financing concerns remain: pharmacy services in many countries, particularly in LMICs, are 
often paid for out-of-pocket (a non-reimbursed, direct payment by the individual).  
As identified by Remme and colleagues (Remme et al., 2019), evidence on how self-care interventions 
are financed is lacking, and with it insights into the equity (or lack thereof) of these interventions. For 
young customers, pharmacy access seems important, yet is it only well-off young people and those living 
in urban areas who take advantage of these services?  
Our own research in peri-urban Coastal Kenya found young people reported contraception purchased at 
a pharmacy to be ‘cheaper’ than going to a health facility. Transport expenses, waiting time, and 
payment for provider-ordered tests made ‘free’ contraception services at public facilities surprisingly 
costly (Gonsalves et al., in press). However, even in settings where pharmacy purchases are objectively 
more expensive, we posit that with the exception of the very poorest, young users with less access to 
money are still likely to absorb the financial cost. For them, contraceptives purchased from private 
sources may still be less ‘costly’ than the financial and especially the non-financial costs of traveling to 
and being seen accessing services in a public health facility. Young users, therefore, may appear willing 
to shoulder the cost of contraception in pharmacies, while still being disproportionately burdened (as 
compared with adults) by the costs. 
Research to understand young people’s willingness to pay and their sources of income is needed, given 
that this is a population group is likely to be financially dependent on other household members. As 
contraceptive services are shared to private retail pharmacies, we urge caution to ensure that 
disproportionate financial burden does not shift to the consumer, even those groups who appear to be 
enthusiastic adopters.  
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7.4 Reaching ‘quality’ adolescent friendly health services in pharmacies  
The enthusiasm for self-care as it relates to contraception services and the role that pharmacies can play 
is not unwarranted. In many countries, private pharmacies are already an integral part of the network of 
providers relied on by young people. Nonetheless, there is still much to be done to improve the current 
provision of contraception services to young people in pharmacies and drug shops around the world. 
We agree with Narasimhan and colleagues’ assertion that ‘self-care’ (provided through pharmacies or 
otherwise) is not a ‘shortcut’ for countries to achieve universal health coverage (Narasimhan et al., 
2019).  
Making additional contraception services available in pharmacies cannot come without improved 
regulation and control of pharmacy services as well as multi-sectoral efforts to improve demand for and 
delivery of quality services. Providing contraception through pharmacies can overcome important 
barriers to accessibility and acceptability for young people. It does not, however, absolve the health 
system and governments of their responsibility to ensure young people are receiving appropriate and 
effective and affordable contraceptive services. 
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8 General discussion and conclusions 
8.1 Review of research objectives 
Young people age 18-24 are a heterogenous population group. As such, no single contraceptive outlet 
(even the ‘friendliest’ public health facility) is likely to ever draw in all youth (Chandra-Mouli et al., 
2014). Instead, understanding service provision and strengthening services in a variety of contraceptive 
outlets can ensure that young people have access to a constellation of quality contraceptive sources 
depending on their needs. This dissertation was prompted by recognition that much of the attention to 
improving contraceptive services for young people had traditionally focused on strengthening services in 
public health facilities. Private pharmacies, by contrast, while recognized as a valuable contraception 
outlet for this age group, have been less systematically studied. There was a need, therefore, to 
understand who chooses pharmacies, why they are perceived to be appealing, and what contraceptive 
services look like in a pharmacy.  
As such, this dissertation used a systematic literature review followed by a mixed-methods study to 
develop an understanding of young people’s experiences accessing contraception through pharmacies, 
globally and then in a peri-urban setting of an LMIC. The research was informed by three research 
objectives, initially described in Chapter 1.7. These objectives are ‘answered’ briefly in the table below, 
drawing from across key points from Chapters 3-7. 
Table 8.1 Dissertation summary results  
Research Objective Summary results (additions to the literature) 
Objective 1: Develop a 
comprehensive 
understanding of the 
experiences of young 
people worldwide who 
access contraception 
through pharmacies 
(Chapter 3) 
• Pharmacies are appreciated for their: longer operating hours, 
accessible locations, speed and ease of access. Mixed appreciation 
for privacy. 
• Making ECP (and other SRH commodities) available through 
pharmacies without prescriptions does not result in adverse sexual 
health-related behaviours or outcomes 
• Young people can appropriately self-screen and use contraceptive 
products. 
157 
 
• That said, young people and pharmacy personnel remain 
concerned that increased access does lead to poor health and 
behavioural outcomes. 
• Young people may leave empty handed if pharmacy personnel are 
unclear on guidelines, uncomfortable dispensing, or if legal minor 
or rural adolescent. 
Objective 2: In Kwale 
County, Kenya, what 
kind of young person 
access contraception 
from pharmacies, and 
why? (Chapter 4) 
• Pharmacies were the single most popular source of contraception 
used at last sex 
• Choice of contraception (particularly ECP and condoms) and living 
situation predict having gone to a pharmacy versus than any other 
source. 
• Pharmacies are appreciated for their: convenience, privacy, non-
judgmental personnel, speed, and low cost.  
Objective 3: Assess the 
contraception-
dispensing practice of 
pharmacies in Kwale 
County, Kenya 
(Chapter 5 and 6) 
• All contraception available in pharmacies is rarely dispensed with 
any screening or counselling 
• ECP and condoms are widely and easily (no gatekeeping) available 
• Injectable contraception also available for purchase, can be 
injected on site in some pharmacies 
• Young people were concerned by the quality (broadly defined) of 
pharmacy services. 
 
The findings from Kwale County addressing Objectives 2 and 3 can be compared to a broader global 
context using the findings from the global systematic review conducted to address Objective 1. There 
are some similarities and a few notable discrepancies to briefly discuss – with the caveat that most 
literature included in the systematic review came from high-income settings. In both the primary 
research and the review, pharmacies were appreciated by young clients for similar qualities including: 
opening hours, locations, ease and speed of access. Where they differed was on perceived anonymity 
and privacy. The systematic review found that some studies reported these to be an advantage of 
pharmacy services, while others cited a lack of privacy as a concern. Meanwhile in the primary research, 
pharmacies were almost uniformly appreciated for the privacy and anonymity offered, particularly in 
comparison to public health facility services. 
This difference may speak to how contraception services are provided in public health facilities and 
pharmacies in HICs versus LMICs. Had pharmacy personnel in Kwale been obliged to run young clients 
through screening protocols in the pharmacy before dispensing a commodity (for example, conducting a 
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patient consultation for every ECP request and ensuring the ECP is ingested on site, as is the case in 
Switzerland (Haag et al., 2019)), perhaps young people would have found the interactions less private. 
Similarly, if public health facilities in HIC settings were set up to be as ‘open’ as those in LMICs (e.g. 
family planning registration windows, public announcements inviting people waiting for contraceptive 
service to identify themselves), perhaps young clients in HICs would have seen pharmacy services as a 
welcome private alternative. 
Separately, in both the systematic review and the primary research, pharmacy personnel expressed 
reservations around the safety and appropriateness of contraception they were dispensing for their 
young clients. Both the review and research found that contraception was often not dispensed with 
information, even when – as in the case of several studies in the review – information-provision was 
part of the dispensing guidelines. Additionally, as described in Chapter 3, six studies from the review 
which used mystery clients (five of which were from HIC settings) found that anywhere between 20-65% 
of the time, the clients were told they would not be able to obtain their desired contraception (ECP in 
five of six studies). The mystery clients in this study were more successful - the ECP mystery shoppers 
both successfully obtained their contraception in 47 of 48 pharmacies visited (94 out of 95 interactions). 
That the findings from Kwale County highlighted some interesting differences between how pharmacy 
services are used, operated, and appreciated in LMIC vs HIC settings speaks to the benefit of further 
research in LMICs. The rest of this section places the Kwale County findings (Objectives 2 and 3) in a 
conceptual model with the broader SRH literature to address the overall dissertation aim of presenting 
an understanding of what drives young people aged 18-24 in Kwale County, Kenya to access 
contraception from pharmacies. 
 Conceptualizing young people’s contraception-seeking behaviour 
Behaviour-change theories including the Health Belief Model, the Theory of Reasoned Action and its 
expanded Theory of Planned Behaviour have been used to describe the complex factors that influence 
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an individual’s intention or readiness to adopt a certain behaviour. Where the desired behaviour 
involves seeking health services, as is the case with this dissertation’s focus on ‘contraception-seeking’, 
there are decades-worth of literature dedicated to understanding health-seeking behaviour.  
‘Pathways models’ focus on the individual’s journey and document a care-seeking process, starting with 
recognizing symptoms and continuing through seeking care, receiving treatment, reaching some 
‘resolution’ (for example, recovery and rehabilitation) (Obrist et al., 2007, Kroeger, 1983). ‘Determinants 
models’ capture characteristics of users as well as characteristics of the health system and available 
services to explain use of a given health service (Mackian et al., 2004, Obrist et al., 2007). For example, 
Anderson’s Behavioural Model of Health Services Use (the original and resulting iterations) identifies 
predisposing factors (traits of the individual like age, sex, race, education), need factors (their perceived 
need for health care, as well as objective health measures), and enabling factors (which either facilitate 
or hinder an individual’s ability to access services) which influence health service use (Babitsch et al., 
2012, Andersen, Aday and Andersen, 1974).  
This dissertation makes use of another determinant model, developed by Axel Kroeger (Kroeger, 1983) 
(Figure 8.1), which considers how various determinants might influence an individual’s choice of 
provider. 
160 
 
Figure 8.1 Original Kroeger framework (1983), reproduced 
 
 Kroeger’s initial framework was developed to better understand individuals’ choice of traditional versus 
‘modern’ health providers in developing countries. An individual’s ‘perceived morbidity’ (any ill-health, 
in the original framework) might result in that individual seeking care from a ‘traditional healer’ 
(herbalist, shaman, etc.), ‘modern healer’ (a physician, nurse, health worker, etc), ‘drug seller’ (not 
specified, but presumed to include pharmacy personnel), or opting for self-care (which was also grouped 
together with ‘no treatment’). A combination of mediating variables would simultaneously influence the 
individual’s choice of provider (or choice not to seek treatment at all), including: characteristics about 
the individual/household; characteristics/perception of the illness; and characteristics of the health 
service (health systems factors). In Figure 8.2 below, Kroeger’s model is adapted for this research, and 
now captures factors influencing a young person in Coastal Kenya’s choice of a contraception provider.  
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Figure 8.2 Determinants of contraception outlet among youth age 18-24 in Kwale County, Kenya (adapted from Kroeger) 
 
’Perceived morbidity’, has been replaced with a ‘desire to obtain contraception’, while provider options 
reflect those most commonly identified in Chapter 4. ‘Desire to obtain contraception’ is used rather than 
‘unmet need for contraception’ to clearly distinguish this individual-level framework’s starting point 
from commonly-used population-level indicators. It is also distinct from ‘desire to prevent pregnancy 
and/or STIs’ to distinguish it from individual-level behaviour change models which might be applied to 
this framework’s preceding step, greyed out in Figure 8.2. The assumption here is that the individual 
wants to engage in protected sex and has decided to do something about it (obtain contraception). This 
dissertation and the model pick up at the remaining question: what influences their choice of 
contraception outlet?  
‘Individual/household characteristics’ reflect characteristics identified in the survey and through FGDs 
with young people. ‘Characteristics/perceptions of contraception need’ refer to how the young person 
understands their own need for contraception, including their perceptions of which method is most 
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appropriate and their own knowledge about methods. Kroeger’s original ‘perceptions of the disorder’ 
included reflections on the illness’ severity and origins: variables which reflect differences in how an 
individual might seek health care for acute diarrhoea versus chronic back pain, for example. Whereas 
Kroeger’s ‘perceived morbidity’ can be any range of illness, in this model, ‘perceived morbidity’ is 
constant: a desire to obtain contraception. Therefore, the determinants here reflect variations in that 
individual’s understanding and familiarity of contraception types, their uses and their relative 
‘appropriateness’ for that person’s situation. Finally, the characteristics of health service has been 
updated to reflect the five elements of ‘youth-friendliness’ described in Chapter 1.  
 Framing the pharmacy-accessing experience 
 
Using the Determinants of contraception outlet model displayed in Figure 8.2, this dissertation’s findings 
and the broader ASRH literature demonstrate how a certain constellation of the above determinants 
would result in a young person choosing to go to pharmacy for contraception.  
8.1.2.1 Characteristics of the individual/household 
Chapter 4 found that young people who reported living alone were more likely to have used a pharmacy 
than their peers who reported living with their children or partner (in more of a ‘head of household’ 
role). The qualitative findings (see Box below) explain why additional differences among youth 
demographic categories were not observed or more pronounced. Here, pharmacies were described as a 
contraception outlet for anyone in the community. Among young people, married and unmarried, male 
and female, those living alone and those leading households, and those with and without children could 
and did get contraception from pharmacies.  
It was also socially acceptable for young ‘heads of households’ (i.e. young people who are already 
married and/or parents) to more openly seek contraception from facilities. By contrast, their peers who 
are still seen as young ‘dependents’ (that is, living in a household headed by an older, non-spousal 
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BOX 1. WHO GOES TO PHARMACIES FOR CONTRACEPTION – QUALITATIVE NOTES 
Chapter 4 used quantitative data only to assess who [what kind of person] goes to pharmacies to buy 
contraception, while qualitative data was restricted to identifying the reasons why pharmacies were 
appealing. Here, qualitative results on ‘who goes to pharmacies’ are presented, feeding into sections 
8.1.2.1 above and 8.1.2.2 below. 
Characteristics of the individual/household: age and sex 
Pharmacy personnel indicated that they sold contraception to a variety of individuals, including but not 
limited to young people. However, the type of contraception sold could be linked to a certain age and sex 
demographic. Condoms were almost exclusively purchased by men (of all ages, including young men). 
Emergency contraception was predominantly purchased by young women. Daily contraceptive pills and 
injection would be purchased by ‘mature’ women (older women of a reproductive age, usually married). 
In the society mostly youths, you cannot see a lady like the age of my mom who comes here to buy P2 
[Postinor-2, an ECP brand]. Most of them, they are the ones buying femiplan [a daily contraception pill] but 
the youths, my age like the university students, those in high school they are the ones using Postinor-2. 
Some men …they use Trust [a condom brand]…. - Pharmacy attendant (no formal training) 
“The emergency pills I see are mostly popular to the young girls who are not married. The others for 21 days 
are for those who are married. They will say, “I can’t use emergency pills because I am with my partner 
every day” And the other one will tell you, “if I use these [daily pills], is it every day that I am with my 
partner? The one day we are together is when I will take them.” – Pharmaceutical Technologist 
“[Condom] is for the males, while P2 is for the females” – Pharmacy attendant (no formal training) 
Characteristics of the individual/household: marital and/or household status  
Married young people were generally perceived to have more contraception options and contraception 
outlets to choose from. Unmarried individuals were perceived to be more heavily reliant on pharmacies. 
“Young people fear going to the hospital, because someone should be married for her to get that one for 
months [likely injectable] or that one for years [implant or IUD].” -Youth female community member (Focus 
group discussion) 
“If maybe you are single, mostly you will go to a chemist. But those that are married, you will find them 
going to hospital to be injected because at chemist there are no such services like that. So [the] status of 
someone contributes to where one is to go.” Youth male community member (Focus group discussion) 
 
family member) might need to ‘sneak out’ for contraception, a result of societal discomfort with 
unmarried young people accessing contraception (Chandra-Mouli et al., 2019). Those living alone in 
particular may have a more sporadic sex life (Chandra-Mouli et al., 2014), necessitating quick, 
unplanned trips to pharmacies and other easy-access outlets. 
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BOX 1. WHO GOES TO PHARMACIES FOR CONTRACEPTION – QUALITATIVE NOTES (CONT.) 
Characteristics of the individual/household: desires of partner 
Pharmacies were perceived to be outlets where women could obtain contraception independent of their 
partner’s wishes. This was the case for married and unmarried individuals.  
“I decided to use the P2 because I did not want to use the condom because my partner refused. And I did not want 
to tell him so I decided on my part [to use P2]” – Young female purchaser: ECP 
Characteristics/perception of individual’s contraception need: time-sensitivity 
Youth participants who purchased emergency contraception and condoms often alluded to buying these in 
preparation for or following a sexual encounter. These did not appear to be regularly scheduled.  
 “The lady I was to visit a certain morning…I [went] to the chemist first… after that, I called her and then she 
came.” – Young male purchaser: condom 
This ‘emergency purchase’ of contraception was even more pronounced for shops. Individuals who reported 
purchasing injection or daily contraceptive pills did not share this pressure, instead reporting desires to space 
birth for economic reasons. 
 
 
 
 
 
 
 
 
 
 
 
 
8.1.2.2 Characteristics/perception of contraception need 
Contraceptive needs can be met in many ways: obtaining contraception can be a spontaneous decision 
or require scheduling and coordination. Box 1 supports the idea of pharmacies serving ‘time-sensitive’ 
contraception needs, pre-sex or post-sex. Additionally, young pharmacy patrons likely went in with a 
method in mind, as evidenced by ‘typical’ interactions of young people coming in, requesting a specific 
commodity, paying for it, and leaving (Chapter 5). As has also been observed in Pakistan, preferred 
contraception also influenced the selection of outlet (Qureshi, 2010).  
Chapter 4 found that condom and ECP users were much more likely to have gone to a pharmacy than 
their peers who reported use of another pharmacy-available contraception. As evidenced by Box 1, 
demographic characteristics of the individual (described previously) were closely linked with that 
individual’s perception of their contraception need: pharmacy personnel reported associating 
contraception methods with a type of purchaser. ECP purchasers were female and unmarried, while 
condom purchasers were male and unmarried, or married and having sex with non-marital partner. 
Condoms, the most widely used contraception used at last sex in this study, have also long been 
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recognized for their popularity among young people (especially unmarried young people) because of 
their affordability and accessibility (Chandra-Mouli et al., 2014, UNFPA, 2016b).  
Perceived eligibility for a given contraceptive method also influenced a young person’s choice of 
provider. Some young people, including those who were married and/or had children, were perceived 
(by the community, health providers, and themselves) to be eligible for the full array of modern 
contraception methods. This included methods only available at facilities, such as intrauterine devices 
(IUDs) and implants. A survey of providers in Nigeria found health facility providers similarly restricting 
access to LARCs based on marital status or parity (Schwandt et al., 2017). Conversely, other groups, 
including unmarried youth, were perceived to be eligible to use a much narrower mix of methods, and 
relied more heavily on short-acting forms of contraception (a global trend (UNFPA, 2016b)). A young 
person may therefore choose a pharmacy in part because they perceive themselves to be eligible for a 
limited number of methods (which happen to be pharmacy-available).  
Finally, ‘perception of contraception need’ is also influenced by an individual’s desire and perceived 
need for counselling and instructions. With a preferred contraceptive in mind, young people would not 
go to a pharmacy expecting or seeking ‘traditional’ counselling on a full spectrum of contraceptive 
options. Chapter 5, which looked specifically into young people’s experiences purchasing condoms and 
emergency contraception found that young people were wary of prolonged interactions, and concerned 
about intrusive questions, and/or having to engage with someone substantially older than them (or of 
the opposite sex). Similar findings were observed among postpartum women in Nairobi, who reported 
going to private providers (including pharmacies) in search of fast access to their preferred 
contraception and respectful treatment, not extended counselling and screening (Keesara et al., 2015a).  
8.1.2.3 Characteristics of health services 
For pharmacy users, the perceived accessibility and acceptability of pharmacy services as compared to 
other outlets was sufficient to overcome concerns about their appropriateness and effectiveness. 
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Accessible: Pharmacies were viewed as highly accessible and were appreciated by young clients for their 
opening hours, locations, and ease of access. Anyone who could pay for contraception was able to 
obtain it (equity implications are addressed below). Factors related to accessibility were among the top 
reasons pharmacies were appreciated by young people, for example: physical accessibility (geographic 
location, convenient opening hours) and financial affordability (including not only the price of services 
on site but indirect and opportunity costs to getting to services (Evans et al., Levesque et al., 2013)). Low 
use of health services is strongly tied to distance, for adolescents (Barker, 2007) as much as other age 
groups. One scoping review of determinants of patient choice of healthcare providers found service 
users are generally averse to travel time and prefer providers to be in close proximity (Victoor et al., 
2012). This holds for contraception services in the region as well, where primary research and secondary 
analyses from sub-Saharan Africa found that distance to a provider of contraception services can be a 
barrier to contraceptive use (Zimmerman et al., 2019, Shiferaw et al., 2017, Silumbwe et al., 2018).  
Acceptable: Unless a client specifically asked a question, pharmacy personnel and clients reported next-
to-no interaction outside of the customer requesting the contraception and paying for it. Pharmacy 
personnel reported keeping interactions brief based on a perception that their young clients did not 
want the information (or anything that would otherwise lengthen the interaction). This allowed young 
clients to enter and exit with their desired commodity quickly, and speed of service was reported as an 
appreciated quality of pharmacy services. The ‘hands-off’ interactions also meant that pharmacy service 
were perceived to provide confidentiality and privacy. No information was collected from the young 
person: indeed, some reported sending in friends to make purchases on their behalf. Pharmacy 
personnel were perceived to be respectful and non-judgmental.  
Appropriate and Effective: Standard contraceptive care includes counselling on an array of methods and 
the opportunity for a young client to make an informed decision as to the one best suited to their needs. 
If they come in with a method in mind, counselling procedures should ensure that a client’s 
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understanding of the method and its appropriateness is accurate, provide instructions on use, and 
information on side effects (World Health Organization and Johns Hopkins Bloomberg School of Public 
Health Center for Communication Programs, 2018). Pharmacies did not consistently offer appropriate, 
effective services. All hands-off interactions reported (and appreciated by young clients) were devoid of 
the counselling described in Kenya’s Family Planning Guidelines. There were various additional concerns 
about the ‘quality’ of the contraception-dispensing interactions. Nearly two thirds of the pharmacies 
visited by an injectable-purchasing mystery shopper were not appropriately registered. Chapter 6 found 
that young people were both aware of and concerned by illegal and substandard pharmacy activity, a 
documented problem across the region (Wafula et al., 2012). However, in choosing to go to pharmacies 
anyway, the advantages of pharmacy services superseded concerns about quality, as has been seen 
elsewhere (Keesara et al., 2015a).   
Appropriate, effective services also indicate that providers can and should make use of referrals when 
necessary to ensure young clients get what they need (World Health Organization, 2012a). This would 
be of particular importance for pharmacies, who have fewer contraceptive methods available than 
health facility providers (in either public or private sectors) (Campbell et al., 2015b). However, referrals 
were not consistent. In 40% of visited pharmacies in our study area, a young person could both purchase 
injectable contraception and be administered on site. In some instances, pharmacies had developed 
regulation-compliant referral strategies – hiring appropriate health workers (like nurses, or doctors) to 
administer on site or linking with nearby facilities or clinics. However, in other cases, pharmacy 
personnel stepped outside their authorized roles and provided the injection themselves. 
Equitable: As described in Chapter 5 and 6, contraception was widely available and young people (as 
reported by them and as observed by mystery shoppers) rarely had any issues obtaining them. 
Purchasers encountered polite, hands-off interactions with pharmacy personnel. Interestingly, the price 
of services was not reported as a factor which might limit access for some young people, despite family 
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planning services supposedly being available for free in public facilities (Radovich et al., 2019). There are 
two possible explanations for this.  
First, as described in Chapter 4, participants reported that in addition to the transport cost to get to a 
public facility, services themselves often had fees associated with them. Some fees might result from 
tests and commodity purchasers outsourced from the health facility. However, research from Nairobi 
and Kisumu has found that that ‘informal fee payments’ for users are common in public facility 
contraception services (Tumlinson et al., 2020). Together, these may explain reports that half of Kenyan 
women who reported accessing contraception in public health facilities reported paying a fee 
(Tumlinson et al., 2020, Radovich et al., 2019).  
Second, as this study took place in a peri-urban setting, participants may have been better-off, 
financially, than young people nationwide. One study of equity of public and private family planning and 
child health services in Kenya found that three-quarters of users of urban and peri-urban facilities (likely 
urban residents themselves) sat in the top two wealth quintiles, nationally (Chakraborty et al., 2019). 
Our peri-urban participants may have perceived costs associated with contraception services to be less 
burdensome that their rural peers. 
 The young person who accesses contraception through a pharmacy 
This dissertation identified a variety individual- and health system-level characteristics that inform a 
young person’s selection of contraception outlet. For the young person who chooses a pharmacy, 
however, several of these are especially salient (see Figure 8.3).  
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Figure 8.3 Determinants of contraception outlet: choosing pharmacy, for youth age 18-24 in Kwale County, Kenya 
 
This study demonstrates that a young person comes to a pharmacy when they know the method they 
want and particularly if looking for condoms or emergency contraception. For these purchasers, there is 
usually a time-sensitive need: recent sex (for ECP shoppers) or the potential for sex in the near future 
(condom shoppers). Young pharmacy purchasers are actively not looking for (nor desire) counselling, out 
of either embarrassment, or possibly because they have used the method previously.  
The findings also confirm that pharmacies are a good option for young people for whom sexual activity 
may not be socially acceptable. However, the ability to reliably obtain your desired method via a quick, 
non-judgmental, affordable, and private interaction at a location close by makes pharmacies appealing 
for various short-acting reversible contraception users. These service characteristics carry 
disproportionate appeal for young people choosing their outlet, outweighing concerns about service 
quality. 
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8.2 Reflections on study methodology and validity 
 Mixed methods approach 
The use of mixed methods was a strength of this study. As alluded to in Chapter 2, the term ‘mixed 
methods’ conjures up a variety of definitions, descriptions, and scope. There have been numerous 
efforts to classify these, based on: the stage in the research process at which the methods are 
integrated (for example, during data collection, data analysis, or data interpretation); which method 
(quantitative or qualitative) is prioritized or ‘drives’ the study; as well as the sequence in which 
quantitative versus qualitative data collection takes place (Östlund et al., 2011, Kroll and Neri, 2009, 
Creswell and Creswell, 2017, Morse, 2016). This study adopted a mixed method approach in order to 
understand a phenomenon (contraception purchasing) which involved multiple actors and multilevel 
influences (Morse, 2016). The quantitative data provided the scale of the behaviour of interest – 
obtaining contraception at a pharmacy. The qualitative data provided the context – the ‘why’ and ‘how’.   
Chapter 2 indicated that the study could be only ‘imperfectly’ classified as concurrent and dependent 
(Schoonenboom and Johnson, 2017). The study’s nesting in the larger ARMADILLO trial meant a more 
precise classification was not possible. Out of necessity, this mixed-methods study adopted a flexible 
and pragmatic approach to data collection, as research activities (including field visits, trainings, etc) 
were largely determined by the research schedule of the larger trial. Within these constraints, however, 
the qualitative methods sequence was well-scheduled and facilitated triangulation (further detailed in 
Section 8.2.3).  
One area for improvement would have been to incorporate a second ‘wave’ of interviews of youth 
purchasers and pharmacy personnel. With more time allocated to field work, it would have been useful 
to review preliminary findings from these groups, conduct mystery shopper visits, and then follow up 
with a subsequent, more focused round of interviews to get richer data. However, as many of the 
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interviews were in Swahili, there was a significant lag time in obtaining the translated transcripts. 
Instead post-interview debriefs with data collectors during the weeks of data collection were relied on 
to adapt interview guides where appropriate. 
 Quantitative data collection and validity 
A strength of quantitative data collection was the rigour with which this cross-sectional survey was 
undertaken, thanks to its nesting in a randomized controlled trial. The resources and scale of the 
ARMADILLO trial enabled this study to capture quantitative data from a large, randomly selected sample 
of 18-24 year olds covering the largest urban area in Kwale County. The resources required to 
enumerate households and their youth residents, and then visit a random subsample for a survey of this 
scale would have been well beyond what was realistic for this study.  
There are some limitations as well, including the missed opportunity to include additional demographic 
questions (precluded by the trial), such as ‘religion of respondent’. Additionally, questions on 
contraception use and contraception source were adapted from validated contraception-related 
surveys. However, as indicated in Chapter 4, the primary intention of these surveys was to capture 
general contraception use, not the nuances of who (in the sexual partnership) purchased it. This created 
some limitations in interpreting this study’s quantitative data in Chapter 4. For the broader dissertation, 
however, the incorporation of qualitative data on demographics of pharmacy purchasers (presented in 
Box 1 of this chapter) enriches the quantitative analysis. 
Several factors strengthen the internal validity (Campbell and Stanley, 1963) of this study’s findings: the 
random selection of participants prevents one source of sampling bias which could resulted from a 
different sampling strategy. Participants also filled out sections of the survey related to this study 
themselves, which mitigates response bias which may have arisen if the interviewer had asked them 
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about details related to their most recent sexual experience (including where they had obtained 
contraception, if used).  
The random sample and large study population also improve the external validity of these results. 
However, there are two points of caution in attempting to generalize these results to 18-24 year olds 
nationwide or even county-wide. First, the eligibility criteria of the randomized controlled trial meant 
that participants in this survey also reported owning their own phone. It is possible that young people 
with the means of owning their own mobile phones, may be more able to purchase contraception at 
pharmacies than their non-phone-owning peers. Second, this study took place in the most urban part of 
an otherwise rural county. The reduced numbers of pharmacies and pharmacy personnel in rural parts 
of the country (Kenya Ministry of Health, 2017, Oketch, 2019) almost certainly means that the mix of 
contraceptive outlets used by youth in this study is different than that of their rural counterparts. 
 Qualitative data collection and validity 
The breadth of participants was a strength of the qualitative data collection. Particularly for young 
participants, there was a benefit to doing both FGDs and IDIs. The FGDs captured broader community 
norms around accessing contraception through pharmacies, while the IDIs zeroed in on the individuals 
purchasing and their process for doing so. The highlight of the qualitative data collection, however, was 
the mystery shopper exercise – the data produced in each 2-3 minute interaction was highly-valuable.  
Limitations of qualitative data collection were related to data collector recruitment and training. Data 
collectors were hired from Kwale County (an area without robust research infrastructure) to map 
pharmacies and interview pharmacy personnel. As locals, they had the benefit of being able to easily 
identify pharmacies and being recognized in their community; however, both had only secondary level 
education and no prior research training. For inexperienced data collectors, learning to probe and to 
create an interview dynamic where participants are comfortable sharing takes time to master. Being 
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familiar enough with a study’s scope and research questions to move a participant through a semi-
structured question guide also takes time. Therefore, it was an oversight not to spend more time (a 
week minimum) on training, with multiple rounds of practice and feedback, before sending them to the 
field.  
Additionally, some of the qualitative data collected by these collectors must be viewed through the lens 
of a hierarchical relationship (described in the reflexivity statement in Chapter 4) that became apparent 
in reading the transcripts, where these new data collectors were viewed as ‘less-educated’ by a few 
qualified pharmacists. This may have factored into how the data collectors perceived their own role, 
resulting in them being more reluctant to probe.  
To address the above concerns, for the second round of planned interviews (with young clients), 
experienced young data collectors from Mombasa County (an area with far more research 
infrastructure) were hired. During the second half of data collection, they conducted additional 
interviews in pharmacies. Their report of the interviews (and subsequent review of transcripts) indicated 
that the Kwale County interviewers’ collected data still well-addressed this study’s objectives, and 
confirmed saturation had been reached in capturing pharmacy personnel perspectives.  
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Concepts of ‘credibility’ and ‘transferability’ replace internal validity and external validity, respectively, 
as alternative criteria against which the ‘trustworthiness’ of a study can be assessed (Lincoln and Guba, 
1985). In order to enhance this study’s ‘credibility’, or confidence that findings reflect participants’ 
experiences, this study used triangulation across methods (see Figure 8.4) (Nowell et al., 2017, Lincoln 
and Guba, 1985, Pandey and Patnaik, 2014). Focus group discussion findings related to general 
contraception-seeking behaviour and stakeholder key informant interview (KI) insight into pharmacy 
practice and regulation resulted in the guides for in-depth interviews (IDI) and KIs with pharmacy 
personnel to be more precisely-focused. These guides evolved further as interviews continued. Findings 
from the KIs, IDIs, and FGDs informed the development of the mystery shopper personas and their data 
collection forms. Testing four ‘typical’ scenarios across nearly 50 pharmacies, provided an ‘objective’ 
Figure 8.4 Triangulation of methods in qualitative data collection 
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perspective that could then enrich or counter findings from earlier research activities with pharmacy 
personnel and young purchasers.  
Modified peer debriefs (where the researcher is extensively probed following data collection)(Lincoln 
and Guba, 1985) also enhanced this study’s credibility. These took place with qualitative data collectors 
(including mystery shoppers) at the end of each day of data collection. Each data collector was 
extensively interviewed by the dissertation author. These interviews captured detailed content of the 
interview and interaction (as reported by the data collector), and explored any assumptions made by 
the data collector, including where they perceived tension or saw need for further inquiry. Feedback 
could be provided on interviewing techniques and questions guides adapted to follow lines of inquiry.  
Transferability describes the extent to which the conclusions of this study might be relevant or 
‘transferable’ to different contexts (Lincoln and Guba, 1985). If this study presents “thick” (detailed) 
descriptions of findings and processes, its results can be adequately compared to findings from similar 
studies in different settings. This study’s use of several methods to build a picture of what happens on 
either side of the counter during a contraception purchase results in a thick description of the 
contraception-accessing experience for young people going to pharmacies.  
8.3 Future research 
The need for the mixed methods study to address Objectives 2 and 3 was confirmed by the systematic 
review, which found minimal literature from LMICs speaking to young people’s use of pharmacies. This 
has been noted as problematic given the recognized reliance on pharmacies in LMICs, particularly for 
emergency contraception (Dawson et al., 2015). This dissertation opens a variety of additional areas of 
research, particularly in LMICs. 
1. Assess pharmacy personnel’s knowledge of contraception use, address misconceptions 
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This study’s findings suggest that many pharmacy personnel may have misconceptions about the 
appropriateness of contraception for young users (particularly nulliparous young users), shared by many 
other cadres of health providers. Additional research should more systematically assess pharmacy 
personnel’s understanding about the different types of contraception available in pharmacies and who 
is eligible to use these. This has been done in several high-income countries; however, there is less data 
for LMICs. Having mystery shoppers who actively ask for advice or assistance (which, as described in 
Chapter 5 and 6, our shoppers did NOT do), could assess this. Intervention research to address provider 
myths and misconceptions around contraception should also include pharmacy personnel.  
2. Understand the dual role of pharmacy personnel as health provider and business person  
There is an additional need for research exploring the tension of being a business versus being a health 
care provider. A concern raised by participants was that pharmacy personnel’s decision-making in 
private retail pharmacies would be primarily influenced by a desire to turn a profit, selling commodities 
irrespective of whether it was an appropriate/effective commodity for the situation. This has also been 
seen elsewhere in the pharmacy literature (Both and Samuel, 2014, Wafula and Goodman, 2010, Smith, 
2009a). There is a healthy scepticism warranted towards too much task-sharing with private pharmacies. 
However, pharmacy personnel are still colleagues in a broader health workforce. In this study, and in 
other pharmacy-practice strengthening interventions (Bunyi, 2018), they expressed an interest in 
improving the quality of services they, as health providers, can offer. For-profit and quality-care 
motivations are not necessarily in conflict with each other. Additional observational research could 
better identify the full spectrum of motivations of trained pharmacy personnel (desire to provide care, 
status in community, pressure to be profitable, desire for return customers) and how these interact with 
each other. Any intervention research targeted at strengthening or broadening pharmacy service 
provision should carefully assess this as well.  
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3. Review quality of contraception commodities available on the local market 
Pharmacy research offers an opportunity to assess the quality of commodities themselves, in addition to 
the quality of service and service 
providers. The mystery shoppers in 
this study collected an array of 
emergency contraception and 
condom brands between them (see 
Figure 8.5). In many sub-Saharan 
Africa countries, commodity 
packaging may not be in alignment 
with national guidelines. An ECP 
brand may market its product as effective for 72 hours post-sex, for example, while national guidelines 
indicate the same drug combination is effective for up to 120 hours. Future research may consider 
reviewing instructions for locally-available brands to help contextualize the advice given by pharmacy 
personnel: commodity mislabelling/labelling could influence the accuracy of advice given. The quality of 
the commodities being distributed can also be assessed, through careful review of labelling (including 
active ingredient name, expiry date), packing, and dosage against a reference sample (World Health 
Organization, 2007).  
4. Understand the role of retail shops in the ‘network’ of contraception outlets 
Figure 8.5 Commodities accumulated as a result of mystery shopper exercise. 
Quality of commodities was not a study objective; therefore packaging was not 
reviewed. Instead these were donated to a local, NGO-run drop-in health centre 
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Finally, as mentioned in Chapter 4, shops were the second most popular source of contraception at last 
sex. This study proposal initially grouped pharmacies and shops together as an alternate source of 
contraception, with the intent to explore them both. However, upon arrival in Kenya, it quickly became 
apparent that they were viewed as two distinct sources. No lower-tier outlet of ‘drug shops’ existed, and 
the generalist shops and corner kiosks which abounded were not part of the formal health system in any 
way (nor viewed as such by community members). Indeed, in all focus group discussions (where 
participants were explicitly asked to list 
sources of contraception), participants 
distinguished between pharmacies and 
shops. Shops were considered even 
more innocuous than pharmacies for 
obtaining condoms (the only 
contraception available) – they stock 
mostly non-health related items, 
making it even harder to identify 
‘condoms’ as the reason a young person 
had gone to a shop. Trained pharmacy 
personnel, like other health workforce 
cadres in LMICs, stay close to 
urban/peri-urban areas, while rural areas have a lack of qualified pharmacy personnel (Kenya Ministry of 
Health, 2017). As such, young people in rural areas with similar profiles to this study’s pharmacy users, 
may turn to shops instead. Therefore, in all areas, but particularly for rural areas, there is a need for 
research to better understand the role of shops as contraception providers for young users. 
Shops: for IMMEDIATE contraception needs 
Like pharmacies, young people reported using shops for 
time-sensitive contraception needs. However, the 
immediacy of sex was even more pronounced for 
pharmacies than shops. FGD participants spoke of shops 
being the outlet of choice when en route to visit a partner 
or when a partner was literally waiting for sex at home.  
 
“Sometimes the young man has found himself with a 
young lady while the mother is not around… it will force 
him run to the shop to pick [condoms].” – Young male FGD 
participant 
 
“The shops are the only places a person can quickly go… 
the person they are expecting to have sex with may decide 
to [leave], so he will quickly go to the shop to get condoms 
then get back home to have sex with his/her partner.” – 
Young female FGD participant 
 
 ‘Shops’ were the go-to if an unexpected or unscheduled 
sexual encounter arose. 
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8.4 Policy and programming considerations for Kenya 
This study was observational in nature, with the understanding that – given broader global trends 
towards ‘self-care’ in SRH and popularity of task-sharing contraception services to pharmacies – future 
SRH interventions which might seek to develop youth-targeted, pharmacy-based interventions, could 
draw upon this work. The study has focused almost exclusively on pharmacies as contraception outlets, 
and the considerations presented below will do the same. However, any pharmacy-focused 
programming should not attempt to view pharmacies as the solution to increasing youth access to 
contraception. Instead, pharmacies should be viewed as one outlet in a broader network of 
contraception sources for young people: programming should aim to strengthen quality and increase 
connectivity between other outlets.   
Policy and programming considerations are divided into two: the first section provides suggestions as to 
how existing contraception provision can be strengthened while maintaining the status quo. The second 
section proposes more medium- to long-term opportunities that would require greater changes to 
pharmacy practice and administration.  
 Improving the status quo: strengthening existing contraception services 
Kwale County’s (and Kenya’s, more broadly) private pharmacies’ existing practice selling emergency 
contraception, condoms, and even daily hormonal contraception is not perfect, but does minimal harm. 
Young people’s reliance on these short acting forms of contraception (and emergency contraception, in 
particular) is certainly less ideal than these young people being able to obtain and appropriately use 
more effective forms of contraception. However, for the young person trying to avoid pregnancy or 
HIV/STIs, it is better than them not accessing contraception at all.  
Existing contraception services can be strengthened with minimal resource investment in health and 
pharmacy infrastructure. These investments should be multi-level and are presented below in line with 
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four approaches for strengthening youth-friendly services, as first outlined in Chapter 2.6 (Chandra-
Mouli et al., 2015): 
1. Train and support providers to be non-judgmental and friendly to young clients 
Using short-courses and/or existing Continuing Professional Development (CPD) requirements – that is, 
in-service training – for registered pharmacists and pharmaceutical technologists could help to dispel 
lingering concerns around the safety and appropriateness of young people’s use of contraception. This 
may increase comfort with recommending more effective forms of contraception (pharmacy-available 
or not), particularly to young ECP purchasers. This study’s participants and the broader literature 
indicated that the commercial pharmaceutical sector and development partners have already begun to 
rely on short-courses – the effect of these interventions needs evaluating (Dawson et al., 2015). 
2. Make health facilities welcoming and appealing 
Pharmacies have existing premises guidelines which, if enforced, provide all clients with a clean and 
welcoming facility (Kenya Ministry of Health - Pharmacy and Poisons Board, 2019). Additionally, youth 
participants in this study requested easy ways for clients to identify a registered provider. Enforcement 
of existing regulations which require the name and registration certificate of the person controlling the 
pharmacy to be visibly displayed (National Council for Law Reporting, 1957 (revised 2012)) can help with 
this, as can more recent PPB initiatives to make properly registered facilities easier to identify via SMS 
services (Chapter 6).  
3. Include communication and outreach activities (alerting young people to available services 
and encouraging to use them)  
As identified in Chapter 5, health education campaigns highlighting important messages about popular 
contraception types could be based in pharmacies. Prominently-displayed promotional materials could 
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serve to reinforce pharmacy personnel’s knowledge, educate young purchasers, and encourage dialogue 
between the two groups. Easy-to-read leaflets in a bag, and broader digital health campaigns can also 
provide instructions on use and even referrals for further information or services. The young client can 
review these in private, on their own time. 
4. Ensure the community is supportive and recognizes the importance of young people being 
able to access services.  
Outside of the four walls of the pharmacy, broader A/YSRH programming in health and education 
sectors (through comprehensive sexuality education, broader community sensitization) must continue 
efforts to normalize, destigmatize, and empower youth use of contraception. Young people, providers, 
and communities must be knowledgeable about and comfortable with young people’s eligibility to 
access and safely use all forms of modern, reversible contraception. This would contribute to an 
enabling environment where a young person’s choice of a contraception outlet can (eventually) be more 
informed by additional factors like convenience or desired commodity, rather than an effort to avoid 
stigma or embarrassment at all costs. 
 Envisioning medium- to long-term change: quality improvements must come first 
As mentioned in the Introduction, in 2018, Kenya’s Family Planning Guidelines were updated (Kenya 
Ministry of Health, 2018). The update, as it 
pertained to pharmacy provision of 
contraception reflected WHO Task Sharing 
recommendations (World Health 
Organization, 2017c) and broader global 
trends towards increased ‘self-care’ in SRH: 
pharmacists were authorized to administer 
injectable contraception, provided they were 
Expanding access can be deceptively difficult  
The results of this dissertation were presented 
to Ministry of Health officials from local, 
County, and National levels, as well as partners 
from NGOs at a June 2019 meeting. In the 
discussion, Ministry of Health officials indicated 
that they were exploring the introduction of 
self-administered injectable contraception to 
pharmacies. However, they had a major 
obstacle - how could they guarantee that 
poorly-regulated pharmacies would responsibly 
and reliably deal with safe sharps disposal? 
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appropriately trained. This, coupled with the introduction of self-administered injectable contraception 
described in Chapter 6, has the potential to further benefit young users who rely on pharmacies as their 
contraception outlet. However, given Kenya’s well-documented and persistent issues with illegal 
pharmacy activity (Monja, 2018, Oketch, 2019, Thiong'o, 2019), any expansion of contraceptive services 
at this stage can only responsibly be undertaken with a corresponding investment in improving the 
quality of services delivered. In this regard, Kenya has two immediate issues that require attention: a 
need for consistent, regulation-compliant services, and improved data.  
8.4.2.1 Pharmacies must reliably provide regulation-compliant services 
Private pharmacies do not consistently provide quality services. Chapter 6 described in detail the multi-
pronged efforts required to holistically and sustainably raise the quality of all pharmacy services. These 
involve a combination of carrot and stick measures, from improving regulators ability to enforce existing 
quality standards to providing trainings and special accreditations which target the dual interests of 
private pharmacies, running a profitable business and delivery good quality health services. These 
should be coupled with community-targeted efforts to raise awareness of and demand for quality 
services. At present, the Pharmacy and Poisons Board has too few human and financial resources to 
adequately enforce its regulation mission. In its current state, it will need to rely on strategic 
collaborations with professional associations, and private entities (for example, drug manufacturers, 
importers and wholesalers). Two example strategies are proposed below: 
1. Regulatory responsibility-sharing 
Regulation within the health system traditionally focuses on the setting and enforcing of standards to 
ensure that services are delivered with a certain level of quality and safety (Kumaranayake et al., 2000). 
Groups involved in regulation can include parliaments, ministries of health or other specialized 
government agencies, local authorities, as well as professional associations (Kumaranayake et al., 2000, 
Europe., 2019). 
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In Kenya, the PPB currently regulates the entirety of pharmaceutical practice, the individuals 
(pharmacist/pharmaceutical technologists), the commodities, as well as the premises (retail 
pharmacies). A government-based regulation system is not unique to Kenya, nor to pharmacy practice. 
However, it is also not the only possible regulatory structure. In 2009-2010, the World Health 
Professions Alliance (WPHA), which serves as a global umbrella organization for international 
associations for dentists, medical doctors, nurses, pharmacists, and physiotherapists, conducted a global 
survey to understand how the five professions were regulated in various countries (Besançon et al., 
2012). Of the 29 systems reported in WHO’s African Region (not including Kenya), 52% regulation 
systems were government-based (like Kenya’s pharmacy sector), 34% were self-regulated through 
professional bodies, while an additional 10% involved some combination of government and self-
regulation (Besançon et al., 2012). 
Basic regulatory systems include registration, while those more complex (such as Kenya’s pharmacy 
practice regulation, in theory if not in practice) include oversight over renewals, continuing professional 
development, defining and enforcing standards of practice. In general, as regulatory systems grow more 
complex (that is, take on more functions) the regulatory role for professional associations also increases. 
Additionally, certain functions (including discipline and investigations) appear to take place more 
frequently when professional associations join with governmental regulatory bodies (Besançon et al., 
2012, Europe., 2019). Standards are often still set by government regulatory entities like the PPB, but 
professional association can step in to enforce these among their members, bringing ‘self-regulation’ to 
pharmacists and pharmaceutical technologists. 
Kenya’s PPB has had ties with its professional associations for decades. The regulatory power given to 
these associations has fluctuated in this period. Under the PPB’s current continuing professional 
development (CPD) guidelines, professional associations like Pharmaceutical Society of Kenya and the 
Kenya Pharmaceutical Association (KPA) for pharmaceutical technologists, take responsibility for 
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administering CPD activities to their members (Kenya Ministry of Health - Pharmacy and Poisons Board, 
2013). During data collection, the PSK participant implied that relations with the PPB were on the 
upswing (with the potential for responsibility-sharing) after a few difficult years. Should membership in 
a relevant professional association become a prerequisite for obtaining and renewing licenses (it has 
been in the past, but did not appear to be at the time of data collection), these professional associations 
could take pressure of the PPB’s Registrar and Inspectorate, by verifying formal and continuing 
education requirements, and holding its members accountable to government-set practicing standards.   
2. Franchising or accreditation systems   
Another opportunity to responsibility-share (touched on in Chapter 6) comes through franchising. 
Franchising links up various private sector providers under a common brand. The resulting network, with 
its accompanying quality and service standards, is theorized to be able to improve standardization and 
self-regulation among disparate independent private sector providers (Beyeler et al., 2013). Private 
providers are incentivized by access to trainings, high-quality commodities, pooled procurement, and 
access to a recognizable brand. Demand among clients is generated through marketing and the brand 
becoming associated with ‘high-quality care’ (Nijmeijer et al., 2014). In LMICs, the term ‘social 
franchising’ is more commonly used, as franchising efforts have traditionally been set up with social 
good objectives (health improvement) in addition to, or instead of, profit-generating objectives 
(Nijmeijer et al., 2014, Qureshi, 2010). Non-governmental organizations have initiated some of the initial 
large social franchising networks (e.g. the Green Star Franchise Network in Pakistan)(Qureshi, 2010), but 
private sector entities can do so as well. Governments have also initiated similar accreditation schemes, 
such as the Tanzania Food and Drugs Authority’s accredited drug dispensing outlet (ADDO) program, 
described in Chapter 6. Two systematic reviews found that in LMICs, social franchising has primarily 
been tried to improve SRH or maternal and child health services among private providers (not 
pharmacists) (Nijmeijer et al., 2014, Beyeler et al., 2013). Evidence is limited and contraception service-
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related findings (related to quality of service provided, service utilization, and client satisfaction) have 
been mixed. 
Kenya has had social franchising in place for nearly 20 years. Major NGOs (Marie Stopes International, 
Population Services Kenya, FHI360, etc) have developed franchise networks, many of which were 
developed to promote uptake of modern contraception. One evaluation of Population Services Kenya’s 
franchise, Tunza, found that while overall current use of contraception did not change, respondents in a 
franchise catchment area were more likely to be using a LARC or permanent contraception method than 
those in a non-franchise catchment area (Chakraborty et al., 2016). This held true for young women age 
18-24 specifically, a notable finding given the tendency for women in this age group to be dissuaded 
from these methods. This may be attributed to successful provider training, full service readiness, as 
well as perceived higher quality (Chakraborty et al., 2016). 
A social franchising effort solely targeting private pharmacies as a strategy to improve contraception 
uptake has not been extensively explored. This may be because previous efforts have focused on 
increasing method mix, specifically uptake of LARC and permanent methods (Chakraborty et al., 2016), 
the administration of which is not appropriate for pharmacy settings. However, for-profit franchising for 
private pharmacies is already working its way into Kenya’s pharmaceutical sector, purporting to bring 
with it improvements in commodity procurement, information management, and client experience 
(Adegoke, 2019). In Chapter 6, this study’s participant from the Pharmaceutical Society of Kenya 
highlighted franchising (a ‘chaining and branding initiative’) as a forward-looking, multi-stakeholder 
opportunity to help the pharmacy sector self-regulate. Under this scenario, the Pharmacy and Poisons 
Board sets the standards (and enforces to the best of its limited ability), the professional association 
(PSK) develops a quality mark against these standards and provides training and oversight to pharmacies 
who choose to join the brand (as well as the hope for increased brand awareness within communities 
and scrutiny of those pharmacies that do not have the mark of quality). PSK’s ‘Green Cross’ brand has 
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attempted to start this1 (Aywak et al., 2017, Pharmaceutical Society of Kenya). Finally, if appropriate, 
private franchisors/investment could offer increased brand recognition as well as pooled procurement 
options and improvements in pharmacy operating procedures. In conclusion, social franchising would 
offer an interesting opportunity for multiple stakeholders to play to their strengths and capacities and 
introduce additional self-regulation into an unregulated sector. 
8.4.2.2 Health systems require better data from pharmacies 
Finally, this research highlighted that there is very little data coming from private pharmacies, leaving a 
void of information related to who uses these popular outlets and how. Findings from this study 
captured in Chapter 5, as well as previous reviews of Kenya’s DHS data (Radovich et al., 2018) indicate 
that a noticeable percentage of contraception for young women is obtained from pharmacies, based on 
self-reporting. However, for pharmacy contraception services, self-report data - be they nationally 
representative (as in the DHS), or from community-based studies like this one - cannot be compared 
against routinely-collected data from the health system. Unlike public health facilities, the private sector 
(including private pharmacies and drug shops) in many LMICs do not feed into health management 
information systems (HMIS). Kenya’s HMIS is the District Health Information Software 2 (DHIS 2), an 
open source software system which the Ministry uses to regularly capture service delivery and product 
information in its public health facilities (Bunyi, 2018). These indicators are aggregated from sub-County 
level upwards. Including pharmacies into the DHIS 2 could provide needed insight into what products 
and services are being used.  
The USAID-funded SHOPS Plus Project attempted this in a 2017-2018 pilot project in several dozen 
pharmacies in Nairobi County (Bunyi, 2018). The project involved extensive consultation with national 
level stakeholders at the PPB, MoH, and professional associations, as well as consultation with private 
pharmacists and commodity importers. Pharmacies volunteered to participate, incentivized by access to 
                                                          
1 However, a look at the ‘Green Cross’ members list online found only 22 members, nationwide.  
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aggregated DHIS 2 data, training on DHIS 2 system use, as well as broader skills-building on business 
operations. The project team designed a data capture tool that was reflective of pharmacy operations 
and commodity naming conventions – this was then later transcribed into an adapted DHIS 2 tool 
designed to capture contraception commodity dispensing by facilities. Data collection techniques were 
dynamic – again, reflective of the diversity in operating procedures across various retail pharmacies - 
and included in-person visit, soft copy and hard copy data entry. 
Findings from this project indicated that private pharmacies could participate in national reporting 
structures (Bunyi, 2018). That said, participants also indicated that reporting requirements could be 
burdensome over time, and while pharmacies appreciated access to data (to get insight on their local 
markets), they would require a sustained business case or incentive to stay engaged in the long term. 
Flexible data collection and dedicated tools designed for pharmacy providers would also be necessary, 
as would strong leadership from public sector Ministry official tasked with DHIS 2 implementation. 
Incorporating private pharmacies (and other private sector providers) into Kenya’s DHIS 2 reporting 
structure would provide the Ministry of Health with better data. For contraception services, this would 
result in the Ministry building a more complete understanding of how different contraceptive outlets in 
a complex web of public and private health care providers are used. However, like broader quality-
improvement efforts, efforts to incorporate data collection into private pharmacies will require a 
combination of better incentives and better regulation.   
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10 Appendices 
10.1 Appendix 1: Study Instruments  
 Focus Group Discussion Guide 
Today we’re going to discuss what young people in this community think about contraceptives and 
where they go when they need it. 
Warm-up 
• Tell me what “contraceptive” means to you? 
o Tell me the kinds of contraceptives you’ve heard of 
Myths and misinformation around contraception 
Vignette: XXX [name determined by FGD participants] is 21 and her boyfriend YYY [name determined by 
FGD participants] is 23. They have been dating for a while and are thinking about using contraceptives. 
However, there are things about contraceptives that they have heard from friends and family members 
which make them uncertain. 
What are some of the things which they may have heard? 
Ask participants to write down on sticky notes at least three things that XX and YY may have heard which 
would make them nervous. Notetaker and Facilitator 3 will post these on the board, grouping together 
the similar ones. After they are all posted, moderator can ask: 
• [read out the reasons listed on the board]: Are there any additional reasons XX and YY may feel 
uncertain that you can think of? 
• [also probe on certain reasons that are vague or broad] 
Where young people get contraceptives 
• Tell me about all the places in _____ (study site town), where a young person can get 
contraceptives? (Facilitator 3 writes out a list) 
• Describe all the different kinds of young people you could find in your community. (keep this 
short) 
For each listed contraception source: 
• Describe the kind of young person who would go to a _______ if he/she needed contraceptives? 
(Draw stick figure under each source name, probe on and label with identifiers: gender, marital 
status, etc) 
Facilitator 3 stops drawing after question above 
• When would a young person choose to go to a _____ to get contraceptives? 
o [Note]: what kind of contraceptives are they getting 
• Why would this young person choose to go to a ________ to get contraceptives over another 
source?  
o [Probe] What are the best qualities about ______ as a resource for contraceptives?  
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• What might other young people dislike about ________ as a resource for contraceptives? 
Qualities of ideal FP-dispensing in non-service sources 
• What are the most important qualities a chemist or a shop needs to have for a young person to 
be comfortable obtaining contraceptives? [Probe on person working vs the shop itself] 
• What could be some reasons why young people would not be comfortable going to chemists or 
shops? 
o What could be done to increase the comfort of young people who might not be 
comfortable going to chemists or shops? 
• What other information and services would a young person needing contraceptives from a 
chemist or a shop also need? 
o [be sure to probe on information AND services separately] 
• What could be done to make sure that young people can get the extra information and services 
(that group mentioned in previous question) that they need from chemists and shops without 
being uncomfortable and without sacrificing their privacy and speed (or whatever is mentioned 
as an important quality).  
 
Close and thank people for their time 
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 In-depth interview guide for young contraception purchasers 
Warm-up 
• Tell me about what life is like for young people (people your age) in this community. 
• What are some of the challenges that young people face? 
As you told us earlier, you recently purchased family planning from a chemist shop nearby. I want to 
ask you about this experience 
• Tell me about what your experience was like when purchasing FP from the chemist – how did it 
go, from beginning to end? [looking for information on environment, interaction with chemists, 
how they were treated] 
o How did you feel at each step? 
o What was the most difficult part of the experience? 
o What was the easiest part of the experience? 
• Describe your interaction with the chemist attendant [probe on: how were you treated?] 
o How did he/she react to your request 
• Tell me about the information you were given by the chemist [probe on: counselling, life advice, 
side effects, referrals other FP] 
• Tell me about what else was going on in the chemist shop while you were purchasing FP. 
• How did you feel after you left the shop? 
• Given the experience you’ve just described to me, how did that compare with what you thought 
would happen when you first walked in the chemist shop? * 
Thinking about the time that you purchased family planning at the chemist, help me understand how 
you made that decision: 
• What situation made you decide that you needed family planning? [Probe on whether others 
were involved in this decision] 
• How did you decide what kind of family planning you wanted? 
• Why did you decide to go to a chemist for family planning instead of other places? 
o Why did you select that particular chemist?  
• How did this experience compare with other times you have bought family planning? 
As a young person who has purchased FP from a chemist, I am interested to hear your ideas for how 
chemist shops could be improved for young people: 
• Were there any parts of your experience that you liked? 
• Based on your experience, was there anything you would’ve liked to happen that didn’t?  
o Probe (if necessary): Based on these, is there any part of the experience that you want 
changed? 
• If you worked at the chemist, what would you do to make young clients buying family planning 
feel comfortable? 
• If you worked at the chemist, how could you improve the shop to be friendlier to young people 
needing family planning? 
• What else do young people need to feel comfortable getting FP from chemists? 
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 Key Informant Interview guide (for a person working in a pharmacy) 
Group 1 (Background – Personal) 
• Tell me about yourself and how you came to work in the chemist? 
o Probe if they are from the area 
o What is their current title? 
• Tell me about the roles and responsibilities of your job - describe a typical day of work 
• What are the things that you enjoy about your job? 
• What are the things you do not enjoy about your job? 
Group 2 (Background – Shop) 
• Tell me about who else works at this chemist  
o Probe: what are their roles and how are they different from yours? 
• Describe how the chemist shop is organized? 
• When are you busiest? 
o Probe: opening hours 
Group 3 (Family planning) 
• Tell me about the family planning in this chemist shop 
o Probe: what kinds are available, most popular, price 
• Tell me about the kinds of people from the community who buy these family planning 
o Probe: Describe them, what they are looking for 
• Why are chemist shops like yours important in providing family planning to the community? 
o Probe: How is this job different from health facilities that also have family planning? 
• If a young person comes in asking for family planning, what are some of things you look at that 
help you decide what to recommend?  
• What are the rules for dispensing family planning? 
o Probe: are there any exceptions to these rules? 
• Describe the kinds training (either from your boss or from previous training) you received about 
family planning? 
Group 4 (Feelings about selling family planning to young people) 
• Think about the last time that a young person (18-24) came to this chemist for family planning. 
Can you describe the interaction, from beginning to end? 
o Probe: what happens, what would they say, what would you say, what do you give 
them? 
• How do young customers feel coming to ask for family planning (Probe:  what do they say)?  
• What could chemist shops like this one do to improve the comfort of young people in the 
community who need family planning? 
• When a young customer comes in asking for family planning, how do you feel?  
o Are things you would like to tell them? 
• If you had the power, what would you do to improve the confidence of chemists to provide 
family planning to young people?  
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 Mystery Shopper Checklist (injection shopper) 
Please select today's date 
yyyy-mm-dd 
 
What time did you enter the chemist? 
hh:mm 
 
What time did you exit the chemist? 
hh:mm 
 
What is the name of this chemist shop? 
[Selects from drop-down list of mapped pharmacies] 
 
Were you offered the chance to buy the injection? 
Yes 
No 
 
If no, why were you refused? 
Didn't have FP card/prescription 
Didn't have injection in stock 
Other 
If other, describe: 
 
Were you told by the person who helped you that it was possible that HE/SHE could inject you in the 
shop? 
Yes 
No 
 
If you were told injection in the chemist shop was impossible, what were you told? [can select more 
than one] 
Person said they were not allowed to give injection themselves 
Referred to another individual qualified to give injections 
Referred to a clinic/office qualified to give injections 
Other 
If other, describe: 
 
Describe the person who helped you and the environment of the chemist 
1a. What was their gender? 
Female 
Male 
 
1b. What was their approximate age? 
Aged 20 or younger 
21-30 
31-40 
41-50 
Aged 50+ 
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2. Where in the chemist shop were you helped? 
_______________________________ 
 
3. Did that location provide privacy for your interaction? 
Yes 
No 
 
4. Were there other people working in the chemist when you visited? 
Yes 
No 
 
5. Were there other customers in the chemist when you visited? 
Yes 
No 
 
5b. Do you feel like you had privacy from the other chemists or customers during your interaction? 
Yes 
No 
 
Describe the interaction 
 
6. Were you asked any questions about your use of injection? 
Yes 
No 
 
7. Did they ask these questions before or after you were offered the injection? 
before 
after 
 
8. Did they ask: 
a. to see your TCA? 
Yes 
No 
 
b. whether you had used injection before? 
Yes 
No 
 
c. the date of your last injection? 
Yes 
No 
 
d. where you received your previous injection 
Yes 
No 
 
e. whether you had experienced (or were experiencing) any side effects? 
Yes 
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No 
 
9. Were you asked any questions about YOURSELF or YOUR HUSBAND? 
Yes 
No 
 
9b. Did they ask these questions before or after you were offered the injection? 
before 
after 
 
10. Did they ask: 
a. Your age? 
Yes 
No 
 
b. Your marital/relationship status? 
Yes 
No 
 
c. Whether you had discussed use with your husband? 
Yes 
No 
 
d. Whether you had any children? 
Yes 
No 
 
11. Did the person react (do or say something) to any of the information you told him/her? 
Did he/she make you feel that something you said affected the way s/he treated you? 
Yes 
No 
If yes, describe the reaction: 
How did he/she react? What did he/she do or say? Were you lectured? 
 
___________  
 
12. Did the chemist give you any information about the injection? 
Yes 
No 
 
12b. Did they give you this information before or after you were offered the injection? 
before 
after 
 
13. Did they tell you: 
a. instructions on when you needed to return for another injection? 
Yes 
No 
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b. side effects you might expect? 
Yes 
No 
c. that this did not protect you against HIV/STIs? 
Yes 
No 
d. Any differences between injection brands? 
For example, differences in costs, how long injection lasts, etc 
Yes 
No 
 
Briefly describe any key differences 
_____________ 
 
14. Did they recommend another FP method, or that you go to a health centre? 
Yes 
No 
 
If yes, what method/where were you referred? 
_____________ 
 
Describe the QUALITY of the interaction 
15. Approximately how many minutes did you speak with the person who helped you? 
_____________ 
 
16. Did the person who helped you seem like they were in a hurry to finish with you? 
Did they seem rushed or give you their undivided attention? 
Yes 
No 
 
17. How friendly or approachable was the person who helped you? 
1 very unfriendly 2 3 4 5 very friendly 
 
Briefly describe 
_______________ 
 
18. How knowledgeable did the person who helped you appear to be about family planning? 
1 not knowledgeable at all 2 3 4 5 extremely knowledgeable 
Briefly describe 
_______________ 
 
19. How private was the interaction? 
1 not private at all 2 3 4 5 very private 
Briefly describe 
________________ 
 
20. How comfortable did the person who helped you seem? 
1 very uncomfortable 2 3 4 5 very comfortable 
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Briefly describe 
_______________ 
 
21. Did the person who helped you do or say anything that was particularly helpful or nice? 
_______________ 
 
22. Did the person who helped you say or do anything that was particularly NOT helpful or NOT nice? 
_______________ 
 
23. How satisfied are you with the overall service? 
1 very unsatisfied 2 3 4 5 very satisfied 
Briefly describe 
________________ 
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 Survey Instrument (Excerpt) 
SOCIO-DEMOGRAPHIC INFORMATION. First, we’re going to talk about who you are. 
1. What is your sex? Mark ONLY ONE. 
 
0 Male 
1 Female 
 
2. What is your birthdate?   
Day |__|__| Month |__|__|  Year |__|__|__|__| 
 
3. What is the highest level of school you attended? Mark ONLY ONE. 
0 I’ve never gone to school 
1 Primary school  
2 Secondary school  
3 Post-secondary education – GO TO 5 
 
4. What is the highest grade you completed at that level?  
 |__|__| grade/form/level – GO TO 6 
 
5. What type of post-secondary education did you attend/are you attending? Mark ONLY ONE. 
1 Technical post-secondary education 
2 University education 
 
6. Who do you currently live with? Mark ALL possible options. 
0 I live alone 
1 Father/stepfather 
2 Mother/stepmother 
3 Siblings 
4 Grandparents 
5 Other relatives 
6 Husband or wife – NOTE: Be sure to ask whether husband/wife or cohabiting partner. 
7 Cohabiting partner 
8 In-laws 
9 Children  
10 Friends 
 
7. What is your current relationship status? 
0 Single 
1 Friends with benefits 
2 Dating 
3 Cohabiting 
4 Engaged 
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5 Married 
6 Other (specify) 
 
8. How many children do you have?  
0  I have no children – GO TO 10 
|__|__| child/children  
 
9. How old were you when you had your first child? 
 |__|__| years old  
… 
[SURVEY CONTINUES] 
Now we’re going to talk about sexual activity to gain a better understanding of some important life 
issues. Let me assure you again that your answers are completely confidential and will not be told to 
anyone.  
29. How old were you when you had sexual intercourse for the very first time? 
 |__|__| years old  
 
 0 I have never had sexual intercourse – GO TO 46 
 
30. Have you ever used any method to prevent pregnancy? By use, I mean that either you, yourself, 
have used the method or that a partner of yours used the method when having sex with you. 
 YES ..........................................................1  
NO............................................................0  
DON’T KNOW.............................................8  
REFUSED ..................................................9 
 
31. When was the last time you had sex? 
 
 |__|__| days ago 
 
 |__|__| weeks ago 
 
 |__|__| months ago 
 
 |__|__| years ago 
 
32. The last time you had sex, what was your relationship to this person with whom you had sexual 
intercourse? 
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1 Boyfriend not living with respondent 
2 Girlfriend not living with respondent 
3 Male cohabiting partner 
4 Female cohabiting partner 
5 Husband 
6 Wife 
7 Male casual acquaintance 
8 Female casual acquaintance 
9 Male sex worker 
10 Female sex worker 
11 Female client (respondent is male sex worker) 
12 Male client (respondent is female sex worker) 
13 Male relative  
14 Female relative 
 
33. The last time you had sex, did you or your partner use a contraceptive method? 
0 No – GO TO 45 
1 Yes 
 
34. The last time you had sex, which contraceptive method did you or your partner use? 
1 Male condom 
2 Female condom 
3 Birth control pill 
4 Injectable 
5 Implant 
6 Intrauterine device (IUD) 
7 Emergency contraception (the morning after pill) 
8 Female sterilization 
9 Male sterilization (vasectomy) 
a. Withdrawal – GO TO 44 
10 Rhythm method – GO TO 44 
 
35. The last time you had sex, where did you or your partner obtain the contraceptive method you 
used? 
1 A pharmacy or chemist 
2 County Hospital 
3 Health centres 
4 A NGO  
5 A private doctor or clinic 
6 A shop/market 
7 A community-based distributor 
8 A peer educator 
9 A traditional healer – GO TO 44 
10 A friend or relative – GO TO 44 
11 A partner – GO TO 44 
12 Other – GO TO 44 
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36. When you obtained your [MOST RECENT CONTRACEPTIVE METHOD], were you told by the 
provider about side effects of problems you might have with a method to delay or avoid getting 
pregnant? 
1 Yes 
2 No 
37. Were you told what to do if you experienced side effects or problems? 
1 Yes 
2 No 
 
38. At that time, were you told by the family planning provider about methods of family planning 
other than [MOST RECENT CONTRACEPTIVE METHOD] that you could use? 
1 Yes 
2 No 
 
39. During that visit did you obtain the method you wanted to delay or avoid getting pregnant? 
1 Yes – GO TO 42  
2 No 
 
40. Why didn’t you obtain the method you wanted? 
1 Method out of stock that day 
2 Method not available at all  
3 Provider not trained to provide the method 
4 Provider recommended a different method 
5 Not eligible for method 
6 Decided not to adopt a method 
7 Too costly 
8 Other 
 
41. During that visit who made the final decision about what method you got? 
1 You alone 
2 Provider 
3 Partner 
4 You and provider 
5 You and partner 
6 Other 
 
42. Would you return to this provider? 
1 Yes 
2 No 
 
43. Would you refer your relative or friend to this provider/facility? 
1 Yes 
2 No 
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44. How important were each of the following characteristics to you in deciding which birth control 
method to use? (read item, asking) Would you say: not at all important, slightly important, quite 
important or extremely important to you in choosing a method? 
 Not at all 
important 
Slightly 
important 
Quite 
important 
Extremely 
important 
A. It is very effective at preventing pregnancy 
 
    
 
B. It has a low cost. 
 
    
C. It is easy to use. 
  
    
D. It doesn’t contain hormones. 
 
    
E. It is acceptable to my partner 
F. It doesn’t interrupt sex. 
 
    
 
G. It is effective at preventing HIV or STIs. 
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10.2 Appendix 2: Mystery Shopper Personas  
Script for mystery shoppers in pharmacy study in Kenya (adapted from Dawn Quin-Chee(Chin-Quee et 
al., 2006)) 
There will be two male and two female mystery shoppers. One male and one female will present as 
youth in need of emergency contraception (epills). One female will present as a married young person in 
need of an injection refill. One male will purchase a condom. 
Mystery shoppers will always dress in the same manner when visiting various pharmacies. They should 
not wear, for example, work apparel on one occasion and casual wear on the next.  The idea is to 
present the same information to all pharmacists, keeping visual characteristics consistent. In that 
manner, preconceived notions or first-impression biases should not vary across pharmacists due solely 
to inconsistent appearance or demeanour of mystery shoppers. 
The chemist - if s/he decides to provide assistance – may ask the mystery shopper questions. The 
mystery shopper can respond based on their profile. 
Mystery Shopper Profiles 
1. ECP shopper female  
Asha, 22 years old, student. Had sex with boyfriend two days ago. They used a condom, but it burst. This 
is her first time using ECP. She does not know her boyfriend’s HIV status, but is only worried about 
pregnancy, not HIV/STIs. Has 100 Kenyan shillings to purchase ECP (if more expensive, she will ‘return 
later with more money’). 
2. Injection – female 
Natsha, 24 years old, newly married. She is timid: her husband and family do not know she is using 
injection. She does not have children, but wants them in future. She is using contraception because she 
thinks her husband can’t provide for a family, financially. She received her first injection from a health 
clinic three months ago, is overdue but within the bounds to get Depo-Provera shot again. She will 
inquire as to the cost of the injection and promise to ‘return later with money’ 
3. ECP shopper – male 
Kevin, 21 years old, student. Has a girlfriend but doesn’t use a condom during sex because ‘he trusts 
her’. They use ECP instead. He is purchasing ECP on his girlfriend’s behalf and does not know the 
instructions for use. He has 100 Kenyan shillings to purchase ECP (if more expensive, he will ‘return later 
with more money’).  
4. Condom – male 
Swaleh, 19 years old, secondary school graduate. Single, known as a ‘hit and run’ (someone who has sex 
with many women, but does not date them). He is going to a party in the evening, and wants to 
purchase condoms in advance. Knows about HIV/STIs but more worried about pregnancy. Has 50 
Kenyan shillings to purchase condoms (if more expensive, he will ‘return later with more money’). 
